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Background: There is limited evidence about the effectiveness of rehabilitation in meeting the longer-term
needs of stroke patients and their carers.
Objective: To determine the clinical effectiveness and cost-effectiveness of an extended stroke rehabilitation
service (EXTRAS).
Design: A pragmatic, observer-blind, parallel-group, multicentre randomised controlled trial with embedded
health economic and process evaluations. Participants were randomised (1 : 1) to receive EXTRAS or usual care.
Setting: Nineteen NHS study centres.
Participants: Patients with a new stroke who received early supported discharge and their informal carers.
Interventions: Five EXTRAS reviews provided by an early supported discharge team member between 1 and
18 months post early supported discharge, usually over the telephone. Reviewers assessed rehabilitation needs,
with goal-setting and action-planning. Control treatment was usual care post early supported discharge.
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Main outcome measures: The primary outcome was performance in extended activities of daily living
(Nottingham Extended Activities of Daily Living Scale) at 24 months post randomisation. Secondary
outcomes at 12 and 24 months included patient mood (Hospital Anxiety and Depression Scale), health status
(Oxford Handicap Scale), experience of services and adverse events. For carers, secondary outcomes included
carers’ strain (Caregiver Strain Index) and experience of services. Cost-effectiveness was estimated using
resource utilisation costs (adaptation of the Client Service Receipt Inventory) and quality-adjusted life-years.
Results: A total of 573 patients (EXTRAS, n = 285; usual care, n = 288) with 194 carers (EXTRAS, n = 103;
usual care, n = 91) were randomised. Mean 24-month Nottingham Extended Activities of Daily Living Scale
scores were 40.0 (standard deviation 18.1) for EXTRAS (n = 219) and 37.2 (standard deviation 18.5) for
usual care (n = 231), giving an adjusted mean difference of 1.8 (95% confidence interval –0.7 to 4.2). The
mean intervention group Hospital Anxiety and Depression Scale scores were not significantly different at
12 and 24 months. The intervention did not improve patient health status or carer strain. EXTRAS patients
and carers reported greater satisfaction with some aspects of care. The mean cost of resource utilisation
was lower in the intervention group: –£311 (95% confidence interval –£3292 to £2787), with a 68%
chance of EXTRAS being cost-saving. EXTRAS was associated with 0.07 (95% confidence interval 0.01 to
0.12) additional quality-adjusted life-years. At current conventional thresholds of willingness to pay for a
quality-adjusted life-year, there is a 90% chance that EXTRAS is cost-effective.
Conclusions: EXTRAS did not improve stroke survivors’ performance in extended activities of daily living
but did improve their overall satisfaction with services. Given the impact on costs and quality-adjusted
life-years, there is a high chance that EXTRAS could be considered cost-effective.
Future work: Further research is required to identify whether or not community-based interventions
can improve performance of extended activities of daily living, and to understand the improvements in
health-related quality of life and costs seen by provision of intermittent longer-term specialist review.
Trial registration: Current Controlled Trials ISRCTN45203373.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 24.
See the NIHR Journals Library website for further project information.
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Plain English summary
Early supported discharge enables stroke patients with mild or moderate disability to be dischargedearlier than usual from hospital to continue rehabilitation at home. Randomised controlled trials have
demonstrated that early supported discharge leads to increased independence for stroke survivors, and
that early supported discharge is cost-effective.
Early supported discharge is usually provided for up to 6 weeks and patients with ongoing physical,
psychological or social needs are then referred to other services. In the UK, provision of longer-term
rehabilitation is often limited. Lack of research evidence has meant that service development in this aspect
of stroke care has lagged behind service development for acute care.
This clinical trial evaluated an extended stroke rehabilitation service (EXTRAS) that started when early
supported discharge ended. Stroke survivors and their carers were randomly assigned to receive EXTRAS
or usual NHS care. EXTRAS involved five rehabilitation reviews conducted over 18 months by an early
supported discharge team member, usually over the telephone. Each review consisted of an assessment of
current needs, goal-setting and action-planning, and sought to improve patients’ abilities and confidence
to undertake extended activities of daily living (mobility, kitchen and domestic tasks, and leisure activities).
There were no specific assessments or actions for carers but it was important to evaluate the impact that
the new service had on carers. Patients and carers were followed up for 2 years and information was
collected about their activities, mood, quality of life and services received.
EXTRAS did not improve stroke survivors’ performance in extended activities of daily living. However,
patients who received EXTRAS reported less anxiety and less depression than those who received usual
care, and patients and carers were more satisfied with some aspects of their care. EXTRAS did not improve
carers’ quality of life or stress. Health economic analyses suggest that EXTRAS improved patients’ quality of
life and may be good value for money. Further research is needed to identify other treatments to address
the longer-term consequences of stroke.
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Scientific summary
Background
Around two-thirds of stroke survivors leave hospital with disability; some make a full recovery, whereas for
others stroke is a long-term condition. Stroke is the most common cause of complex disability in the UK,
affecting over 1.2 million people. Owing to an ageing population, the number of stroke survivors living
with disability is expected to increase by one-third by 2035.
Stroke units and early supported discharge services have been shown to be both clinically effective and
cost-effective and are the cornerstones of ‘organised stroke care’. Their key features are multidisciplinary
stroke specialist expertise, regular review, co-ordination of care, and active patient and carer involvement.
However, after patients leave early supported discharge, there is limited evidence to guide rehabilitation to
optimise recovery and meet the longer-term needs of stroke patients and their carers.
Rehabilitation is a broad term that encompasses focused interventions for specific impairments through to
complex care processes that involve teams of health-care professionals delivering a package of interventions.
Different types of interventions and services that seek to improve long-term outcomes post stroke have been
evaluated (e.g. stroke support workers), but results have been mixed and have not provided sufficient evidence
of clinical effectiveness or cost-effectiveness to support further investment in community stroke services.
This research project evaluated an extended stroke rehabilitation service (EXTRAS). EXTRAS sought to help
individuals to maximise their recovery and/or adjust to residual disability in the context of their day-to-day
activities through intermittent assessment, goal-setting and action-planning, with referral if required. Both
stroke survivors and their carers were included in the study. EXTRAS did not include any assessment of carer
needs or specific interventions for carers, but it was important to evaluate how a new service may affect
carers. EXTRAS was delivered by early supported discharge teams and provided continuation of specialist
stroke care beyond early supported discharge.
Aim and objectives
The aim of the EXTRAS trial was to determine the clinical effectiveness and cost-effectiveness of an
extended stroke rehabilitation service.
The objectives were to:
l determine whether or not EXTRAS improved patient outcomes
l determine whether or not EXTRAS improved carer outcomes
l determine the cost-effectiveness of EXTRAS
l document how EXTRAS was implemented and delivered in different settings
l seek the views and experiences of patients, carers and rehabilitation staff about the community
rehabilitation that they received or provided
l explore the impact of the severity of activity limitation, pre-stroke health status and comorbidity on the
effectiveness of the intervention.
Methods
This study was a pragmatic, observer-blind, parallel-group, multicentre randomised controlled trial with
health economic and process evaluations.
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Setting
The study was conducted in 19 NHS study centres.
Participants
Adults with a new stroke (first ever or recurrent) were eligible to take part if they received early supported
discharge care and were able to participate in a rehabilitation programme focusing on extended activities
of daily living. We also sought to recruit informal carers (the main family member or friend) who provided
support after the stroke.
Randomisation
Randomisation to a study group took place at discharge from early supported discharge services and was
conducted by NHS staff at participating study centres using an online web-based service. Stratification
was by study centre and permuted block sequences assigned participants to the intervention or control
group in a 1 : 1 ratio.
Study intervention treatment
EXTRAS consisted of five rehabilitation reviews conducted at 1, 3, 6, 12 and 18 months post discharge
from early supported discharge services. Reviews were conducted by a senior member of the early
supported discharge team, usually by telephone, and covered issues identified in a national survey of
patient needs and other literature, and by clinicians, patients and carers. These issues were mobility;
personal care; mealtimes; domestic activities; work and volunteering; hobbies and interests; driving and
transport; communication; memory and concentration; mood, anxiety and depression; medical issues; pain;
and other issues. The patient’s progress was assessed along with their current rehabilitation needs and
service provision. Rehabilitation goals were agreed and an action plan was made at each review. Action
plans could include verbal advice and encouragement; discussion with services currently involved in the
patient’s care; signposting to local activities, community services or voluntary services; and referral to stroke
services, rehabilitation services or primary care.
Study control treatment
Patients randomised to the control group received usual NHS care. Following completion of early
supported discharge, patients who had ongoing rehabilitation needs received standard care for that
locality according to clinical judgement, including referral to a range of available services (e.g.
neurorehabilitation teams, day hospital and community rehabilitation services).
Data collection and outcome measures
For patients, data concerning demography and stroke details were collected, and baseline measurements
for (1) performance in extended activities of daily living (Nottingham Extended Activities of Daily Living
Scale), (2) health status (Oxford Handicap Scale), (3) mood (Hospital Anxiety and Depression Scale) and
(4) health-related quality of life [EuroQol-5 Dimensions, five-level version (EQ-5D-5L)] were obtained by
face-to-face assessment prior to randomisation. Carers completed a baseline questionnaire that captured
demographic data, carer stress (Caregiver Strain Index) and health-related quality of life (EQ-5D-5L).
Outcome data were collected at 12 and 24 months post randomisation. For patients, in addition to the
measurement scales listed above, an experience of services survey (designed by Northumbria Healthcare
NHS Foundation Trust based on Picker Institute questions), the resource utilisation data (adaption of the
Client Service Receipt Inventory) and adverse events data were collected. A telephone interview was the
intended method for outcome assessments but face-to-face visits and postal questionnaires could also
be used. Carers completed a postal questionnaire that recorded carer stress (Caregiver Strain Index),
health-related quality of life (EQ-5D-5L) and experiences of services using the survey described above.
Owing to the nature of the intervention, the patients, carers and staff providing EXTRAS could not be
blinded to the study group. However, outcome data were intended to be collected by a blinded researcher
and any unblinding (e.g. as a result of a participant revealing the study group) was recorded.
SCIENTIFIC SUMMARY
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Sample size
The primary outcome was the Nottingham Extended Activities of Daily Living Scale. To provide 90% power
to detect a clinically important difference of 6 points on the Nottingham Extended Activities of Daily Living
Scale (scored 0–66, standard deviation 18), 382 patients split equally between the intervention and control
groups were required. Based on other stroke rehabilitation studies, it was estimated that there could be up
to 25% attrition between randomisation and 24 months. To allow for this, 510 patients were required to
be randomised.
Statistical analysis
Mean scores on the Nottingham Extended Activities of Daily Living Scale (the primary outcome) were
compared at 24 months between the intervention and control groups using multiple linear regression,
including terms for centre, baseline Oxford Handicap Scale, age and sex. The Oxford Handicap Scale was
analysed using ordinal regression, adjusting for the same covariates as the primary analysis. The Hospital
Anxiety and Depression Scale and Caregiver Strain Index were analysed using multiple linear regression
adjusting for appropriate covariates. For the experience of services survey, responses were dichotomised as
‘in agreement or not’ or ‘satisfied or not’, and differences in proportions were calculated with 95%
confidence intervals.
Health economic analysis
Responses to the EQ-5D-5L were mapped to utility values and combined with observed mortality to create
quality-adjusted life-years. NHS and social care resources used by participants in each study group
were collected using an adaption of the Client Service Receipt Inventory, and costs of the intervention
were based on the time spent with each participant. Cost and quality-adjusted life-year differences were
estimated using appropriate generalised linear models and uncertainty quantified by random sampling
with replacement.
Process evaluation
The process evaluation used quantitative and qualitative methods to (1) document how EXTRAS was
implemented and delivered in different settings, (2) seek the views and experiences of patients and carers
about the rehabilitation services they received, and (3) seek the views and experiences of early supported
discharge teams and community rehabilitation staff about the services provided to intervention and
control groups.
Results
A total of 573 patients with 194 carers were randomised to a study group between January 2013 and
October 2015 (EXTRAS: patients, n = 285, carers, n = 103; usual care: patients, n = 288, carers, n = 91).
Study groups were well matched at baseline. Most patients had suffered a first ischaemic stroke; the
median time from stroke to randomisation was 72 days. The majority of carers were female and the
spouse/partner of the patient. At 24 months, outcome data were available for 450 out of 573 (78%)
patients and 153 out of 194 (79%) carers.
Primary outcome
There was no significant difference between the groups for the primary outcome. The mean Nottingham
Extended Activities of Daily Living Scale score (range 0–66) at 24 months was 40.0 (standard deviation 18.1)
in the intervention group and 37.2 (standard deviation 18.5) in the control group, an adjusted mean
difference of 1.8 (95% confidence interval 0.7 to 4.2).
Secondary outcomes
The Nottingham Extended Activities of Daily Living Scale scores at 12 months were similar to those at
24 months, with no significant difference between study groups.
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For health status, measured using the Oxford Handicap Scale at 24 months, the odds of the intervention
group being in worse (instead of better) health was 0.7 times as high as that for control patients (95%
confidence interval 0.5 to 1.0), which was not significantly different from equal odds in both groups.
The comparison at 12 months was similar.
The mean anxiety and depression Hospital Anxiety and Depression Scale scores were lower for patients in
the intervention group at 12 and 24 months, but the 95% confidence intervals for the difference in scores
included zero.
No association was found between the effectiveness of the intervention and the pre-stroke Oxford Handicap
Scale score, the baseline Nottingham Extended Activities of Daily Living Scale score and the time in organised
stroke care (defined as time as an inpatient plus time in early supported discharge), which were prespecified
exploratory analyses.
For 4 of the 19 aspects of care examined in the patients’ experience of services survey at 24 months, the
95% confidence interval for the differences in the percentage of ‘in agreement’ or ‘satisfied’ between the
groups did not cover the value zero. These were ‘staff treated you with dignity and respect’, ‘staff met
your needs’, ‘overall satisfaction’ and ‘help with mobility’.
Serious adverse events were reported for 125 out of 285 (44%) patients in the intervention group (total
250 events) and 130 out of 288 (45%) patients in the control group (total 254 events). These medical
events were predominantly admissions to hospital and none were believed to be related to EXTRAS.
For carers, there were no significant differences between the groups for carer stress measured by the
Caregiver Strain Index or for quality-adjusted life-years. For the experience of services survey with 19 aspects,
at 24 months a significantly higher proportion of carers reported that they were ‘in agreement’ or ‘satisfied’
with ‘overall satisfaction with services your friend/relative received’ and ‘help with mobility’.
Post hoc analysis
A post hoc analysis of the Hospital Anxiety and Depression Scale case versus non-case at standard clinical
thresholds found that there were significantly fewer cases of depression at 12 months in the intervention
group (29% intervention group vs. 40% control group; adjusted odds ratio 0.59, 95% confidence interval
0.39 to 0.90) and significantly fewer cases of anxiety at 24 months (28% intervention group vs. 38%
control group; adjusted odds ratio 0.64, 95% confidence interval 0.41 to 0.99).
Health economic evaluation
Patients who were randomised to receive EXTRAS gained, on average, 0.07 additional quality-adjusted
life-years (95% confidence interval 0.01 to 0.12). The mean cost of resource utilisation was lower in the
intervention group at –£311 (95% confidence interval –£3292 to £2787), with a 68% chance of EXTRAS
being cost saving. The changing resource use pattern suggests that it is likely that additional costs to
health services were offset by savings in social care. At the current standard willingness to pay of £20,000
per quality-adjusted life-year, there is a 90% probability that EXTRAS is cost-effective for the NHS.
Process evaluation
Depending on time point, between 91% (1-month review) and 81% (12-month review) of the expected
EXTRAS reviews were undertaken. Health-care professionals conducting the reviews included physiotherapists
(56% of reviews), occupational therapists (28%) and nurses (8%). The majority of reviews were undertaken
by telephone, as intended. Mobility and hobbies and interests were the most commonly selected topics for
goals. Action plans predominantly featured telephone advice from the reviewer with related actions for the
patient and/or carer to carry out. Very few new referrals were made to health or social services.
A total of 20 patients, 6 carers and 41 NHS staff took part in semistructured interviews. Patient and carer
interviews were conducted after the 24-month outcome assessment was completed, that is 6 months after
SCIENTIFIC SUMMARY
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the last EXTRAS review. Most patients and carers did not have a detailed recollection of EXTRAS reviews
but those who did reported that they were helpful in terms of providing regular contact and the relevance
of the advice given. Staff felt that the advice and approach to self-management was likely to improve
patient confidence, well-being and emotional health, but they felt that the intervention was unlikely to
have an impact on performance in extended activities of daily living as it did not involve direct supervision
of the patient practising activities.
Conclusion
EXTRAS did not improve stroke survivors’ performance in extended activities of daily living. The lack of
effect on the primary outcome is likely to be a result of the concept of the intervention rather than the
fidelity of the intervention. However, EXTRAS provided more quality-adjusted life-years and was associated
with lower costs. In addition, patients and carers in the intervention group were more satisfied with
aspects of their overall care. EXTRAS did not improve patients’ health status or carers’ quality of life or
stress. A post hoc finding was that the intervention group had fewer cases of anxiety and depression than
those who received usual care.
Given the impact on costs and quality-adjusted life-years, there is a high chance that EXTRAS could be
considered cost-effective at conventional thresholds of the NHS/UK society’s willingness to pay for a
quality-adjusted life-year (currently £20,000 per quality-adjusted life-year), despite there being no
difference in the primary outcome.
Implications for health care
The decision-makers will probably be most interested in the finding that, although there is no evidence
of any treatment effect on the primary outcome, the estimated cost-effectiveness analysis is consistent
with EXTRAS being associated with cost saving and quality-of-life gain. Another consideration for
decision-makers is that cost savings were predominantly made in social care rather than health services.
Our findings suggest that EXTRAS may be an affordable addition to improve stroke care.
Implications for research
The EXTRAS trial has demonstrated that a large multicentre trial to evaluate a new innovative community
stroke service is achievable. Multicentre trials evaluating community stroke services are rare and there
remains a need to develop and evaluate different approaches to addressing the wide range of long-term
needs of stroke survivors and carers and improving physical, psychological and quality-of-life outcomes.
In particular, further research is required to identify whether or not longer-term community-based
interventions tailored to the individual needs of stroke survivors can improve performance of extended
activities of daily living, and to understand the mechanisms by which health-related quality of life is
improved and costs are reduced by provision of intermittent longer-term specialist review.
Trial registration
This trial is registered as ISRCTN45203373.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 24.
See the NIHR Journals Library website for further project information.
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Chapter 1 Introduction
Some parts of this report are based on Rodgers et al.1 © 2019 The Authors. Stroke is published onbehalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access
article under the terms of the Creative Commons Attribution License, which permits use, distribution,
and reproduction in any medium, provided that the original work is properly cited. In 2010, the National
Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme identified the need
to evaluate the clinical effectiveness and cost-effectiveness of rehabilitation interventions that aimed to
improve ability to perform extended activities of daily living (EADL) in the longer term after stroke. EADL
include mobility, housework, hobbies and leisure interests.2 This report describes findings of the research
commissioned for this evaluation.
Problems after stroke
In the UK, approximately 113,000 strokes currently occur per year.3 Although the incidence of stroke has
fallen, survival rates have improved and the prevalence of stroke has increased.4 At present, there are over
1.2 million stroke survivors living in the UK.5
The effects of stroke are diverse and, despite recent improvements in acute treatments (e.g. stroke unit care,
thrombolysis and thrombectomy), currently around two-thirds of survivors leave hospital with a disability.5
Some people will make a full recovery but for others disabilities persist long term.6,7 At the time of planning
this research project in 2010, a national survey of stroke survivors more than 1 year after stroke had shown
that nearly half of respondents reported unmet needs in relation to issues such as personal care, mobility,
emotional problems and leisure activities.8,9 Later work continues to report similar findings.10–12 Stroke
survivors, carers and health-care professionals are repeatedly requesting that this situation is improved.
Rehabilitation after stroke
Rehabilitation is a broad term that encompasses specific interventions to target specific issues (e.g. robot-
assisted training for upper limb function) through to complex care systems that involve teams of health-care
professionals delivering a package of interventions.13
It is well established that hospital stroke unit care and early supported discharge (ESD) services are both
effective and cost-effective ways to improve patient outcomes following stroke.14,15 The ESD services provide
ongoing rehabilitation in a patient’s own home following the period of stroke unit care. They enable patients
to leave hospital earlier than would be possible without such a service.
Stroke units and the ESD services are referred to as ‘organised stroke care’ and their key features are
multidisciplinary stroke specialist expertise and co-ordination of care.16,17 The National Clinical Guideline
for Stroke recommends specialist stroke unit care for the duration of the inpatient stay unless stroke is not
the main illness.16 In 2016/17, 83.8% of patients spent at least 90% of their stay In a stroke unit.18 ESD is
recommended for patients with mild to moderate disability16 and in 2016 81% of stroke units had access
to an ESD service.19
Evidence and guidelines also continue to grow about specific rehabilitation interventions for different
problems after stroke.13,16,20 However, most research to date has focused on the acute and subacute
phases of stroke, and there is less evidence to guide rehabilitation in the longer term following stroke.16
When planning this research project, several publications were noting this lack of evidence for longer-term
rehabilitation and the need for further research.21,22
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A 2008 Cochrane review of therapy-based rehabilitation services for patients living at home > 1 year
after stroke found only five trials suitable for inclusion and reported that there was inconclusive evidence
about whether or not these services improved patient outcomes.21 Although a 2010 Cochrane review of
community stroke liaison workers reported that there was no evidence that this intervention could improve
outcomes for all stroke patients, it showed that people with milder disability had a reduction in death and
dependence.23 Another Cochrane review, which included 14 trials of non-ESD therapy-based rehabilitation
services, which were provided at home for patients within 1 year of stroke, reported that these services
decreased the odds of a poor outcome (defined as death or deterioration in ability to perform activities
of daily living) and had a beneficial effect on performance of activities of daily living.24 However, most of
the services included in this review commenced soon after discharge rather than later after stroke.
Probably in part a result of the lack of evidence of the effectiveness of rehabilitation in the longer term
after stroke, at the time of planning this research project, it was recognised that provision of longer-term
services for stroke patients was limited and varied across the UK.25 Following discharge from ESD services,
the concept of ‘organised stroke care’ disappears and patients who have ongoing rehabilitation needs may
be referred to a range of services, if available (e.g. neurorehabilitation teams, day hospital and community
rehabilitation services). Reports from both the National Audit Office and Care Quality Commission
highlighted that the longer-term care after stroke needed to be improved.22,25
The literature about interventions to improve longer-term outcomes after stroke has of course expanded
since 2010; however, the evidence is still mixed. For example, a 2014 review of several specific physical
therapy interventions concluded that those involving repetitive task practice improved outcomes, including
outcomes for patients later after stroke.26 A 2015 Cochrane review that examined interventions that aimed
to improve ambulation in the community reported that there was insufficient evidence to determine if these
interventions were beneficial.27 A review examining the effect of physiotherapy interventions that aimed to
improve mobility or independence in activities of daily living in patients at least 6 months after stroke showed
a significant improvement in mobility but no improvement in independence in activities of daily living.28 A
2016 Cochrane review of self-management programmes for stroke survivors living in the community found
that these interventions led to improved quality of life, but not to improvements in activities of daily living or
mood.29 A large cluster randomised controlled trial published in 2015 evaluated a system of Longer-Term
Stroke (LoTS) care in which stroke care co-ordinators, who were community-based health-care professionals
with experience in stroke care, were trained to follow a structured assessment and treatment plan working
with patients and carers after discharge from hospital (29 centres, 800 patients, 208 carers).30 Follow-up was
at 6 months and 12 months following patient recruitment, and included assessment of quality of life and
performance in EADL. Neither patients nor carers in the intervention group had improved outcomes
compared with usual care.
Although improvements in stroke services have taken place since this research was commissioned,18
the evidence base supporting longer-term rehabilitation is still limited and post acute stroke care
remains variable.31
The EXTRAS trial
This research project has evaluated an extended stroke rehabilitation service (EXTRAS). The service
consisted of five rehabilitation reviews conducted at 1, 3, 6, 12 and 18 months post discharge from
ESD services. Reviews were undertaken by senior members of ESD teams and consisted of a structured
assessment of rehabilitation needs, goal-setting and action-planning. Reviews covered mobility; personal
care; mealtimes; domestic activities; work and volunteering; hobbies and interests; driving and transport,
communication; memory and concentration; mood, anxiety and depression; medical issues; pain and other
issues. Both stroke patients and their carers were included in the study and outcomes were assessed at
12 and 24 months post randomisation. Although EXTRAS did not include any assessment of carer needs or
specific interventions for carers, we hypothesised that the new service may also influence carer outcomes.
INTRODUCTION
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An evaluation of a longer-term stroke specialist service was undertaken because of the strong evidence
showing that stroke units and ESD services improve patient outcomes and are cost-effective. If EXTRAS
is effective and affordable, it could extend ‘organised stroke care’ and improve longer-term outcomes
after stroke.
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Chapter 2 Methods
Parts of this chapter have been reproduced from Rodgers et al.32 © 2015 Crown copyright; licenseeBioMed Central. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly credited. The Creative Commons
Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data
made available in this article, unless otherwise stated.
Study aim and objectives
1. Aim
To determine the clinical effectiveness and cost-effectiveness of an extended stroke rehabilitation service
(EXTRAS).
2. Objectives
l To determine whether and extended stroke rehabilitation service (intervention) improved patient
outcomes compared to usual care (control). The primary outcome was extended activities of daily living
at 24 months following randomisation. Secondary outcomes were health status, quality of life, mood
and experience of services (12 and 24 months following randomisation).
l To determine whether an extended stroke rehabilitation service improved carer outcomes compared
to usual care. Outcomes were quality of life, carer stress, experience of services (12 and 24 months
following randomisation).
l To determine the cost-effectiveness of an extended stroke rehabilitation service.
l To document how the extended stroke rehabilitation service was implemented and delivered in
different settings.
l To seek the views and experiences of patients, carers and rehabilitation staff about the community
rehabilitation that they received or provided.
l To explore the impact of the severity of activity limitation, pre-stroke health status and comorbidity on
the effectiveness of the intervention.
Study design
The study was a pragmatic, observer-blind, parallel-group, multicentre randomised controlled trial with
health economic and process evaluations. The study protocol has been published.32
Study setting
The study was conducted in 19 NHS study centres in the UK. All study centres provided an ESD service.
To be eligible to take part, the ESD service had to meet the following criteria:
l had a multidisciplinary stroke team that provided community rehabilitation following discharge
from hospital
l was able to provide stroke rehabilitation at home within 48 hours of patient discharge from hospital
l was able to provide stroke rehabilitation for a specified period of time and/or had clear criteria for
discharge of patients from the service.
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Study participants
Adults with a stroke who fulfilled the following criteria were eligible.
1. Inclusion criteria
l Aged ≥ 18 years.
l Confirmed diagnosis of new stroke (first ever or recurrent).
l Planned discharge from hospital under the care of ESD or currently receiving ESD.
2. Exclusion criteria
l Unable to participate in a rehabilitation programme that focused on EADL.
A carer was the main family member or friend who provided support after stroke. He or she was not
required to be a co-resident of the patient. If an eligible patient had no carer or a carer who did not wish
to participate in the study, the patient was still able to take part.
Case ascertainment, recruitment and consent
1. Patients
Potential patients were identified and recruited by NHS staff (clinicians, staff from the Local Clinical
Research Network and senior members of an ESD team). Potential patients could be recruited prior to
discharge from hospital or while receiving care from an ESD service. Although EXTRAS did not commence
until routine ESD services ended, identification and recruitment of patients in hospital or during ESD was
used to maximise recruitment opportunities.
It was intended that screening data would be collected to report eligibility and subsequent recruitment or
reason for lack of recruitment. Unfortunately, collecting these data was not possible owing to workload at
the NHS study centres.
As stroke survivors can have impairments that result in difficulties with communication and/or cognition,
a number of consent methods were used to facilitate participation.
For patients with mental capacity to consent to research, a standard research information sheet and
consent form were used by NHS staff. If a person had capacity to consent to research but was unable
to sign the consent form (e.g. because of weakness of the dominant hand due to stroke), consent was
confirmed orally in the presence of a witness (an individual not involved in the trial) who signed the
consent form on behalf of the participant. For patients with communication difficulties owing to aphasia,
an ‘easy access’ study information sheet and consent form were used. For patients without mental capacity
to consent to research, a personal consultee was identified, was provided with a consultee information
sheet and signed a consultee declaration form if they believed that the patient would have no objection
to taking part in the study. Due to the nature of this study, potential patients lacking in capacity also
needed to have a relative/friend (carer) who was prepared to assist with EXTRAS reviews and outcome
assessments, as these were unlikely to be possible without their support.
2. Carers
Potential carers were identified by ESD senior team members while the patient was receiving routine ESD
care. At the time of patient discharge from routine ESD services, if the patient had an identified carer,
she/he was provided with an invitation letter, study information sheet, study carer baseline questionnaire
METHODS
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and prepaid envelope (addressed to the study co-ordinating centre). Provision of the invitation letter and
study documents could be in person by an ESD senior team member, by post by the local study team, or
by a consented patient. These three options were used to maximise potential opportunities for carers to
take part in the study, as carers were not always present at staff visits. The invitation letter asked the carer
to complete and return the baseline questionnaire if she/he was willing to participate in the study.
Recruitment and baseline assessments
Patient baseline data were collected during face-to-face recruitment and baseline assessments. Both
assessments were performed by NHS staff after informed consent had been obtained. The recruitment
assessment could be performed within 4 days prior to planned discharge from hospital, or during routine
ESD care. The baseline assessment was performed at discharge from routine ESD services and immediately
prior to randomisation. Both assessments could be conducted together at discharge from ESD if preferred.
Data collection was divided in this format for logistical ease. As patient recruitment could be during hospital
stay, data that were more easily obtainable by hospital staff were collected in the recruitment assessment.
Data pertaining to patient characteristics at discharge from ESD were collected at the baseline assessment.
The following data were collected during the recruitment assessment: demographic data, pre-stroke
performance in EADL [Nottingham Extended Activities of Daily Living (NEADL) Scale33], pre-stroke health
status [Oxford Handicap Scale (OHS)34], date of hospital admission, date of stroke, stroke type and subtype,35
National Institutes of Health Stroke Scale (NIHSS),36 comorbidity and pre-stroke resource usage [adaptation
of the Client Service Receipt Inventory (CSRI)37–39].
The following data were collected during the baseline assessment: date of hospital discharge, date of ESD
discharge, Abbreviated Mental Test Score,40 Sheffield Aphasia Screening Test,41 EADL (NEADL Scale),33
health status (OHS),34 mood [Hospital Anxiety and Depression Scale (HADS)42] and quality of life [EuroQol-5
Dimensions, five-level version (EQ-5D-5L)43].
Carers received a baseline questionnaire with the study invitation letter. The questionnaire collected the
following data: demographic, carer stress [Caregiver Strain Index (CSI)44] and quality of life (EQ-5D-5L).43
Randomisation
Randomisation was conducted by NHS staff at participating study centres using a central independent
web-based service hosted by Newcastle University Clinical Trials Unit. Participants were stratified according
to study centre and randomised to intervention and control in a 1 : 1 ratio using permuted block sequences.
Stroke patients and their carers were randomised as a single unit.
Study control treatment
Stroke patients in the control group received usual ESD care with subsequent referral to other rehabilitation
services post discharge from ESD if required, and in accordance with the local usual care. Patients who had
ongoing rehabilitation needs following completion of ESD could be referred to a range of services, for example
neurorehabilitation teams, day hospital and community rehabilitation services. The availability of rehabilitation
services for patients taking part in this study was recorded during a mapping exercise (see Chapter 7).
Control participants also received the booklet Care After Stroke or Transient Ischaemic Attack. Information
for Patients and their Carers written by the Intercollegiate Stroke Working Party.45 This booklet described
what a stroke is and its assessment, acute management and rehabilitation. It was based on the National
Clinical Guideline for Stroke in 200846 updated in 2012.47
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Study intervention treatment
Stroke patients in the intervention group received EXTRAS for 18 months following completion of
rehabilitation with their ESD team. This was in addition to usual care. They also received the Intercollegiate
Stroke Working Party booklet about stroke care and rehabilitation.45
EXTRAS was developed by the investigator team and consisted of reviews conducted by a senior member
of the ESD team at 1, 3, 6, 12 and 18 months post discharge from routine ESD (randomisation).
Each EXTRAS review consisted of:
l Identification of rehabilitation needs. A semistructured interview was conducted to determine the
patient’s progress, current rehabilitation needs and service provision. The interview addressed daily
activities (mobility, personal care, mealtimes, domestic activities), social participation (work and
volunteering, hobbies and interests, driving and transport) and wider issues (communication, memory
and concentration, mood, medical issues, pain), which may be problematic for stroke survivors. The
views of both the patient and the carer (where appropriate) could be sought. The interview topics were
based on the literature about stroke survivors’ long-term needs including the UK Stroke Survivor Needs
Survey8 and input from stroke survivors, carers and health-care professionals.
l Joint rehabilitation goal-setting. From the identified progress and rehabilitation needs, up to five individual
rehabilitation goals could be set by the patient (and carer) in collaboration with the senior ESD team
member who conducted the review. The focus of joint goal-setting was intended to be on increasing
participation in everyday activities. From the second review, progress towards the goals set previously was
assessed prior to further goal-setting. Achievement of goals was recorded using a Goal Attainment Scale.48
l Action-planning. The patient (and carer) agreed an action plan for each rehabilitation goal. Action plans
could include:
¢ Verbal advice and encouragement.
¢ Discussion with the stroke team, rehabilitation team, primary care team or social services involved
in care.
¢ Signposting to local activities, community organisations or voluntary services.
¢ Referral to stroke services, rehabilitation services or primary care services for further assessment and
treatment if required according to local guidelines and/or service provision.
Subsequent to each review, the ESD therapist/nurse could contact the services currently involved in the
patient’s care to discuss progress, goals and care plan.
The EXTRAS reviews were intended to be predominantly undertaken by telephone. The senior ESD team
member would know the patient and carer, as he/she had treated the patient as part of the ESD service.
However, if the patient and/or carer was unable to participate in a telephone review, a home visit could
be undertaken. On randomisation to the intervention group, patients were given a study appointment
card that also contained a short checklist of rehabilitation issues to be covered in each review. This was
intended to allow patients (and carers) time to consider the topics to be discussed prior to each review.
Patients with aphasia received an ‘easy access’ version of the appointment card. Following each review,
a summary of the interview and recommendations for rehabilitation were sent to the patient by post and
could be copied to other health-care professionals involved in care as appropriate. Patients with aphasia
received an ‘easy access’ version of the summary.
On opening a study centre, all senior ESD staff taking part in delivery of the new service received face-to-face
training from the trial co-ordinating centre team. As delivery of the intervention for this study was conducted
for almost 5 years (recruitment commenced in late 2012 and delivery of the intervention ceased in mid-2017),
inevitable staffing changes took place in ESD teams. New members of staff received cascade training from
existing trained staff and/or further training visits from the trial co-ordinating centre.
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A manual describing EXTRAS was also provided to each member of staff. This manual described how to
conduct the reviews and included guidance on exploring rehabilitation needs, goal-setting and appropriate
interventions to meet a patient’s needs. Study-specific paperwork was completed for each review, including
documentation of identified needs, goals set and action plans made.
The choice of ESD team staff member (e.g. physiotherapist, occupational therapist, nurse) to conduct each
individual review was at the discretion of each participating centre. The trial co-ordinating centre sent all
participating study centres weekly reminders about forthcoming reviews and a regular data report that
illustrated which review data were entered onto the study database, therefore highlighting overdue or
missing reviews.
A description of EXTRAS using the Template for Intervention Description and Replication (TIDieR) checklist49
is shown in Appendix 1, Table 31.
EXTRAS did not include any assessment of carer needs or specific interventions for carers.
Outcome assessments
Outcomes were intended to be assessed at 12 months (± 7 days) and 24 months (± 7 days) post randomisation.
1. Patients
Patient outcome assessments could be undertaken over the telephone, by postal questionnaire or during
a face-to-face visit. The preferred method was telephone questionnaire but postal or face-to-face options
were possible where use of a telephone was unfeasible. Postal questionnaires were also used when it had
not been possible to make contact by telephone.
Telephone interviews were conducted by a researcher based in the study co-ordinating centre at Newcastle
University, Newcastle upon Tyne, UK. This researcher also co-ordinated any postal questionnaires and
conducted any required face-to-face visits for patients in north-east England. When patients required a
face-to-face visit outside north-east England, this was undertaken by staff from the local participating
centre following training by the co-ordinating centre researcher.
The following data were collected: EADL (NEADL Scale),33 health status (OHS),34 mood (HADS),42 experience
of services (adaption of an experience survey designed by Northumbria Healthcare NHS Foundation Trust
based on Picker Institute questions,50 quality of life (EQ-5D-5L)43 and resource utilisation (adaptation of
the CSRI).37–39 The primary outcome was the NEADL Scale.33 The OHS,34 HADS42 and experiences of services
survey were secondary outcome data. The EQ-5D-5L43 and resource utilisation were collected for the
economic evaluation.
The NEADL Scale is a 22-item scale to assess performance in carrying out EADL. The items are ordered as
four subscales covering ‘mobility’, ‘in the kitchen’, ‘domestic tasks’ and ‘leisure activities’. Respondents are
asked to indicate what they have actually done, not what they perceive they could do, ought to do or would
like to do. Each item is scored as follows: 0 is ‘no’, 1 is ‘with help’, 2 is ‘on my own with difficulty’ and 3 is
‘on my own’. Responses are summed, giving a score of 0–66, where higher scores indicate greater activity.
The OHS34 is a derivative of the Modified Rankin Scale,51 which, in turn, is a derivative of the original
Rankin Scale.52 The OHS used in this study was a self-report version. The scale has ordinal scale scoring:
0 is ‘I have no symptoms at all and cope well with life’, 1 is ‘I have a few symptoms but these do not
interfere with my everyday life’, 2 is ‘I have symptoms which have caused some changes in my life but I am
still able to look after myself’, 3 is ‘I have symptoms which have significantly changed my life, prevent me
coping fully on my own, and I need some help in looking after myself’, 4 is ‘I have quite severe symptoms
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which mean I need to have help from other people but I am not so bad as to need attention day and
night’, 5 is ‘I have major symptoms which severely handicap me and I need constant attention day and
night’. A score of 6 is used to indicate death.
The HADS42 is made up of anxiety and depression subscales of seven items each. Each item is scored 0–3, so
patients can score from 0 to 21 on each subscale. Higher scores are indicative of anxiety and depression. In
addition, ‘cut-off’ scores have been defined as follows: a score of 0–7 is ‘non-case’, 8–10 is ‘doubtful case’
and 11–21 is ‘definite case’.
The experience of services scale was an adaptation of an experience survey designed by Northumbria
Healthcare NHS Foundation Trust based on Picker Institute questions.50 It had three parts. Part 1 involved
15 questions about services received with responses on a five-point Likert scale: ‘strongly disagree’,
‘disagree’, ‘agree’, ‘strongly agree’ and ‘does not apply’. Part 2 was about overall satisfaction. Participants
were asked ‘Overall, how satisfied are you with the services you received?’. There were five responses from
‘extremely satisfied’ to ‘extremely unsatisfied’. Part 3 contained three questions about meeting needs in
relation to speaking, mobility and emotional problems. Responses were ‘yes, definitely’, ‘yes, to some
extent’, ‘no I did not get enough help from the NHS’ and ‘I did not have any difficulties’. There was no
numerical scoring for this questionnaire, so questions were dichotomised to create proportions of patients
answering ‘strongly agree’ and ‘agree’, for comparison with ‘disagree’ and ‘strongly disagree’; or,
‘extremely satisfied’, ‘very satisfied’ and ‘quite satisfied’, for comparison with ‘not very satisfied’ and
‘extremely unsatisfied’.
The EQ-5D-5L43 instrument has two parts: a descriptive system comprising five dimensions
(i.e. mobility, self-care, usual activities, pain/discomfort and anxiety/depression) and a visual analogue
scale (VAS). In the descriptive system, each dimension has five responses: no problems, slight problems,
moderate problems, extreme problems and unable to do. The VAS is vertical with ‘the best health you can
imagine’ at the top (score of 100) and ‘the worst health you can image’ at the bottom (score of 0).
Responses to the EQ-5D-5L were converted into utility values, which were combined with observed
mortality to create quality-adjusted life-years (QALYs). Data are presented in Chapter 8.
An adaption of the CSRI37–39 was used to measure resource utilisation. This instrument captures data about
accommodation and living, hospital care, primary care, other NHS services (e.g. physiotherapy, occupational
therapy) and social services.
2. Carers
Carers’ outcome assessments were undertaken by a postal questionnaire sent by and returned to the study
co-ordinating centre. The following data were collected from carers: carer stress (CSI),44 experience of
services (adaption of an experience survey designed by Northumbria Healthcare NHS Foundation Trust
based on Picker Institute questions)50 and quality of life (EQ-5D-5L).43 Responses to the EQ-5D-5L were used
to create QALYs, and these data are presented in the health economic evaluation chapter (see Chapter 8).
The CSI44 is a tool used to identify strain in informal carers for physically ill and functionally impaired elderly
adults. It comprises 13 items, each answered as ‘no’ (score of 0) or ‘yes’ (score of 1). Scores are summed
and a higher score indicates more strain. Because the CSI asks some sensitive questions about the impact
of stroke on the carer, it was not felt appropriate to conduct telephone interviews as carers may have
modified their answers if they could be overheard on the telephone by the patient.
Blinding
Owing to the nature of the study intervention, it was not possible to blind stroke patients or carers to
treatment allocation. Where patient outcome assessments were undertaken by telephone or face-to-face
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visit, it was intended that they were conducted blinded to treatment allocation. After each assessment,
the assessor was asked to record whether or not they had unintentionally become aware of treatment
allocation as a result of conversation with the participant.
Study withdrawal
No specific study withdrawal criteria were pre-set. Stroke patients and/or carers could withdraw from the
study at any time for any reason. Reasons for withdrawal were sought but participants could withdraw
without providing an explanation. Investigators, senior ESD team members and/or a patient’s consultee
(in the case of mental incapacity) could also withdraw participants from the study at any time if they felt
that it was no longer in their interest to continue, for example because of intercurrent illness. Participants
were informed that data collected prior to withdrawal would be used in the study analysis, unless consent
for this was specifically withdrawn. Participants who wished to receive no further intervention were not
withdrawn from study follow-up unless they specifically requested this.
Safety evaluation
Adverse events were collected by including the following questions in the study outcome questionnaires at
12 and 24 months:
l Have you suffered any new medical illnesses in the last 12 months?
l Have you suffered any falls resulting in injury in the last 12 months?
Any event potentially fulfilling the criteria to be a serious adverse event (SAE) was further investigated by
local study centre staff who had access to medical records, and fully detailed on a separate study SAE form
as appropriate. As local study centre staff could become aware of events fulfilling the criteria to be SAEs at
any time during a participant’s involvement in the study, the study SAE form was also used to directly
capture any such events. A causality and expectedness assessment was undertaken for all SAEs.
The standard definition for SAE was used. A SAE is an untoward occurrence that:
l results in death
l is life-threatening
l requires hospitalisation, or prolongation of existing hospitalisation
l results in persistent or significant disability or incapacity
l consists of a congenital anomaly or birth defect
l is otherwise considered medically significant by the investigator.
Data management
Study data were collected onto study-specific paper case-record forms and subsequently entered onto an
online database by NHS staff at participating centres and/or staff at the study co-ordinating centre.
Sample size
A difference of 6 points on the NEADL Scale (scored 0–66, SD 18) is considered to be clinically important,
and power calculations for previous multicentre rehabilitation trials had been based on this difference.38,53
Responses from 382 patients who were split equally between intervention and control groups would
provide 90% power to detect a difference in mean NEADL Scale of 6 points. Based on attrition in
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other stroke rehabilitation trials, it was estimated that there could be up to 25% attrition between study
randomisation and the 24-month (primary) outcome assessment. To allow for this, 510 patients were
required to be randomised into the study.
Because patients could be recruited at any time from within 4 days prior to hospital discharge to discharge
from ESD, there could be several weeks between recruitment and randomisation. As dropout was observed
during this time interval, it was planned that recruitment would cease when it was estimated that at least
510 patients would be randomised. Reasons for loss from the trial were recorded.
Statistical analysis of primary and secondary outcome data
1. Analysis populations
Analyses were carried out on an intention-to-treat (ITT) basis, retaining patients and carers in their
randomisation groups, and including protocol violators and ineligible patients.
2. Analysis data sets
The pattern and extent of missing observations because of loss to follow-up was examined. Unless specified
by the scale developers, where no more than 20% of questions were missing or uninterpretable on specific
scales, the score was calculated by using the mean or median value (as appropriate) of the respondent-
specific completed responses on the rest of the scale to replace the missing items (i.e. simple imputation).54
It was planned to investigate the use of multiple imputation techniques if the primary outcome was still
missing for > 20% of patients after the use of simple imputation; however, this was not necessary. Complete-
case, simple imputation and a sensitivity analysis data set were analysed. The sensitivity analysis data set
excluded data from patients who had follow-up conducted 1 month before and 3 months after the due date
for their 12- and 24-month assessments, and patients whose NEADL Scale scores recorded post stroke were
higher than those recorded prior to their stroke.
3. Descriptive analyses
Characteristics of study patients and carers were summarised separately for each randomisation group.
This included primary and secondary outcome variables and covariates. Continuous variables were
summarised by the numbers of observations and the mean and SD, or the median and interquartile
range (IQR), depending on whether or not the distribution was symmetric. Numbers of observations and
percentages were reported for categorical variables. No significance testing for any baseline imbalance
was carried out, but any noted differences were reported descriptively.
4. Inferential analyses
Mean scores on the NEADL Scale (the primary outcome) were compared at 24 months between the
intervention and the control groups using multiple linear regression, including terms for centre, baseline
OHS, age and sex. Mean scores with bootstrapped confidence intervals (CIs) are reported for:
l data with complete-case NEADL Scale scores
l a complete-case set adjusted for centre, baseline OHS, age and sex
l data with simple imputation for partially completed NEADL Scale scores
l a simple imputation set, adjusted for centre, baseline OHS, age and sex (primary analysis)
l a sensitivity analysis of above, excluding data from patients outside –1 and + 3 months of their expected
visit date and those whose NEADL Scale scores appeared to be unlikely as they had increased (improved)
post stroke.
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This analysis was repeated for the 12-month NEADL Scale scores for:
l data with simple imputation for partially completed NEADL Scale scores
l a simple imputation set adjusted for centre, baseline OHS, age and sex
l a sensitivity analysis of above, excluding data from patients outside –1 and +3 months of their expected
visit date and those whose NEADL scores appeared to be unlikely as they had increased (improved)
post stroke.
In terms of secondary outcomes, ordinal regression was used to analyse the 12- and 24-month OHS scores
by randomisation group, using the same covariates as for the primary analysis. This was carried out for
categories 0–5, with category 0 set as the reference group. To come closer to a full ITT analysis, patients who
had died were included in a second analysis in a separate category, as a score of 6. Odds ratios with 95% CIs
were reported for an unadjusted model and one adjusted for centre, baseline OHS, age and sex.
The HADS scores were analysed as the two separate domains of anxiety and depression. Multiple linear
regression was used to compare the intervention and the control groups at 12 and 24 months. Mean scores
with bootstrapped CIs were reported for data with simple imputation for partially completed HADS scores,
and the simple imputation set adjusted for centre, baseline OHS, age and sex. In addition, a post hoc
analysis considered those patients scoring ≥ 8 to have cases of anxiety or depression, and logistic regression
was used to compare the randomisation groups on this binary variable at 12 and 24 months. Odds ratios
with 95% CIs were reported for an unadjusted model and one adjusted for centre, baseline OHS, age and
sex. The HADS can be presented as either scores or ‘cases’, with the latter being more meaningful to a
clinical audience. During the trial, the Trial Steering Committee (TSC) and the Data Monitoring Committee
(DMC) reports had included both methods as they are considered to be of equal importance. This post hoc
analysis of ‘cases’ was undertaken owing to an omission from the statistical analysis plan. This was the only
post hoc analysis that was undertaken for this report.
Experience of service questions for both patients and carers at 12 and 24 months were reported as a
difference in the proportion of patients and carers satisfied or in agreement between the control and the
intervention groups with a 95% CI. No adjustment for covariates was undertaken for this scale analysis.
For the CSI, mean scores at 12 and 24 months were compared between carers whose patients were in the
control group and those whose patients were in the intervention group, using multiple linear regression
and adjusting for the age and sex of the carer, and using the patients’ baseline OHS score as a measure of
the patient’s health status.
5. Exploratory analyses
Pre-planned exploratory descriptive analyses examined the association of the severity of activity limitation
measured by the baseline NEADL Scale score and the pre-stroke health status measured by the pre-stroke
OHS, with the effectiveness of the intervention (24-month NEADL Scale score). These are reported as
separate scatterplots of the 24-month NEADL Scale score against the severity variables. A boxplot showing
24-month NEADL Scale scores by pre-stroke OHS category and randomisation group is also reported.
The study protocol included a third pre-planned exploratory analysis, which was to examine the impact of
comorbidity on the effectiveness of the intervention. On preparing the detailed statistical analysis plan, it
was decided that this would not be conducted because although free-text comorbidity had been recorded
for patients, a quantifiable measure of comorbidity had not been included.
In preparing the detailed statistical analysis plan, it was decided to include an additional analysis to examine
the effect of time in organised stroke care (time as an inpatient plus the time in ESD) on the effectiveness of
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the intervention. This is illustrated as a scatterplot of the 24-month NEADL Scale score against the duration
of organised stroke care.
All analyses were carried out using Stata® version 15 (StataCorp LP, College Station, TX, USA).
Economic analysis
The economic evaluation consisted of a cost-effectiveness analysis (CEA) and a cost–utility analysis.55
Methods are described in the health economic evaluation chapter (see Chapter 8).
Parallel process evaluation
Parallel process evaluations of complex interventions being tested by randomised controlled trials are
increasingly recommended.56 They can provide information about unanticipated consequences, reasons for
success and how an intervention can be improved, and can identify contextual factors associated with
variations in outcome.57 The study process evaluation consisted of the following components, and the
methods are described at the start of each respective chapter:
l mapping the routine rehabilitation and follow-up services provided for stroke patients in each study
centre (see Chapter 7)
l analysis of the study intervention paperwork completed by ESD staff to understand implementation and
delivery of the new service in the different study settings (see Chapter 5)
l conducting interviews to seek the views and experiences of patients and carers about the rehabilitation
services they received (see Chapter 6)
l conducting interviews to seek the views and experiences of senior members of the ESD teams and
community rehabilitation staff about the services provided to the intervention and control groups
(see Chapter 6).
Ethics and regulatory issues
The study sponsor was Northumbria Healthcare NHS Foundation Trust. Ethics approval was granted by the
National Research Ethics Committee North-East – Newcastle and North Tyneside 1 (reference 12/NE/0217).
Local NHS approvals were obtained from all participating NHS organisations. The study was conducted in
accordance with the Research Governance Framework for Health and Social Care58 and Good Clinical Practice.59
Monitoring of study conduct and data collection was performed by regular visits to all participating study
centres. The trial was managed by a co-ordinating centre based at Newcastle University, Newcastle upon Tyne,
UK. An independent DMC and TSC were in place for the duration of the project.
Amendments made to the study after it commenced
1. Modification of the enrolment process for carers
When the study commenced, carer enrolment was in keeping with the patient enrolment procedures
described above. There was a face-to-face approach and written consent to participate in the study was
sought. This was followed by a face-to-face recruitment assessment and then a separate self-completion
baseline questionnaire. It was soon noted that carer recruitment rates were not as high as had been
anticipated and it appeared that this may have been due to the enrolment procedures. The procedures
appeared to be proving logistically challenging due to carers and NHS staff not being available at mutually
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
14
convenient times. The carer enrolment procedure was, therefore, amended to invitation by letter and
return of one self-completion baseline questionnaire (as described above).
2. Inclusion of stroke patients with communication difficulties (aphasia)
The study commenced without inclusion of patients with significant communication difficulties. The
documentation required to support their involvement (‘easy access’) was developed during the first year
of the trial.
3. Widening of options for patient outcome assessments
The original study protocol did not include postal questionnaires when telephone contact had failed or the
option to mail reminder questionnaires for non-response. These options were later included.
4. Revision of recruitment target
The sample size of 510 patients included inflation for 25% attrition. This was based on the estimated loss
between study randomisation and the 24-month (primary) outcome assessment. Randomisation for this
study was at discharge from ESD services, but to maximise recruitment opportunities, patients could be
recruited from 4 days prior to hospital discharge until discharge from ESD services. This could lead to
a delay of up to several weeks between recruitment and randomisation, and dropout was observed during
this time, which had not been anticipated. The protocol was therefore revised to clarify that 510 patients
would need to be randomised to a study group and that recruitment would be kept under review, ceasing
when it was estimated that this would be achieved.
In total, 573 patients were randomised. This is a larger number of participants than described in the sample
size calculation, as during the study we felt that there was a risk that attrition at 24 months could be greater
than anticipated and, as a result, the primary analysis would be underpowered. The ethics committee
approved a minor amendment to increase the number of participants recruited and randomised.
5. Increasing number of study centres
The original study protocol proposed 12 study centres. The number of centres was increased to maintain
the proposed recruitment rate.
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Chapter 3 Randomised controlled trial results:
patients
Patient recruitment and randomisation
Between 15 November 2012 and 6 July 2015, 674 patients were recruited to the trial from 19 participating
study centres. Patients could be invited and consent to take part in the trial from 4 days prior to hospital
discharge to discharge from an ESD service. Randomisation to a study group was conducted at discharge
from an ESD service. The duration of ESD services ranged from a few days to several months. A total of
101 patients dropped out of the trial during the time between recruitment and randomisation. Reasons for
this included the choice of patients [49/101 (49%)] and study centre staff [20/101 (20%)] to discontinue
involvement. Full details about reasons for dropout are shown in Appendix 2, Table 32.
A total of 573 patients were randomised to a study group. Randomisation occurred at a median of 73 days
(IQR 48–111.5 days) post stroke in the intervention group and 70 days (IQR 48–106.5 days) post stroke in
the control group. Predicted and actual cumulative recruitment and actual cumulative randomisation are
shown in Figure 1. Recruitment and randomisation per study centre are illustrated in Appendix 2, Table 33.
Patient retention and follow-up
Of the 573 randomised patients, 285 were allocated to the intervention group and 288 were allocated to
the control group. Patient retention is illustrated in Figure 2. Outcome data were collected for 487 out of
573 (85%) patients at 12 months and 450 out of 573 (78%) patients at 24 months. Further detail about
the patients who were alive and did not have follow-up data collected is shown in Appendix 2, Table 34.
Timing of patient outcome assessments
According to the study protocol, assessments were due at 12 and 24 months (± 7 days) post randomisation.
At 12 months, 351 out of 487 (72%) assessments took place within this time frame; at 24 months this was
295 out of 450 (66%). The investigators felt that data collected more than 1 month before the assessment
was due and 3 months after it was due may not reflect the outcomes that would have been collected at the
planned time points. Figures 3a and 3b show how closely data were collected in relation to the 12-month
and 24-month due dates, with reference lines indicating the –1/+3 months outside the time window.
A sensitivity analysis was conducted excluding people whose data collection fell outside the –1/+3 months.
Patient baseline characteristics
Demographic, stroke and baseline characteristics for the 573 randomised patients are shown in Table 1.
The groups were well matched. Most people had suffered a cerebral infarction that was a first stroke. Just
over half of the patients were male, with a median age of 71 years at the stroke. The median duration of
hospital stay was 14 days and the median duration of ESD services was 43 days, and the time between
stroke and randomisation was 72 days. Most people were living in their own home at randomisation.
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Randomisation
(n = 573)
Remained in study at 12 months
(n = 262)
• Withdrawn, n = 13b
• Died, n = 10
Allocated to intervention group
(n = 285)
Allocated to control groupa
(n = 288)
Remained in study at 12 months
(n = 262)
• Withdrawn, n = 8
• Died, n = 18
• Withdrawn, n = 7c
• Died, n = 13
• Withdrawn, n = 1
• Died, n = 14
Remained in study at 24 months
(n = 242)
Remained in study at 24 months
(n = 247)
• Assessment conducted, n = 239 • Assessment conducted, n = 248
• Assessment conducted, n = 219 • Assessment conducted, n = 231
• Assessment not conducted, n = 23 • Assessment not conducted, n = 14
• Assessment not conducted, n = 23 • Assessment not conducted, n = 16
FIGURE 2 Patient retention. a, One patient allocated to control received intervention in error; b, study SAE
information indicates that 2 out of 13 patients died after withdrawal and within the 24-month follow-up period;
and c, study SAE information indicates that one out of seven patients died after withdrawal and within the
24-month follow-up period.
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FIGURE 3 Time from randomisation to patient outcome assessments. (a) 12-month follow-up date; and (b) 24-month
follow-up date. (continued )
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FIGURE 3 Time from randomisation to patient outcome assessments. (a) 12-month follow-up date; and (b) 24-month
follow-up date.
TABLE 1 Patient demographic, stroke and baseline characteristics
Characteristic Intervention Control
Sex, n (%) n = 285 n = 288
Male 174 (61.1) 168 (58.3)
Female 111 (39.0) 120 (41.7)
Age (years) n = 285 n = 288
Median (IQR) 71 (60–77) 71 (62–79)
Pre-stroke NEADL Scale, mean (SD) n = 285 n = 288
Mobility (scored 0–18) 16.7 (3.1) 16.1 (3.8)
Kitchen (scored 0–15) 14.7 (1.5) 14.5 (2.1)
Domestic tasks (scored 0–15) 13.7 (2.8) 13.5 (3.3)
Leisure activities (scored 0–18) 16.0 (3.1) 15.6 (3.4)
Total (scored 0–66) 61.0 (8.6) 59.7 (10.6)
Pre-stroke OHS (scored 0–5) score, n (%) n = 285 n = 287
0 179 (62.8) 170 (59.2)
1 52 (18.3) 56 (19.5)
2 39 (13.7) 43 (15.0)
3 14 (4.9) 15 (5.2)
4 1 (0.4) 3 (1.1)
5 0 (0.0) 0 (0.0)
Stroke type, n (%) n = 285 n = 288
Cerebral infarction 250 (87.7) 253 (87.9)
Intracerebral haemorrhage 30 (10.5) 29 (10.1)
Subarachnoid haemorrhage 5 (1.8) 5 (1.8)
Unknown 0 (0.0) 1 (0.4)
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TABLE 1 Patient demographic, stroke and baseline characteristics (continued )
Characteristic Intervention Control
Stroke subtype, n (%) n = 284 n = 286
TACS 55 (19.4) 60 (21.0)
PACS 125 (44.0) 133 (46.5)
LACS 56 (19.7) 44 (15.4)
POCS 47 (16.6) 49 (17.1)
Uncertain 1 (0.4) 0 (0.0)
First ever stroke, n (%) n = 285 n = 288
Yes 235 (82.5) 227 (78.8)
NIHSS scorea n = 285 n = 288
Median (IQR) 2 (1–4) 2 (1–4)
Comorbidity, n (%) n = 285 n = 288
Ischaemic heart disease 45 (15.8) 47 (16.3)
Previous myocardial infarction 25 (8.8) 29 (10.1)
Peripheral arterial occlusive disease 11 (3.9) 9 (3.1)
Previous transient ischaemic attack 46 (16.1) 53 (18.4)
Diabetes mellitus 51 (17.9) 53 (18.4)
Hypertension 166 (58.3) 170 (59.0)
Hyperlipidaemia 92 (32.4) 98 (34.2)
Atrial fibrillation 59 (20.7) 65 (22.6)
Congestive heart failure 15 (5.3) 7 (2.4)
Thromboembolism 15 (5.3) 13 (4.5)
Valvular heart disease 15 (5.3) 7 (2.4)
Other 205 (71.9) 199 (69.1)
Duration of hospital stay (days) n = 282 n = 286
Median (IQR) 13.5 (6–33) 14 (6–35)
Duration of ESD (days) n = 283 n = 285
Median (IQR) 43 (36–68) 43 (31–68)
Time (days) from stroke to randomisation n = 284 n = 288
Median (IQR) 73 (48–111.5) 70 (48–106.5)
Residence at randomisation, n (%) n = 283 n = 283
Own house 261 (92.2) 261 (92.2)
Living with family/friends 13 (4.6) 14 (5.0)
Sheltered accommodation 4 (1.4) 5 (1.8)
Residential care/nursing home 2 (0.7) 2 (0.7)
Other 3 (1.1) 1 (0.4)
Lived alone at randomisation, n (%) n = 283 n = 284
Yes 94 (33.2) 78 (27.5)
Total patients 283 284
Abbreviated Mental Test Score (scored 0–10) n = 281 n = 285
Median (IQR) 9.9 (9–10) 9 (9–10)
continued
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TABLE 1 Patient demographic, stroke and baseline characteristics (continued )
Characteristic Intervention Control
Sheffield Screening test for acquired language disorders
Receptive (scored 0–9) n= 282 n= 285
Median (IQR) 8 (7–9) 8 (7–9)
Expressive (scored 0–11) n= 282 n= 285
Median (IQR) 11 (10–11) 11 (10–11)
Total (scored 0–20) n= 282 n= 285
Median (IQR) 19 (18–20) 19 (18–20)
Baseline NEADL Scale
Mobility (scored 0–18) n= 283 n= 285
Mean (SD) 10.5 (5.5) 10.3 (5.5)
Kitchen (scored 0–15) n= 283 n= 286
Mean (SD) 12.1 (4.0) 11.8 (4.3)
Domestic tasks (scored 0–15) n= 283 n= 285
Mean (SD) 8.0 (5.2) 7.8 (5.2)
Leisure activities (scored 0–18) n= 281 n= 284
Mean (SD) 9.3 (4.2) 9.3 (4.1)
Total (scored 0–66) n= 281 n= 282
Mean (SD) 39.8 (16.1) 39.1 (16.1)
Baseline OHS (scored 0–5) score, n (%) n = 283 n = 285
0 9 (3.2) 8 (2.8)
1 42 (14.8) 43 (15.1)
2 104 (36.8) 95 (33.3)
3 100 (35.3) 99 (34.7)
4 18 (6.4) 34 (11.9)
5 10 (3.5) 6 (2.1)
HADS
Anxiety (scored 0–21) n= 282 n= 285
Mean (SD) 5.7 (4.2) 5.6 (3.9)
Score, n (%)
0–7 (non-case) 203 (72.0) 201 (70.5)
8–10 (doubtful case) 39 (13.8) 50 (17.5)
11–21 (definite case) 40 (14.2) 34 (11.9)
Depression (scored 0–21) n= 282 n= 285
Mean (SD) 5.4 (3.8) 5.4 (3.7)
Score, n (%)
0–7 (non-case) 215 (76.2) 211 (74.0)
8–10 (doubtful case) 40 (14.2) 42 (14.7)
11–21 (definite case) 27 (9.6) 32 (11.2)
LACS, lacunar stroke; PACS, partial anterior circulation stroke; POCS, posterior circulation stroke; TACS, total anterior
circulation stroke.
a The NIHSS was recorded at different times post stroke as it was part of the patient recruitment assessment.
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The distributions of performance in EADL (NEADL Scale), health status (OHS) and mood (HADS) at baseline
(and pre stroke for NEADL Scale and OHS) were well matched between the intervention and the control
groups. The majority of people had a high level of performance in activities of daily living before their
stroke and this decreased post stroke.
A comparison of the characteristics of patients who dropped out of the trial between recruitment and
randomisation with those of patients who were randomised is shown in Appendix 2, Table 35. Patients
who were not randomised tended to be slightly older and have poorer function prior to stroke (pre-stroke
NEADL Scale and OHS).
Primary outcome
The distribution of the NEADL Scale scores (primary outcome) at pre stroke, baseline, 12 months and
24 months is shown in Table 2. Patients reported that they undertook the most activities before their stroke,
but the mean scores at baseline decreased to 39.9 in the intervention group and 39.1 in the control group.
Thereafter, the mean scores remained very similar over time for those patients still providing data in the
intervention group and decreased very slightly in the control group.
The primary comparison was at 24 months, adjusting for covariates and using simple imputation for
partially completed scores. The mean NEADL Scale scores at 24 months were 40.0 in the intervention
group and 37.2 in the control group: an adjusted difference in means of 1.8 (95% CI –0.7 to 4.2). The
minimum clinically important difference on the NEADL Scale is 6 units, so the results were not consistent
with a meaningful change on this scale.
Other analyses of the NEADL Scale were complete-case data and a sensitivity analysis that excluded both
patients providing data outside the –1 and +3 months of the expected assessment date and those with
improbable NEADL Scale scores. The differences in means between trial groups remained similar at both
time points and for each analysis group.
The distribution of the subscales of the NEADL Scale at each time point is shown in Appendix 2, Table 36.
TABLE 2 Comparison of performance in EADL (NEADL Scale) scores from pre stroke to 24 months
Time point
Intervention Control
Difference in mean score
(intervention – control) (95% CI)
n Mean (SD) n Mean (SD) Unadjusted
Adjusted for centre,
baseline OHS, age
and sex
Pre stroke 285 61.0 (8.6) 288 59.7 (10.6) NA NA
Baseline: simple imputation 281 39.8 (16.1) 282 39.1 (16.1) NA NA
12 months: simple imputation 239 40.6 (17.7) 247 38.3 (17.0) 2.3 (–0.5 to 5.2) 1.5 (–0.8 to 3.7)
12 months: simple imputation and
sensitivity
229 40.9 (17.7) 228 38.5 (17.2) 2.5 (–0.8 to 5.7) 1.5 (–1.0 to 4.0)
24 months: complete cases 217 39.9 (18.1) 230 37.3 (18.4) 2.5 (–0.5 to 5.6) 1.6 (–0.7 to 3.8)
24 months: simple imputation 219 40.0 (18.1) 231 37.2 (18.5) 2.8 (–0.6 to 6.2) 1.8 (–0.7 to 4.2)
24 months: complete case and
sensitivity
208 40.4 (17.9) 214 37.6 (18.3) 2.9 (0.0 to 5.7) 2.0 (–0.9 to 4.9)
24 months: simple imputation and
sensitivity
210 40.5 (17.9) 215 37.4 (18.4) 3.1 (–0.4 to 6.6) 2.2 (–0.7 to 5.2)
NA, not applicable.
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Patient secondary outcomes
1. Health status (Oxford Handicap Scale)
The distribution of the health status score (OHS) at pre stroke, baseline, 12 months and 24 months is
shown in Table 3. Relatively few patients reported significant symptoms or disability pre stroke, but by
baseline the majority of patients reported symptoms that were affecting their well-being. This distribution
changed little over time in those providing data, except for a small number of deaths.
The OHS scale was compared in two ways: first using the 0–5 scale (i.e. not including death) and second
including deaths (i.e. scoring 6 for death). At 24 months, ordinal regression adjusting for covariates and
using the 0–6 scale estimated that the odds of the intervention group patients having a worse health
status (compared with better) was 0.7 times as high as those for control patients (95% CI 0.5 to 1.0).
This was not significantly different from equal odds in both groups. There were very similar results at
both time points and for each analysis group. Figure 4 shows the unadjusted distribution of OHS scores
at 12 and 24 months.
2. Mood (Hospital Anxiety and Depression Scale)
Tables 4 and 5 show the distribution of the anxiety and depression scores (HADS) at baseline, 12 months
and 24 months. Scores at baseline showed relatively low levels of both anxiety and depression, and the
mean scores changed very little over time in those who remained in the trial.
The mean scores at 24 months for anxiety were 5.5 in the intervention group and 6.4 in the control group:
an adjusted difference in means of –0.6 (95% CI –1.4 to 0.1). The mean scores for depression at 24 months
were 5.9 in the intervention group and 6.7 in the control group: an adjusted difference in means of –0.7
(95% CI –1.4 to 0.0). The differences at 12 months were very similar. The differences in means between
trial groups were consistently small with narrow CIs.
3. Experience of services (experience survey)
Table 6 shows the dichotomised responses to the experiences of services questionnaire at 12 and 24 months.
There were high levels of satisfaction for all aspects of experiences of care. The difference in the percentage of
patients who were satisfied between study groups was usually quite small, but the 95% CIs were quite wide.
The wider CIs occurred when there was a high proportion of patients either not completing that question or
saying that it did not apply. The detailed breakdown of scores is shown in Appendix 2, Tables 37 and 38.
These tables show that by 24 months, approximately half of the patients were reporting that each question
‘did not apply’. This means that the comparisons between study groups were based on much reduced
sample sizes.
Nevertheless, there were 4 out of 19 aspects of care at 24 months where the 95% CI for the differences
in percentage satisfied between groups did not cover the value zero. These were ‘staff treated you with
dignity and respect’, ‘staff met your needs’, ‘overall satisfaction’ and ‘help with mobility’. However, these
must be interpreted with some caution because of multiple significance testing. In addition, the largest
difference at 24 months came from the question about overall satisfaction (‘Overall, how satisfied are you
with the services you received?’): 97.7% in the intervention group compared with 87.5% in the control
group, which is a difference of 10.2% (95% CI 5.3% to 15.0%).
Patient post hoc analysis
Post hoc analyses of the HADS used established ‘cut-off’ scores where patients scoring ≥ 8 on a subscale
are considered to have a case of anxiety or depression (see Tables 4 and 6). For anxiety, the proportion of
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TABLE 3 Comparison of health status (OHS) from pre stroke to 24 months
Oxford Handicap Scale (score)
Time point, n (%)
Pre stroke Baseline 12 months 24 months
Intervention Control Intervention Control Intervention Control Intervention Control
Total patients, n 285 287 283 285 249 265 242 262
No symptoms (0) 179 (62.8) 170 (59.2) 9 (3.2) 8 (2.8) 14 (5.7) 14 (5.3) 17 (7.0) 13 (5.0)
Few symptoms (1) 52 (18.3) 56 (19.5) 42 (14.8) 43 (15.1) 52 (20.9) 37 (14.0) 38 (15.7) 36 (13.7)
Symptoms caused some change (2) 39 (13.7) 43 (15.0) 104 (36.8) 95 (33.3) 80 (32.1) 82 (30.9) 72 (29.8) 65 (24.8)
Symptoms caused significant change (3) 14 (4.9) 15 (5.2) 100 (35.3) 99 (34.7) 62 (24.9) 84 (31.7) 60 (24.8) 73 (27.9)
Severe symptoms (4) 1 (0.4) 3 (1.1) 18 (6.4) 34 (11.9) 19 (7.6) 19 (7.2) 20 (8.3) 26 (9.9)
Major symptoms (5) 0 0 10 (3.5) 6 (2.1) 12 (4.8) 11 (4.2) 12 (5.0) 17 (6.5)
Death (6) – – – – 10 (4.0) 18 (6.8) 23 (9.5) 32 (12.2)
Intervention: control, OR (95% CI) Intervention: control, OR (95% CI)
Unadjusted NA NA 0.8 (0.6 to 1.1) 0.7 (0.5 to 1.0)
Unadjusted including death NA NA 0.7 (0.5 to 1.0) 0.7 (0.5 to 1.0)
Adjusteda NA NA 0.8 (0.5 to 1.1) 0.7 (0.5 to 1.0)
Adjusteda including death NA NA 0.7 (0.5 to 1.0) 0.7 (0.5 to 1.0)
NA, not applicable.
a Adjusted for centre, baseline OHS, age and sex.
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FIGURE 4 Distribution of OHS scores at 12 and 24 months.
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TABLE 4 Comparison of mood (HADS scores) from baseline to 24 months
Time point
Intervention Control
Difference in means (intervention – control)
(95% CI)
n
Mean
score (SD) n
Mean
score (SD) Unadjusted
Adjusted for centre,
baseline, OHS,
age and sex
Anxiety at baselinea 282 5.7 (4.2) 285 5.6 (3.9) NA NA
Anxiety at 12 monthsa 238 5.8 (4.3) 246 6.5 (4.7) –0.7 (–1.5 to 0.0) –0.7 (–1.3 to 0.0)
Anxiety at 24 monthsa 217 5.5 (4.3) 230 6.4 (4.6) –0.9 (–1.8 to 0.0) –0.6 (–1.4 to 0.1)
Depression at baselinea 282 5.4 (3.8) 285 5.4 (3.7) NA NA
Depression at 12 monthsa 239 5.7 (4.3) 247 6.5 (4.2) –0.8 (–1.6 to 0.0) –0.7 (–1.5 to 0.0)
Depression at 24 monthsa 217 5.9 (4.3) 230 6.7 (4.6) –0.8 (–1.5 to –0.1) –0.7 (–1.4 to 0.0)
NA, not applicable.
a All using simple imputation on partially completed scales.
TABLE 5 Comparison of mood (HADS cases) from baseline to 24 months
Time point
Intervention Control OR (intervention/control) (95% CI)a
n Cases (%)b n Cases (%)b Unadjusted
Adjusted for centre,
baseline, OHS,
age and sex
Anxiety at baselinea 282 28 285 29 NA NA
Anxiety at 12 monthsa 238 34 246 39 0.79 (0.55 to 1.15) 0.83 (0.55 to 1.25)
Anxiety at 24 monthsa 217 28 230 38 0.62 (0.41 to 0.92) 0.64 (0.41 to 0.99)
Depression at baselinea 282 24 285 26 NA NA
Depression at 12 monthsa 239 29 247 40 0.61 (0.42 to 0.89) 0.59 (0.39 to 0.90)
Depression at 24 monthsa 217 34 230 39 0.80 (0.55 to 1.18) 0.81 (0.52 to 1.24)
NA, not applicable.
a All using logistic regression and simple imputation on partially completed scales.
b Case defined as score of 8–21 on anxiety or depression scales.
TABLE 6 Comparison of patient experience of services at 12 and 24 months
About the services
received in the last
12 months, to what
extent do you
agree that
12 months 24 months
Patients satisfied/in
agreement
Difference in
proportion of
patients satisfied
(intervention –
control) (95% CI)
Patients satisfied/in
agreement
Difference in
proportion of
patients satisfied
(intervention –
control) (95% CI)
Intervention,
n (%)
Control,
n (%)
Intervention,
n (%)
Control,
n (%)
Staff were welcoming
and friendly
230 (99.1) 230 (97.5) 1.7 (–0.7 to 4.0) 114 (98.3) 123 (96.9) 1.4 (–2.4 to 5.3)
Staff treated you with
dignity and respect
227 (98.3) 230 (97.1) 1.2 (–1.5 to 4.0) 117 (100.0) 122 (96.8) 3.2 (0.1 to 6.2)
Staff assessed your
needs
219 (95.6) 229 (96.6) –1.0 (–4.5 to 2.5) 113 (96.6) 114 (92.7) 3.9 (–1.8 to 9.6)
Staff met your needs 217 (93.9) 222 (93.7) 0.3 (–4.1 to 4.6) 114 (97.4) 111 (88.8) 8.6 (2.4 to 14.9)
continued
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TABLE 6 Comparison of patient experience of services at 12 and 24 months (continued )
About the services
received in the last
12 months, to what
extent do you
agree that
12 months 24 months
Patients satisfied/in
agreement
Difference in
proportion of
patients satisfied
(intervention –
control) (95% CI)
Patients satisfied/in
agreement
Difference in
proportion of
patients satisfied
(intervention –
control) (95% CI)
Intervention,
n (%)
Control,
n (%)
Intervention,
n (%)
Control,
n (%)
You have been
involved as much as
you wanted to be
in decisions about
your care
211 (91.3) 213 (91.4) –0.1 (–5.2 to 5.0) 110 (94.0) 108 (89.3) 4.8 (–2.2 to 11.8)
You were able
to discuss your
preferences, beliefs
and concerns as part
of your care
211 (93.0) 208 (92.4) 0.5 (–4.3 to 5.3) 106 (93.0) 112 (91.8) 1.2 (–5.6 to 7.9)
You were told who
to contact if you
had any worries or
concerns
220 (94.4) 218 (93.6) 0.9 (–3.5 to 5.2) 110 (94.0) 116 (92.8) 1.2 (–5.0 to 7.5)
You were confident
that the staff you saw
had the right skills
and knowledge to
help you
223 (97.0) 223 (94.1) 2.9 (–0.9 to 6.6) 116 (97.5) 119 (94.4) 3.0 (–1.9 to 7.9)
You were treated
fairly, regardless
of your age, race,
sex, belief, sexual
orientation or
disability
223 (96.5) 228 (96.6) –0.1 (–3.4 to 3.2) 116 (99.2) 124 (96.9) 2.3 (–1.2 to 5.7)
You were given the
information you
wanted
220 (94.8) 219 (93.6) 1.2 (–3.0 to 5.5) 114 (96.6) 115 (92.0) 4.6 (–1.2 to 10.4)
You were able to see
the same health-care
professional/team
whenever possible
211 (92.5) 203 (87.1) 5.4 (–0.1 to 10.9) 103 (92.0) 107 (87.7) 4.3 (–3.4 to 12.0)
If you had important
questions to ask, you
got answers that you
could understand
212 (93.0) 212 (95.5) –2.5 (–6.8 to 1.8) 107 (93.0) 113 (92.6) 0.4 (–6.1 to 7.0)
If you needed more
than one service, staff
made sure they were
well co-ordinated
196 (91.2) 189 (88.7) 2.4 (–3.3 to 8.1) 91 (91.9) 95 (91.4) 0.6 (–7.0 to 8.2)
If you needed more
than one service, staff
made sure that your
care information was
clearly and accurately
shared
197 (92.1) 192 (89.7) 2.3 (–3.1 to 7.8) 91 (91.0) 94 (90.4) 0.6 (–7.4 to 8.6)
You were told who
to contact if you
had any ongoing
health-care needs
217 (93.1) 215 (91.5) 1.6 (–3.2 to 6.5) 110 (94.8) 115 (92.7) 2.1 (–4.0 to 8.2)
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cases was slightly lower in the intervention group (34%) than in the control group (39%) at 12 months,
with an adjusted OR of 0.83 (95% CI 0.55 to 1.25). This proportion was lower again by 24 months with
28% of the intervention group versus 38% of the control group considered to be cases, with an adjusted
OR of 0.64 (95% CI 0.41 to 0.99). For depression, the proportion of cases was lower in the intervention
group (29%) than the control group (40%) at 12 months, with an adjusted OR of 0.59 (95% CI 0.39 to
0.90), but only slightly lower by 24 months, with 34% in the intervention group versus 39% in the control
group adjusted OR 0.64, (95% CI 0.52 to 1.24).
Patient exploratory analyses
A set of prespecified exploratory analyses investigated whether or not there was an association between
the effectiveness of EXTRAS and pre-stroke health status (OHS), and baseline performance in activities of
daily living (NEADL Scale) and time in organised stroke care (inpatient and ESD).
Figure 5 shows the NEADL Scale scores at 24 months plotted against baseline NEADL Scale scores with
different symbols for study groups. Although this shows, not surprisingly, that those who had higher NEADL
Scale scores at baseline tended to have higher scores at 24 months, there does not seem to be an indication
that the relationship differs between study groups.
Figure 6 shows the NEADL Scale scores at 24 months plotted against pre-stroke health status (OHS) as pairs
of boxplots for intervention and control groups. Those patients with better health status pre stroke tended
to have higher NEADL Scale scores at 24 months, but there was little indication that the relationship differed
between study groups.
TABLE 6 Comparison of patient experience of services at 12 and 24 months (continued )
About the services
received in the last
12 months, to what
extent do you
agree that
12 months 24 months
Patients satisfied/in
agreement
Difference in
proportion of
patients satisfied
(intervention –
control) (95% CI)
Patients satisfied/in
agreement
Difference in
proportion of
patients satisfied
(intervention –
control) (95% CI)
Intervention,
n (%)
Control,
n (%)
Intervention,
n (%)
Control,
n (%)
Overall, how satisfied
are you with the
services you received?
228 (95.4) 227 (92.3) 3.1 (–1.1 to 7.4) 208 (97.7) 189 (87.5) 10.2 (5.3 to 15.0)
In the last 12 months,
have you had enough
help with speaking
difficulties from
the NHS?
79 (87.8) 89 (84.8) 3.0 (–6.6 to 12.7) 29 (69.1) 35 (63.6) 5.4 (–13.5 to 24.3)
In the last 12 months,
have you had enough
treatment to help
improve your mobility
from the NHS?
167 (82.7) 166 (76.2) 6.5 (–1.2 to 14.2) 95 (67.4) 81 (48.5) 18.9 (8.0 to 29.7)
In the last 12 months,
have you had enough
help with emotional
problems from
the NHS?
80 (70.8) 112 (76.7) –5.9 (–16.7 to 4.9) 52 (71.2) 59 (62.1) 9.1 (–5.1 to 23.4)
Bold text indicates statistically significant results.
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Figure 7 shows the NEADL Scale scores at 24 months plotted against length of organised stroke care with
different symbols for study groups. This shows, not surprisingly, that those who had experienced longer
organised stroke care tended to have lower (worse) NEADL Scale scores at 24 months, but there does not
seem to be an indication that the relationship differs between study groups.
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Patient outcome assessment blinding
Outcome assessments were conducted by telephone interview [12 months: n = 408/487 (84%); 24 months:
n = 371/450 (82%)], face-to-face assessment [12 months: n = 8/487 (2%); 24 months: n = 10/450 (2%)]
or postal questionnaire [12 months: n = 71/487 (15%); 24 months: n = 69/450 (15%)]. For assessments
conducted by telephone and face to face, it was intended that the researcher was blinded to study group.
At 12 months, 371 out of 416 (89%) assessments undertaken by phone or face to face were conducted
blinded to study group and at 24 months this was 363 out of 450 (81%). Data are shown in Appendix 2,
Table 39.
Patient safety data
1. Serious adverse events
Serious adverse events were reported for 125 out of 285 (43.9%) patients in the intervention group (total
250 events) and 130 out of 288 (45.1%) patients in the control group (total 254 events). The number of
events per patient is shown in Table 7. No significant differences were seen between the study groups.
The reasons for the reported events being considered to be SAEs are shown in Appendix 2, Table 40.
The most common reason for an event to be reported as a SAE was because it resulted in hospitalisation
(intervention group, n = 163; control group, n = 168). A total of 58 reported events resulted in death
(intervention group, n = 26; control group, n = 32). Note that in the retention flow diagram (see Figure 2),
23 participants in the intervention group and 32 participants in the control group are reported to be
deceased. The SAEs in the control group (n = 32) match the control group deaths (n = 32). In the intervention
group, the cause of death for two participants could not be established and no SAE form was received.
However, for a further five participants, a SAE was initially reported during their involvement in the study
but the date of death from this event was after their involvement ceased. For two out of five participants,
the date of death was after the 24-month outcome assessment; for three out of five participants, the date of
death was after withdrawal but within the study period.
A summary of the events that resulted in death is shown in Appendix 2, Table 41. A summary of all other
events is shown in Appendix 2, Table 42.
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During SAE reporting, a standard causality assessment was undertaken for all SAEs and none were reported
to be related to the study intervention.
As safety monitoring started from participant consent and this could be several weeks before randomisation
to a study group, some patients had SAEs reported before randomisation (16 patients, 19 events). These
data are shown in Appendix 2, Tables 43–45. In addition, some patients who were recruited but dropped
out of the study before randomisation had SAEs reported before their involvement in the study ended
(14 patients, 22 events). These data are shown in Appendix 2, Tables 46–48.
2. Non-serious adverse events
At each outcome assessment, patients were asked to self-report adverse events by means of the following
question: ‘Have you suffered any new medical illnesses in the last 12 months?’. Any events potentially
fulfilling the criteria to be a SAE were investigated and reported as SAEs, as appropriate. Such events are
included in Serious adverse events. All other events are reported here.
At 12 months, 66 out of 239 (27.6%) participants in the intervention group who had the assessment
conducted reported at least one non-serious AE. For the control group, this was 57 out of 248 (22.9%)
participants. The difference in proportions was 4.6% (95% CI –3.1% to 12.3%).
At 24 months, 53 out of 219 (24.2%) participants in the intervention group who had the assessment
conducted reported at least one non-serious AE. For the control group, this was 50 out of 231 (21.6%)
participants. The difference in proportions was 2.6% (95% CI –5.2% to 10.3%).
The number of events per participant is shown in Appendix 2, Table 49, and events are summarised in
Appendix 2, Table 50.
TABLE 7 Number of SAEs per patient
Number of SAEs per patient
Number of patients, n (%)
Difference in proportion (95% CI)
Intervention
(N= 285)
Control
(N= 288)
0 160 (56.1) 158 (54.9) 1.3 (–6.9 to 9.4)
1 70 (24.6) 69 (24.0) 0.6 (–6.4 to 7.6)
2 30 (10.5) 31 (10.8) –0.2 (–5.3 to 4.8)
3 11 (3.9) 17 (5.9) –2.0 (–5.6 to 4.8)
4 4 (1.4) 3 (1.0) 0.3 (–1.4 to 2.2)
5 3 (1.1) 3 (1.0) For > 4 events: 0.0 (–2.9 to 3.0)
6 2 (0.7) 4 (1.4)
7 1 (0.4) 3 (1.0)
8 2 (0.7) 0 (0.0)
9 1 (0.4) 0 (0.0)
12 1 (0.4) 0 (0.0)
Total events 250 254
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3. Injurious falls
Participants were asked to self-report injurious falls at outcome assessments by means of the following
question: ‘Have you suffered any falls resulting in injury in the last 12 months?’. To avoid undercounting falls
where an outcome assessment had not been conducted, SAE data were also examined. Participants were
recorded as suffering from ‘at least one’ injurious fall if they answered ‘yes’ to the self-report question at
either 12 or 24 months or if any SAE reports indicated that an injurious fall had occurred. Where a SAE
report was unclear about an injurious fall (e.g. the report documented a fractured hip but did not state
whether or not a fall had occurred), adjudication took place to determine whether or not the event
should be considered an injurious fall.
There were slightly more patients in the intervention group [82/285 (29%)] than in the control group
[74/288 (26%)] who suffered at least one injurious fall, but this difference was not significant: difference
in proportions 3.1 (95% CI –4.2 to 10.4).
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Chapter 4 Randomised controlled trial results:
carers
Carer enrolment
In the early months of the study, carer enrolment included a face-to-face consent process and a carer
recruitment assessment that was conducted at a similar time to the corresponding patient recruitment
assessment. Recruited carers were subsequently asked to self-complete a baseline questionnaire at the
time of the patient baseline assessment and randomisation. Owing to difficulties with identifying and
contacting carers to conduct the face-to-face consent and recruitment assessment, carer enrolment was
later modified to invitation by letter, with return of a self-completion baseline questionnaire indicating
consent to participate. The time point for this revised invitation was the patient baseline assessment and
randomisation (further details are given in Chapter 2).
Recruitment and/or baseline data were returned for 200 carers. Return per study centre is shown in
Appendix 2, Table 51. When the enrolment process for carers was modified (January 2014), staff collecting
patient baseline data were asked to record whether or not a carer had been identified and study invitation
paperwork had been issued. These data were not collected before this time and are therefore not available
for all patients. However, when these data were collected, staff reported inviting carers for 301 out of
440 patients (68%). For 80 out of 139 patients (58%) where a carer was not reported to be invited, the
reason provided was that no carer was identified. A full summary of reasons provided for not inviting a
carer to participate is shown in Appendix 2, Table 52.
Carer retention
Carer retention is illustrated in Figure 8. Where a recruited patient did not subsequently undergo
randomisation into the trial, the corresponding carer data collection also ceased. Of 200 enrolled carers,
six were associated with patients who were not randomised, resulting in 194 carers taking part in the
trial. Thirty-four percent of patients, therefore, had a carer who participated. Of the 194 participating
carers, 103 were associated with patients allocated to the intervention group and 91 were associated,
with patients allocated to the control group. Follow-up data were available for 166 out of 194 (86%)
carers at 12 months and 153 out of 194 (79%) carers at 24 months.
Carer baseline characteristics
The baseline characteristics of carers are shown in Table 8. Study groups were well matched. There were
more female carers, with the majority being retired, the spouse/partner of the patient and co-resident.
Carer outcomes
1. Caregiver strain
Table 9 shows the distribution of the CSI at baseline, 12 months and 24 months. At baseline, carers typically
reported low levels of strain, and there was little change over time for those who continued to provide data.
There was little difference in mean scores between study groups at any time point. The mean scores at
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24 months were 4.2 (SD 3.9) in the intervention group and 5.0 (SD 3.9) in the control group: an adjusted
difference in means of –1.0 (95% CI –2.3 to 0.2).
2. Experience of services
Table 10 shows the dichotomised responses to the experiences of services questionnaire for carers at 12
and 24 months. There were high levels of satisfaction for all aspects of experiences of care. The differences
in the percentage of carers who were satisfied between study groups were usually quite small, but the
95% CIs were quite wide. The wider CIs occurred when there was a high proportion of carers either not
completing that question or saying that it did not apply. The detailed breakdown of scores is shown in
Carers taking part
(n = 194)
Carer of patient in intervention
group
(n = 103)
Carer of patient in control
group
(n = 91)
Still in study at 12 months
(n = 100)
Still in study at 24 months
(n = 96)
Still in study at 24 months
(n = 76)
Still in study at 12 months
(n = 81)
• Patient withdrawn, n = 2
• Patient died, n = 1
• Patient withdrawn, n = 4
• Patient died, n = 6
• Patient withdrawn, n = 0
• Patient died, n = 4
• Patient withdrawn, n = 0
• Patient died, n = 5
Recruitment and/or baseline
data available
(n = 200)
Patient not randomised
(n = 6)
• 12-month data returned, n = 92
• Data not returned, n = 8
• 12-month data returned, n = 74
• Data not returned, n = 7
• 24-month data returned, n = 83
• Data not returned, n = 13
• 24-month data returned, n = 70
• Data not returned, n = 6
FIGURE 8 Carer retention.
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TABLE 8 Carer baseline characteristics
Characteristic
Patients allocated to
intervention
Patients allocated to
control
Sex, n (%) n = 102 n = 89
Male 30 (29.4) 24 (26.9)
Female 72 (70.6) 65 (73.0)
Age (years) n = 100 n = 82
Median (IQR) 66.5 (53.5–72.5) 67 (58–74)
Employment, n (%) n = 98 n = 84
Retired 63 (64.3) 59 (70.2)
Working full time 16 (16.3) 12 (14.3)
Working part time 19 (19.4) 13 (15.5)
Relationship to patient, n (%) n = 102 n = 87
Spouse/partner 86 (84.3) 76 (87.4)
Son/daughter (in-law) 11 (10.8) 7 (8.0)
Brother/sister 1 (1.0) 2 (2.3)
Other 4 (3.9) 2 (2.3)
Currently living with patient, n (%) n = 102 n = 87
Yes 91 (89.2) 82 (94.3)
No 11 (10.8) 5 (5.8)
If ‘yes’
Lived with patient before stroke 87 (95.6) 79 (98.8)
Patient moved in with carer after stroke 2 (2.2) 1 (1.3)
Carer moved in with patient after stroke 2 (2.2) 0 (0.0)
If ‘no’
Time to travel to patient’s home, median (IQR) 7.5 (4–15.5) 15 (6–30)
CSI (scored 0–13)a n = 99 n = 83
Mean (SD) 4.9 (3.6) 5.3 (4.0)
Time (days) after patient randomisation that carer baseline
questionnaire was completed
n = 96 n = 80
Median (IQR) 2 (0–6) 1 (0–3)
a Simple imputation used for partially completed questionnaires.
TABLE 9 Comparison of caregiver strain (CSI) from baseline to 24 months
Time point Intervention (n) Mean (SD) Control (n) Mean (SD)
Adjusteda mean difference
(intervention – control) (95% CI)
Baselineb 99 4.9 (3.6) 83 5.3 (4.0) NA
12 monthsb 92 4.8 (3.8) 74 5.3 (4.0) –0.7 (–1.9 to 0.5)
24 monthsb 80 4.2 (3.9) 67 5.0 (3.9) –1.0 (–2.3 to 0.2)
NA, not applicable.
a Adjusted for age and sex of carer and patient baseline OHS.
b With simple imputation for partially completed cases.
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TABLE 10 Comparison of carer experience of services at 12 and 24 months
About the
services, to what
extent do you
agree that
12 months 24 months
Carers satisfied/in
agreement
Difference in
proportion of
carers satisfied
(intervention –
control) (95% CI)
Carers satisfied/in
agreement
Difference in
proportion of
carers satisfied
(intervention –
control) (95% CI)
Intervention,a
n (%)
Control,a
n (%)
Intervention,a
n (%)
Control,a
n (%)
Staff were
welcoming and
friendly
83 (100) 69 (100) 0.0 52 (98.1) 34 (97.1) 1.0 (–5.7 to 7.6)
Staff treated your
relative/friend with
dignity and respect
83 (98.8) 68 (98.7) 0.3 (–3.4 to 3.9) 52 (98.1) 35 (100.0) –1.9 (–5.6 to 1.8)
Staff assessed your
relative’s/friend’s
needs
81 (96.4) 68 (98.6) –2.1 (–7.0 to 2.7) 48 (94.1) 32 (91.4) 2.7 (–8.6 to 14.0)
Staff met your
relative’s/friend’s
needs
77 (92.8) 66 (97.1) –4.3 (–11.2 to 2.6) 47 (90.4) 28 (80.0) 10.4 (–5.1 to 25.9)
You have been
involved as much as
you wanted to be
in decisions about
their care
76 (92.7) 64 (95.5) –2.8 (–10.3 to 4.7) 47 (92.2) 32 (88.9) 3.3 (–9.4 to 15.9)
You were able
to discuss your
preferences, beliefs
and concerns as
part of their care
71 (88.8) 58 (89.2) –0.5 (–10.7 to 9.8) 46 (95.8) 31 (91.2) 4.7 (–6.4 to 15.7)
You were told who
to contact if you
had any worries or
concerns
75 (88.2) 65 (92.9) –4.6 (–13.7 to 4.5) 52 (94.6) 29 (80.6) 14.0 (–0.3 to 28.2)
You were confident
that the staff your
relative/friend saw
had the right skills
and knowledge to
help them
81 (96.4) 67 (97.1) –0.7 (–6.3 to 4.9) 52 (94.6) 34 (100.0) –5.5 (–11.5 to 0.5)
Your relative/friend
was treated fairly,
regardless of their
age, race, sex,
belief, sexual
orientation or
disability
84 (97.7) 71 (100.0) –2.3 (–5.5 to 0.9) 56 (96.6) 35 (94.6) 2.0 (–6.7 to 10.6)
You were given the
information you
wanted
77 (92.8) 64 (92.8) 0.02 (–8.3 to 8.3) 50 (92.6) 31 (91.2) 1.4 (–10.4 to 13.2)
Your relative/friend
was able to see the
same health-care
professional/team
whenever possible
73 (89.0) 58 (86.6) 2.5 (–8.2 to 13.1) 50 (94.3) 29 (85.3) 9.0 (–4.4 to 22.5)
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TABLE 10 Comparison of carer experience of services at 12 and 24 months (continued )
About the
services, to what
extent do you
agree that
12 months 24 months
Carers satisfied/in
agreement
Difference in
proportion of
carers satisfied
(intervention –
control) (95% CI)
Carers satisfied/in
agreement
Difference in
proportion of
carers satisfied
(intervention –
control) (95% CI)
Intervention,a
n (%)
Control,a
n (%)
Intervention,a
n (%)
Control,a
n (%)
If you had
important questions
to ask, you got
answers that you
could understand
77 (95.1) 61 (91.0) 4.0 (–4.3 to 12.3) 47 (95.9) 32 (97.0) –1.1 (–9.1 to 7.0)
If your relative/
friend needed more
than one service,
staff made sure
they were well
co-ordinated
70 (88.6) 51 (85.0) 3.6 (–7.8 to 15.0) 41 (93.2) 25 (89.3) 3.9 (–9.8 to 17.6)
If your friend/
relative needed
more than one
service, staff made
sure that their care
information was
clearly and
accurately shared
72 (92.3) 54 (88.5) 3.8 (–6.2 to 13.7) 39 (90.7) 25 (89.3) 1.4 (–13.0 to 15.8)
You were told who
to contact if your
relative/friend had
any ongoing
health-care needs
74 (88.1) 62 (91.2) –3.1 (–12.7 to 6.6) 45 (88.2) 31 (88.6) –0.3 (–14.1 to 13.4)
Overall, how
satisfied are you
with the services
your friend/relative
received?
84 (92.3) 65 (91.6) 0.8 (–7.7 to 9.2) 68 (94.4) 40 (78.4) 16.0 (3.6 to 28.5)
In the last
12 months, has your
relative/friend had
enough help with
speaking difficulties
from the NHS?
23 (74.2) 21 (80.8) –6.6 (–28.2 to 15.0) 16 (72.7) 12 (70.6) 2.1 (–26.4 to 30.7)
In the last
12 months, has your
relative/friend had
enough treatment to
help improve their
mobility from the
NHS?
65 (83.3) 43 (69.4) 14.0 (–0.2 to 28.1) 39 (75.0) 18 (40.0) 35.0 (16.5 to 53.5)
In the last
12 months, has
your relative/friend
had enough help
with emotional
problems from
the NHS?
46 (79.3) 30 (68.2) 11.1 (–6.1 to 28.4) 24 (66.7) 22 (61.1) 5.6 (–16.6 to 27.7)
a The denominator for each question may change as the patients who responded ‘did not apply’ are excluded from these
analyses. The numbers who responded for each question can be found in Appendix 2, Table 53.
DOI: 10.3310/hta24240 HEALTH TECHNOLOGY ASSESSMENT 2020 VOL. 24 NO. 24
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Shaw et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
39
Appendix 2, Table 53. This table shows that by 24 months, approximately half of the carers were reporting
that each question ‘did not apply’.
Nevertheless, there were 2 out of 19 aspects of care at 24 months where the 95% CI for the differences in
percentage satisfied between groups did not cover the value zero. The ‘overall satisfaction’ at 24 months
(question ‘Overall, how satisfied are you with the services your friend/relative received?’) was 94.4% in the
intervention group compared with 78.4% in the control group, a difference of 16.0% (95% CI 3.6% to
28.5%). The satisfaction with ‘help with mobility’ was 75.0% in the intervention group compared with
40.0% in the control group, a difference of 35% (95% CI 16.5% to 53.5%).
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Chapter 5 Delivery and implementation of EXTRAS
S taff delivering EXTRAS reviews completed study-specific paperwork and data were uploaded onto thestudy database. These data are reported in this chapter.
The EXTRAS paperwork recorded the content of each review, including the method of conduct (telephone
or face to face), rehabilitation issue identification, goals or action points set and action plans made. A record
of why a review was not undertaken was documented if relevant. Data that concerned the rehabilitation
issues identified, goals/action points set and action plans made were free text. To analyse these data, the
free text for each rehabilitation issue and goal/action point was examined and coded to map onto the
rehabilitation areas, which were prespecified for discussion in the semistructured interview (e.g. mobility
issue, personal care goal). Free text for action plans was also examined and coded. Full details of this
analysis are given in Action plans.
EXTRAS reviews also included the assessment of goal and action point achievement, and the details of
these data and analysis are provided in Goal and action point achievement.
EXTRAS reviews conducted
It was intended that each patient in the intervention group would participate in an EXTRAS review at
five time points during their involvement in the trial. These reviews were scheduled for 1, 3, 6, 12 and
18 months following randomisation (which occurred at discharge from ESD). However, because of death
or withdrawal from the study, the expected number of reviews decreased for some participants. Table 11
illustrates the number of reviews expected to be conducted at each time point, the number actually
conducted and the mode of the reviews. Overall, 86% (1155/1338) of expected EXTRAS reviews were
undertaken. Per participant, the median number of EXTRAS reviews received was five (full details of
expected and undertaken reviews per participant are found in Appendix 2, Table 54).
TABLE 11 EXTRAS review conduct, by review stage
Review stage
(month)
Reviews expected
to be conducted,a n
Reviews conducted,
n (% of expected) Mode of review, n (%)
1 282 258 (91) Telephone: 201 (78)
Face to face: 47 (18)
Missing: 10 (4)
3 276 245 (89) Telephone: 191 (78)
Face to face: 45 (18)
Missing: 9 (4)
6 269 231 (86) Telephone: 185 (80)
Face to face: 40 (17)
Missing: 6 (3)
12 262 211 (81) Telephone: 167 (79)
Face to face: 43 (20)
Missing: 1 (< 1)
18 249 210 (84) Telephone: 170 (81)
Face to face: 40 (19)
a Expected: removal of deaths and withdrawals.
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In addition to study withdrawal and death, reasons were recorded for other lack of review conduct. The
most common reason for a review not being conducted was inability to contact the patient, in that they
did not answer the telephone when the reviewer called. A summary of the reasons for all non-conducted
reviews is shown in Appendix 2, Table 55.
EXTRAS reviews could be conducted by any senior member of the ESD team. In total, 649 (56%) reviews
were conducted by a physiotherapist, 320 (28%) were conducted by an occupational therapist, 98 (8%)
were conducted by a nurse, and 58 (5%) were conducted by a speech and language therapist (SLT). A
detailed breakdown of staff involved in each review, including banding, is shown in Appendix 2, Table 56.
Services were encouraged to provide the same reviewer for each participant’s EXTRAS review. Of 258
patients who completed at least two reviews, 167 (65%) had the same reviewer for all their reviews,
77 (30%) had two reviewers and 13 (5%) had three reviewers. One patient received reviews from four
different individuals.
Rehabilitation issues and goals/action points
Rehabilitation issues were assessed over 12 prespecified domains plus an ‘other’ category to capture any
issues identified that fell outside those 12 domains. The domains were mobility; personal care; mealtimes;
domestic activities; work and volunteering; hobbies and interests; driving and transport; communication;
memory and concentration; mood, anxiety and depression; medical issues; and pain. Each domain was
further categorised into prespecified ‘activity issues’ to guide assessment. Following identification of
rehabilitation issues, it was intended that up to five would be prioritised and used to formulate goals or
action points.
Table 12 shows the number of rehabilitation issues identified and prioritised at each EXTRAS review. Most
patients identified rehabilitation issues at each review, but some did not prioritise any issues. At the 1-month
review, the median number of priority rehabilitation issues was three; at the 18-month review, it was zero.
Patients could have multiple priority rehabilitation issues in multiple domains. Proportions of patients with
issue(s) in each domain are illustrated in Figure 9. A breakdown of the identified activity issues within
a domain is shown in Appendix 2, Table 57. Mobility issues were the most common priority rehabilitation
issue at each review stage. Hobbies and interests were also a common priority. Medical issues increased
over the duration of the study.
TABLE 12 Number of rehabilitation issues identified
1 month
(N= 258)a
3 months
(N= 245)a
6 months
(N= 231)a
12 months
(N= 211)a
18 months
(N= 210)a
One or more issues
identified, n (%)
247 (96) 230 (94) 211 (91) 184 (87) 148 (70)
One or more priority
rehabilitation issues, n (%)
187 (72) 164 (67) 145 (63) 108 (51) 74 (35)
No issues, n (%) 11 (4) 15 (6) 20 (9) 27 (13) 62 (30)
Number of priority rehabilitation issues
Minimum 0 0 0 0 0
Median (IQR) 3 (0–4) 2 (0–3) 1 (0–3) 1 (0–2) 0 (0–1)
Maximum 6 7 8 8 7
a N =, number of patients completing a review.
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FIGURE 9 Priority rehabilitation issues.
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Table 13 shows the numbers of goals/action points set at each review. More patients had goals/action
points recorded at each review stage than had priority issues recorded (see Table 12). This is probably
because of an administrative error, in that issues were identified as priorities during the review (and used
to formulate goals/action points) but were not marked as priority issues in the study paperwork.
The goals/action points per domain is illustrated in Figure 10. Unsurprisingly, the nature of goals/action
points set at each review stage mirrored the priority rehabilitation issues.
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(b)
FIGURE 10 Goals/action points by domain at each EXTRAS review. (a) 1month, 742 goals/action points were set in total;
(b) 3 months, 547 goals/action points were set in total; (c) 6 months, 427 goals/action points were set in total; (d) 12 months,
313 goals/action points were set in total; and (e) 18 months, 146 goals/action points were set in total. (continued)
TABLE 13 Numbers of goals/action points set at each EXTRAS review
1 month
(n= 258)a
3 months
(n= 245)a
6 months
(n= 231)a
12 months
(n= 211)a
18 months
(n= 210)a
Patients with one or more goals/action
points recorded, n (%)
233 (90) 200 (82) 180 (78) 142 (67) 79 (38)
Number of goals/action points
Minimum 0 0 0 0 0
Median (IQR) 3 (2–4) 2 (1–3) 2 (1–3) 1 (0–3) 0 (0–1)
Maximum 9 8 8 5 6
a N =, number of patients completing a review.
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FIGURE 10 Goals/action points by domain at each EXTRAS review. (a) 1month, 742 goals/action points were set in total;
(b) 3months, 547 goals/action points were set in total; (c) 6 months, 427 goals/action points were set in total; (d) 12 months,
313 goals/action points were set in total; and (e) 18 months, 146 goals/action points were set in total.
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Action plans
Action plans were intended to be set for each goal/action point. Depending on the review stage, between
97% and 99% of goals/action points had an action plan (see Appendix 2, Table 58). The free text of the
action plans was coded into different ‘actions’ and these actions were categorised as the responsibility of
the reviewer, patient or carer. Each action plan could have multiple actions. The analysis includes actions
that were completed during the review (e.g. advice to patient, information to patient) as well as actions to
be carried out at some point after the review. Table 14 shows descriptions and/or examples of the free text
that was coded as each action where this was not evident from the action code.
Figure 11 shows that the most common action taken by reviewers was giving advice to the patient. Advice
was recorded in 71–75% of action plans (depending on the review stage). Referrals to other services were
recorded in 5–9% of action plans. The most common action to be taken by patients was to practise the
activity that the goal related to (e.g. outdoor mobility). This featured in 22–34% of action plans.
Table 15 shows the breakdown of action plans by the domains of the associated goals/action points.
TABLE 14 Descriptors of action codes
Action code Description/example of free text (if required)
Reviewer actions
Advice to patient Advice/encouragement given
Liaise with HSCP Liaise with the HSCPs treating the patient
Referral to make
Referral to follow-up
Provide aid Source aid/equipment for the patient
Information to patient
Signposting Signposted the patient to local/community/voluntary service
Patient actions
Attend therapy (Continue to) attend therapy session/group or review with the therapist (PT, OT, SLT, sensory
team, counsellor/psychologist)
Liaise with employment
contact
Discuss with employer/mentor/human resources/advisor
Review information Seek/review information (e.g. internet search), self-monitor symptoms (e.g. fatigue)
Obtain aid/equipment Obtain aid/adaptation/equipment (e.g. adapted cutlery, memory aid)
Practise activity The activity that the goal relates to
Practise exercises For example, home exercise programme, memory strategies
Lifestyle change For example, healthy eating, fitness, exercise referral scheme
Arrange activity Arrange/attend activity, for example social activity (not therapy)
Liaise with HCP Seek advice/treatment from non-therapy health-care professional (e.g. GP, dietitian, orthoptist,
audiologist)
Liaise with other Seek advice/help from non-health-care professional (e.g. DVLA, mobility centre, social worker)
Carer action
Carer action For example, make appointment on patient’s behalf
DVLA, Driver and Vehicle Licensing Agency; GP, general practitioner; HCP, health-care professional; HSCP, health and social
care professional; OT, occupational therapist; PT, physiotherapist.
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FIGURE 11 Action plan composition. HCP, health-care professional; HSCP, health and social care professional.
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TABLE 15 Actions in the action plans, by domain
Action
Mobility
(n= 446)
Personal care
(n= 118)
Mealtimes
(n= 141)
Domestic
activities
(n= 159)
Work and
volunteering
(n= 106)
Hobbies and
interests
(n= 276)
Driving and
transport
(n= 178)
Communication
(n= 127)
Memory and
concentration
(n= 58)
Mood, anxiety
and depression
(n= 75)
Medical
issues
(n= 220)
Pain
(n= 98)
Other
issues
(n= 172)
Reviewer actions, n (%)
Advice to patient 322 (72) 86 (73) 113 (80) 131 (82) 72 (68) 193 (70) 103 (58) 104 (82) 41 (71) 54 (72) 140 (64) 75 (77) 113 (66)
Signposting 10 (2) 11 (9) 6 (4) 4 (3) 8 (8) 9 (3) 28 (16) 2 (2) 2 (3) 14 (19) 15 (7) 7 (7) 18 (10)
Information 13 (3) 5 (4) 16 (11) 6 (4) 2 (2) 5 (2) 9 (5) 9 (7) 2 (3) 4 (5) 19 (9) 1 (1) 19 (11)
Referral to make 52 (12) 6 (5) 7 (5) 4 (3) 6 (6) 7 (3) 5 (3) 10 (8) 5 (9) 9 (12) 17 (8) 7 (7) 17 (10)
Referral to follow-up 5 (1) 1 (1) 2 (1) 0 (0) 0 (0) 0 (0) 2 (1) 1 (1) 4 (7) 1 (1) 5 (2) 1 (1) 3 (2)
Liaise with HSCP 38 (9) 20 (17) 15 (11) 9 (6) 5 (5) 9 (3) 10 (6) 9 (7) 7 (12) 9 (12) 21 (10) 11 (11) 15 (9)
Provide aid 0 (0) 1 (1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (2) 0 (0) 0 (0) 0 (0) 2 (2) 1 (1)
Patient actions, n (%)
Arrange activity 2 (< 0.5) 0 (0) 2 (1) 2 (1) 11 (10) 57 (21) 7 (4) 0 (0) 1 (2) 4 (5) 7 (3) 0 (0) 6 (3)
Attend therapy 140 (31) 19 (16) 24 (17) 25 (16) 10 (9) 24 (9) 12 (7) 26 (20) 6 (10) 5 (7) 10 (5) 28 (29) 20 (12)
Lifestyle change 27 (6) 2 (2) 16 (11) 6 (4) 1 (1) 10 (4) 3 (2) 0 (0) 0 (0) 1 (1) 68 (31) 2 (2) 9 (5)
Practise activity 205 (46) 47 (40) 44 (31) 95 (60) 13 (12) 113 (41) 37 (21) 59 (46) 17 (29) 2 (3) 9 (4) 3 (3) 15 (9)
Practise exercises 83 (19) 22 (19) 27 (19) 24 (15) 5 (5) 20 (7) 5 (3) 33 (26) 9 (16) 3 (4) 5 (2) 19 (19) 31 (18)
Review information 24 (5) 9 (8) 19 (13) 17 (11) 21 (20) 27 (10) 26 (15) 9 (7) 4 (7) 10 (13) 31 (14) 2 (2) 48 (28)
Obtain aid/
equipment
7 (2) 5 (4) 18 (13) 4 (3) 0 (0) 4 (1) 1 (1) 2 (2) 2 (3) 0 (0) 6 (3) 0 (0) 2 (1)
Liaise with HCP 38 (9) 14 (12) 11 (8) 3 (2) 17 (16) 23 (8) 51 (29) 11 (9) 6 (10) 40 (53) 75 (34) 49 (50) 31 (18)
Liaise with other 7 (2) 7 (6) 5 (4) 3 (2) 13 (12) 6 (2) 44 (25) 1 (1) 0 (0) 4 (5) 3 (1) 0 (0) 16 (9)
Liaise with
employment contact
0 (0) 0 (0) 0 (0) 0 (0) 18 (17) 0 (0) 0 (0) 0 (0) 0 (0) 1 (1) 0 (0) 0 (0) 0 (0)
Carer action, n (%) 6 (1) 1 (1) 3 (2) 2 (1) 1 (1) 4 (1) 1 (1) 1 (1) 1 (2) 0 (0) 2 (1) 0 (0) 4 (2)
No action plan, n (%) 14 (3) 1 (1) 2 (1) 6 (4) 4 (4) 15 (5) 4 (2) 1 (1) 1 (2) 2 (3) 1 (< 0.5) 0 (0) 3 (2)
HCP, health-care professional; HSCP, health and social care professional.
Note
N = total goals/action points in the domain.
D
ELIVERY
A
N
D
IM
PLEM
EN
TA
TIO
N
O
F
EXTRA
S
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
48
During the coding of individual action plans, it was noted that advice, information and/or signposting
offered by the reviewers was usually complemented by an action for the patient to do something based on
that advice. Given this, it was felt that presenting these separately (see Figure 11) was masking the extent
to which the action plans concerned what the patient was going to do. A second analysis was therefore
undertaken where each action plan was placed into a single category that was felt to best describe the
main action(s) in the plan. For example, if the plan involved only the patient/carer undertaking actions
following advice/information/signposting from the reviewer, this was categorised as a patient/carer action
only. This analysis is shown in Table 16 and illustrates that 80% of the action plans focused on what the
patient was going to do.
One of the actions that a reviewer could take was to refer the patient to another service. During the trial,
117 unique referrals (intentions to refer) were recorded. A total of 162 action plans included a referral,
but some referrals were recorded more than once for the same patient at different review stages. The
most common referrals were to physiotherapy (n = 20 patients; 7%), occupational therapy (n = 16 patients;
6%) or an exercise group/referral scheme (n = 14 patients; 5%). Full details about referrals are shown in
Appendix 2, Table 59.
Goal and action point achievement
Over the five EXTRAS reviews, a total of 2175 goals/action points were recorded. The process for recording
and evaluating goals was as follows:
l Goals were given a baseline score indicating the patient’s status regarding that goal.
l Goals that were set at the first four review stages were evaluated in the subsequent review and rated
on the extent to which they had been achieved. The exception was goals with a longer time frame than
the next review, for example a goal set at the 1-month review that was to be achieved by the 6-month
review would not need to be evaluated at the 3-month review.
l The goal evaluation rating is on a six-point scale representing descriptors of progress towards the goal,
from ‘yes (achieved), much better than expected’ to ‘no (not achieved), worse than baseline’.
l Goals/action points set at the 18-month review (n = 146) were not evaluated.
The process for evaluating action points was to assign as ‘yes (achieved)’ or ‘no (not achieved)’. Neither a
baseline score nor a rating was required.
Unfortunately, the study paperwork did not prompt the reviewer to record whether an entry was a goal or
an action point. Because of this, these data were analysed in two ways.
First, Table 17 shows whether any entry was reported as achieved or not, broken down across the domains.
TABLE 16 Main actions in action plans
Action
Number of goals
(N= 2175), n (%)
Patient/carer action(s) only 1735 (80)
Reviewera action(s) only 202 (9)
Both reviewera and patient/carer actions 155 (7)
Reviewer advice, signposting or information only 29 (1)
No action plan 54 (2)
a Includes liaise with health and social care professional, referral to make, referral to follow-up and provide aid.
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Second, some assumptions were made to determine which entries were goals and which entries were
action points for separate analyses. An entry was defined as a goal where the record included a baseline
score and an evaluation rating on the six-point scale described above. An entry was defined as an action
point if there was no baseline score and there was an evaluation of ‘yes (achieved)’ or ‘no (not achieved)’.
Using these definitions, 524 out of 2029 (26%) of the entries were unclassifiable as goals or action points.
Table 18 shows the separated goal and action point evaluation.
When goals/action points were not achieved by the next review (and the goal/action point was not
intended to be ongoing beyond that review), the reviewer was prompted to record a reason. This was
completed for 594 out of 688 (86%) of the non-achieved goals/action points. For 73% (500/688) of the
non-achieved goals/action points, the reason seemed to be related to the patients’ circumstances. Reasons
included patients not being motivated or changing their mind about the goal; co-existing conditions or
illness; and having limited opportunities to carry out the action plan (e.g. lack of time or poor weather).
In 7% (49/688) of cases, the reason was service related; most often the patient was awaiting input or a
decision from a service such as community therapy or the Driver and Vehicle Licensing Agency. Another
7% (45/688) of comments reported that the patient had not made sufficient progress to meet a goal.
For the remaining 14% (94/688), no reason was recorded.
Differences between study centres
The number of patients randomised to receive EXTRAS at each study centre ranged from 3 to 41. The
proportion of reviews that were conducted (of those expected to be conducted, i.e. removing deaths and
withdrawals) ranged from 53% to 100%, as shown in Figure 12. Detailed data, including reasons for
non-conduct of reviews by study centres, are available in Appendix 2, Table 60.
Study centres could choose which staff to involve in the delivery of EXTRAS. In some centres, reviews were
predominantly undertaken by one member of staff and in others it could be multiple members of staff; one
TABLE 17 Goal/action point achievement at the first four EXTRAS reviews
Domain
Combined goals
and action points, n
Achieved,a
n (%)
Not achieved,b
n (%)
Not recorded,c
n (%)
Mobility 419 224 (53) 152 (36) 43 (10)
Personal care 113 52 (46) 44 (39) 17 (15)
Mealtimes 135 75 (56) 45 (33) 15 (11)
Domestic activities 155 93 (60) 47 (30) 15 (10)
Work and volunteering 105 53 (50) 41 (39) 11 (10)
Hobbies and interests 254 105 (41) 120 (47) 29 (11)
Driving and transport 164 81 (49) 59 (36) 24 (15)
Communication 122 65 (53) 35 (29) 22 (18)
Memory and concentration 57 26 (46) 16 (28) 15 (26)
Mood, anxiety and depression 69 44 (64) 16 (23) 9 (13)
Medical issues 196 99 (51) 52 (27) 45 (23)
Pain 86 50 (58) 22 (26) 14 (16)
Other issues 153 89 (58) 39 (25) 25 (16)
Total 2029 1057 (52) 688 (34) 284 (14)
a Includes ‘Yes, much better than expected’, ‘Yes, little better than expected’, ‘Yes, as expected’ and ‘Only Yes reported’.
b Includes ‘No, partially achieved’, ‘No, same as baseline’, ‘No, worse than baseline’ and ‘Only No reported’.
c Any goal/action point where achievement data were not provided including achievement not being assessed because of
reviews not being undertaken (e.g. patient death).
DELIVERY AND IMPLEMENTATION OF EXTRAS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
50
TABLE 18 Goal and action point evaluation, by domain
Mobility Personal Mealtimes
Domestic
activities
Work and
volunteering
Hobbies and
interests
Driving and
transport Communication
Memory and
concentration
Mood, anxiety
and depression
Medical
issues Pain
Other
issues Total
Goal achievement rating
Total goals 325 80 103 129 78 199 116 87 30 41 92 52 88 1420
Achieved, n (%) 189 (58) 45 (56) 65 (63) 85 (66) 40 (51) 94 (47) 66 (57) 55 (63) 17 (57) 28 (68) 48 (52) 33 (63) 55 (63) 820 (58)
Much better
than expected,
n (%)
41 (13) 5 (6) 7 (7) 9 (7) 4 (5) 26 (13) 13 (11) 7 (8) 3 (10) 2 (5) 7 (8) 6 (12) 8 (9) 138 (10)
Little better
than expected,
n (%)
38 (12) 10 (13) 14 (14) 28 (22) 8 (10) 21 (11) 10 (9) 17 (20) 7 (23) 7 (17) 3 (3) 12 (23) 10 (11) 185 (13)
As expected,
n (%)
110 (34) 30 (38) 44 (43) 48 (37) 28 (36) 47 (24) 43 (37) 31 (36) 7 (23) 19 (46) 38 (41) 15 (29) 37 (42) 497 (35)
Not achieved,
n (%)
136 (42) 35 (44) 38 (37) 44 (34) 38 (49) 105 (53) 50 (43) 32 (37) 13 (43) 13 (32) 44 (48) 19 (37) 33 (38) 600 (42)
Partially
achieved, n (%)
59 (18) 14 (18) 19 (18) 19 (15) 14 (18) 40 (20) 9 (8) 17 (20) 6 (20) 4 (10) 14 (15) 9 (17) 13 (15) 237 (17)
Same as
baseline, n (%)
58 (18) 19 (24) 18 (17) 23 (18) 21 (27) 59 (30) 37 (32) 15 (17) 7 (23) 8 (20) 29 (32) 9 (17) 19 (22) 322 (23)
Worse than
baseline, n (%)
19 (6) 2 (3) 1 (1) 2 (2) 3 (4) 6 (3) 4 (3) 0 (0) 0 (0) 1 (2) 1 (1) 1 (2) 1 (1) 41 (3)
Action point rating
Total action
points, n
9 1 3 3 8 3 6 6 2 9 20 6 8 85
Achieved, n (%) 9 (100) 1 (100) 3 (100) 3 (100) 6 (75) 2 (67) 4 (67) 5 (58) 1 (50) 9 (100) 14 (70) 6 (100) 8 (100) 71 (84)
Not achieved,
n (%)
0 (0) 0 (0) 0 (0) 0 (0) 2 (25) 1 (33) 2 (33) 1 (17) 1 (50) 0 (0) 6 (30) 0 (0) 0 (0) 14 (16)
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study centre involved 16 members of staff at the 1-month review stage. In 7 out of the 19 study centres, at
least half of the patients had the same reviewer over the course of the intervention (see Appendix 2, Table 61).
Individual staff members conducted a minimum of 1 and a maximum of 28 reviews at one specific review
stage (see Appendix 2, Table 62).
The number of goals/action points set per patient over the reviews varied across the study centres, for
example the median number of goals/action points ranged from 2 to 13 (Figure 13).
In most of the action plans, it was recorded that reviewers offered advice, signposting and/or information,
and this was generally complemented by an action for the patient to do something based on that advice.
In Figure 14, advice, signposting and information from the reviewer are excluded from the ‘reviewer
action’ category. Figure 14 shows that, at most study centres, most of the action plans focus on what the
patient is going to do.
Reviews conducted (% of expected)
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FIGURE 12 Review completion as a proportion of review completion expected, per study centre.
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FIGURE 13 Goals/action points set per patient, by study centre.
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FIGURE 14 Ownership of action plans by study centre. n= number of goals/action points set at the study centre. Advice, signposting and information from the review are
excluded from the ‘reviewer action’ category.
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Chapter 6 Patient, carer and staff interviews
As part of the process evaluation, we undertook interviews with samples of patients and carersparticipating in the trial, staff involved in delivering EXTRAS and therapists working for community
rehabilitation services.
Aim and objectives
The overall aim was to seek the views and experiences of patients, carers and rehabilitation staff about the
community rehabilitation that they received or provided. Underpinning this aim were three objectives with
associated question areas, shown below. The objectives/questions map on to sections of this chapter.
l Objective 1: to understand rehabilitation staff, patient and carer experiences of usual care.
Question areas –
¢ Staff experiences of delivering usual care to stroke patients.
¢ Patient and carer experiences of usual care after stroke.
l Objective 2: to understand staff experiences of EXTRAS.
Question areas –
¢ Staff experiences of preparing for and delivering EXTRAS, including the service context.
¢ Staff views on factors that promoted or challenged the delivery of EXTRAS.
¢ Staff views on the benefits and/or disadvantages experienced by patients and carers receiving EXTRAS.
¢ Staff views on the impact of provision of EXTRAS on other community stroke services.
l Objective 3: to understand patient and carer experiences of EXTRAS.
Question areas –
¢ Patient and carer experiences of EXTRAS.
If EXTRAS was found to be effective, the interview study would help us to understand for which patients
and under which circumstances the new service appeared to ‘work’, and to identify improvements that
could be made to promote provision of EXTRAS in clinical practice. If the service was not found to be
effective, the interview study would help to identify possible causes, such as poor delivery, poor patient
response, an inadequate design or another reason.
Patient and carer interviews: methods
Interviews were semistructured and conducted in the patients’ own home or care home by the research
assistant (RA) (patients and carers had the option to request an alternative venue, e.g. their local hospital).
Interviews lasted between 25 and 40 minutes (median 30 minutes).
The topic guide was based on examples used in previous studies that were led by the process evaluation
lead (CM) and was informed by literature on stroke rehabilitation experiences.60–62
Patients and carers were asked about their rehabilitation needs after their current stroke (physical, emotional,
social), their experience of health care and rehabilitation, and about any unmet needs. Intervention group
patients and carers were asked for their views about the reviews that they received as part of EXTRAS.
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The RA piloted the topic guide in face-to-face interviews with three stroke survivors not involved in the
EXTRAS trial (all male, aged 30–75 years) who were recruited from the King’s College London Stroke
Research Patients and Family Group. A carer participated in one of the interviews. As volunteers reported
that the questions were clear and they did not find the interview burdensome, no changes were made to
the topic guide.
We included a limited number of study centres in the patient and carer study to ensure that fieldwork was
feasible. Nine study centres were selected. Study centre selection was based on:
l number of recruited participants (centres that had recruited higher numbers of participants were
preferred as they created a larger potential sampling frame)
l achieving a range of regions and urban/rural settings.
We decided not to devise an overall sampling frame at the outset of data collection; for pragmatic reasons, we
wanted to identify groups of patients in the same geographical region who could potentially be interviewed
within an agreed time window (3 months after their 24-month assessment). Multiple sampling frames were,
therefore, identified over the course of the trial. At the start of the study, all patients and carers in the frame
were sampled because of small numbers. As recruitment progressed, we prioritised sampling patients with
characteristics under-represented among those interviewed in each study group [i.e. age, sex and health status
at baseline (OHS34)]. As the interview data analysis proceeded concurrently, the RA continued to sample
patients until no new themes relevant to the research aim and objectives were created.
Inclusion criteria for inviting patients to interview:
l current participant in the EXTRAS trial at one of the nine selected study centres
l able to give consent to participate in the patient and carer interview study.
Exclusion criteria:
l withdrawn from the study
l refused contact about the interview study when asked during the 24-month outcome assessment
l cognitive impairment or aphasia of a degree that they would be unable to participate in an interview
(identified by comments on outcome assessment records).
In total, 34 patients and their carers (when the carer was participating in the study, n = 6) were informed
about the patient and carer interview study and invited to take part by letter (with a study information
sheet) and a follow-up telephone call. Patients and carers received separate letters. All except one of the
carers were cohabiting with the patient. One carer lived separately from the patient so was telephoned
separately. A total of 20 patients and 6 carers participated.
In total, 10 intervention patients, 10 control patients and 6 carers participated in the interview study.
Table 19 shows respondent characteristics, including baseline and 24-month data, although only patient
sex, age and baseline health status (OHS34) were considered when sampling.
Interviews were conducted after patients’ final (24-month) outcome assessment was completed to avoid
influencing their outcome assessment responses. At the end of the outcome assessment, the assessor
informed patients that they might be contacted by another RA (Eleanor Stevens) about the patient and
carer study; any comments or refusals were recorded.
The RA confirmed and sought signed consent, including permission to record the interview, from
the patient and separately from their carer (where applicable) using standard forms at the interview
appointment. Carers were asked whether or not they would prefer to be interviewed separately, but all
preferred to be interviewed jointly with the patient. In the interviews with two intervention and two
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control patients whose carers were not participating in the study, it was their preference that their carer
(spouse/partner) was present during the interview.
The RA was given only the names and contact details of patients and carers who were part of the interview
sample and who the trial co-ordinating centre confirmed would be able to take part in an interview. These
details were passed to the RA via telephone calls from the trial co-ordinating centre and held in a password-
protected computer file, with access limited to the RA only.
Staff interviews: methods
The staff interviews were semistructured and conducted by telephone. They were intended to take place
within 6 weeks of the last 18-month (final) review of EXTRAS at a study centre. Owing to a combination
of a delay in finalising the interview topic guides and staff unavailability, four interviews with EXTRAS staff
were conducted much later than this time window. Identifying and recruiting community rehabilitation
staff tended to take several weeks, so only two of the community rehabilitation staff interviews were
conducted within 6 weeks of the last 18-month review. Interviews lasted between 20 and 50 minutes
(median 25 minutes).
Two versions of the topic guide were developed for staff who provided EXTRAS and for community
rehabilitation staff, respectively. These were informed by literature on community stroke rehabilitation and
process evaluation.61,63–65 Both versions included questions about the provision of longer-term support for
TABLE 19 Respondent characteristics: patient and carer interviews
Characteristic Intervention patients (n= 10) Control patients (n= 10)
Sex (n)
Male 8 5
Female 2 5
Age at interview (years)
Median (IQR) 73 (60–78) 70 (69–74)
Range 48–86 56–92
OHS baseline assessment scorea
Median (IQR) 2 (1–3) 2 (2–3)
Range 1–4 1–5
OHS 24-month assessment score
Median (IQR) 2 (1–3) 3 (2–3)
Range 1–4 1–5
NEADL Scale baseline assessment score
Median (IQR) 43 (30–63) 42 (30–50)
Range 17–66 8–66
NEADL Scale 24-month outcome assessment score
Median (IQR) 57 (28–65) 34 (21–54)
Range 16–66 6–66
Carer participation
Carer took part in study and participated in interview (n) 4 (1 daughter,
3 female spouses/partners)
2 (1 male spouse/partner,
1 female spouse/partner)
a Baseline OHS scores (and baseline NEADL33) were not available for one intervention patient because of missing data.
DOI: 10.3310/hta24240 HEALTH TECHNOLOGY ASSESSMENT 2020 VOL. 24 NO. 24
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Shaw et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
57
stroke patients and carers in their locality (i.e. usual care), and any changes to their service during the
intervention delivery period.
EXTRAS staff were asked to describe and give their opinions on the preparation for and implementation
and impact of the new service, including how patients and carers responded, and their experiences of trial
procedures such as data management (if applicable).
Community rehabilitation staff were additionally asked about their experiences of delivering rehabilitation
to stroke patients, focusing on EADL and perceived barriers or facilitators.
The first two EXTRAS staff interviews and the first two community rehabilitation staff interviews were used
to pilot the topic guides. In response to their responses, a change was made to the EXTRAS staff topic
guide: one unclear/redundant question was omitted.
Sampling was purposive and aimed to include:
l One key member of EXTRAS staff from each of the 20 ESD services that participated in the trial
(at 1 of the 19 study centres, ESD was provided by two separate teams).
l Two or three community rehabilitation staff in each ESD service locality. These were staff in services to
which participating ESD teams regularly referred patients in usual care. These staff were not involved in
delivering EXTRAS.
EXTRAS staff were invited to participate by e-mail. If unwilling or unable to participate, they were asked
to nominate a colleague who had delivered the intervention. In the case of two ESD services, two staff
members were interviewed as the first staff member suggested that the second would be able to ‘fill gaps’
in responses.
EXTRAS staff were asked to nominate one or more community rehabilitation staff members as potential
respondents. The RA gained the nominees’ e-mail address where possible. Three community rehabilitation
staff did not respond to direct e-mail contact. At seven study centres, EXTRAS staff agreed to forward by
e-mail a summary of the interview to potential community rehabilitation staff respondents, which meant
that the RA did not have direct contact. This produced a nomination in three of those seven study centres.
Respondent characteristics are shown in Table 20. In total, 22 EXTRAS staff were interviewed; in two of
the ESD teams, two staff members were interviewed individually. At one study centre, the EXTRAS staff
respondent had conducted some of the EXTRAS reviews but was based in a neurology outpatient service,
not in an ESD team. A second person, who was a member of the ESD team, conducted the remaining
reviews at that study centre but was unavailable for interview. A total of 19 community rehabilitation staff
were interviewed. Five community rehabilitation staff worked in a participating ESD team for at least part
of the trial period but did not conduct EXTRAS reviews.
Invited staff were asked to consent via an e-mail to the RA once any queries were resolved. Consent,
including to record the discussion, was confirmed at the start of the interview. Respondent identities and
contact details were held in a password-protected computer file, with access limited to the RA.
Patient, carer and staff interviews: data analysis
Interviews were transcribed verbatim. A thematic approach to analysis was used.66 The analysis approach
was a combination of inductive (i.e. derived from the data themselves) and deductive (i.e. looking for
evidence pertaining to the study objectives and question areas, and to the key components of the
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intervention). The key components were identified through reviewing the trial protocol and the EXTRAS
manual, and through discussion with the study team:
l ongoing contact with advice, encouragement and signposting as appropriate
l regular structured review of rehabilitation needs
l goal-setting and action-planning
l route to referral.
An analysis framework was retrospectively applied to the staff interview data to structure the evidence on
promoters of and challenges to implementation of the EXTRAS intervention. Normalisation process theory
(NPT) was chosen because it is a general theory of how complex interventions become routinely embedded
in health services,67 and it has previously been applied retrospectively in a study of a community-based
stroke intervention.68 NPT categorises the operationalisation of implementing interventions into four
mechanisms: (1) coherence, (2) cognitive participation, (3) collective action and (4) reflexive monitoring.
Identifying staff responses relating to these mechanisms gives some insight into factors that could lead to
implementation success or failure.
Interview transcripts were managed and coded using NVivo qualitative data analysis software version 11
(QSR International, Warrington, UK). The RA (ES) checked and corrected transcripts and read them closely,
annotating as necessary to clarify responses. The meanings of responses were summarised into initial
codes. The lead investigator for the process evaluation (CM) independently coded a sample of transcripts.
The resulting codes were similar to those generated by the RA; a few additional codes were incorporated
into the coding process for other transcripts.
The initial codebooks developed as further transcripts were analysed and comparisons were made between
them: codes were added, amended and grouped into themes. ES and Christopher McKevitt discussed
themes generated from the data to agree which were highly relevant to the study aim and objectives and
would be included in this report, and which were emergent findings that could be explored in further
work. The analysis of the interview study and drafting of this chapter except the discussion was done prior
to the intervention outcomes being known.
TABLE 20 Respondent characteristics: staff interviews
Characteristic
EXTRAS staff (N= 22
interviewed, from 19 ESD
services and 1 neurology
outpatient service)
Community rehabilitation
staff (N= 19 interviewed,
nominations from
14/20 study centres)
Discipline, n (%)
Physiotherapy 10 (45) 14 (74)
Occupational therapy 6 (27) 3 (16)
Nursing 5 (23) 1 (5)
Speech and language therapy 1 (5) 1 (5)
Years in post
Median (IQR) 8 (3–8) 8 (3–13)
Range 3–23 3–23
Service type, n (%)
ESD 21 (95) 6 (32)
Community: generic 0 (0) 4 (21)
Community: neurology 0 (0) 3 (16)
Outpatients: neurology 1 (5) 5 (26)
Outpatients: generic 0 (0) 1 (5)
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Staff experiences of delivering usual care
This section draws on the interviews with staff who provided EXTRAS and community rehabilitation staff.
All but one EXTRAS staff who were interviewed were working in stroke ESD teams while the intervention
was being delivered. The community rehabilitation staff worked in a variety of services – stroke, neurological
and generic – and were therefore seeing different proportions of stroke patients in their caseloads. Some
staff dealt with mild–moderately affected stroke patients only, whereas others also treated more severely
affected patients. Some worked only with patients who had recently had a stroke; others (also) worked
with patients who had been referred back into their service several months post stroke.
Staff described supporting stroke patients and carers to address physical, emotional and psychosocial
rehabilitation issues and the impact of post-stroke fatigue. Some described seeing patients who had been
discharged home very quickly from hospital without any follow-up. After a period of ‘natural recovery’,
some of these patients would gain ‘rehabilitation potential’ or they would exhibit signs of cognitive
impairment that had not been identified or addressed during their inpatient stay. Patients would then
be referred [usually by their general practitioner (GP)] to their service.
In some areas, staff reported that stroke patients and carers who received usual care could expect good-
quality longer-term care with a range of services available and a clear pathway. For example, one area
offered an outpatient ‘life after stroke’ course that included monitored rehabilitation gym sessions, relevant
talks and peer support.
In other areas, staff described usual follow-up care after ESD as un-co-ordinated, unavailable or ‘stop-start’,
with patients experiencing delays while being referred between different services. Lack of services for
‘hidden’ (less apparent) issues such as fatigue and health anxieties was highlighted.
Staff mentioned that it could be challenging and demotivating for patients when they were stepped
down from intensive ESD therapies to community services, which are likely to be at a much lower intensity.
Staff said that they wanted to encourage self-management but there were not always services available to
support patients in this. Some staff also commented that it was hard to keep track of available patient and
family support services because their availability tended to change often.
The most commonly cited challenge to delivering rehabilitation for stroke patients was the time that staff
spent in meetings and undertaking administrative and management tasks. Individual staff reported other
challenges, such as:
l referrals not being appropriate or timely
l being the sole member of staff in their profession in a service
l travel time (domiciliary services in large catchment areas)
l in integrated teams – allocating resources between ESD patients and longer-term patients.
Patient and carer experiences of usual care
Patients and carers were asked about their experiences of health care and other forms of support provided
by health and social care professionals after their stroke. It is possible that some intervention patients/carers
could not distinguish rehabilitation provided as part of usual care from rehabilitation provided through
EXTRAS. Their views are included in this section if it was clear from the community services mapping work
(see Chapter 7) and from individuals’ intervention records that they were referring to services provided as
part of usual care in their area.
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Most patients and carers reported that therapy was provided very quickly after discharge from hospital.
Four patients (two from each of the control and the intervention samples) felt that delays in starting
rehabilitation in hospital, or recommencing rehabilitation once at home, had hindered their recovery.
Some patients and carers in both the intervention and the control samples described the care that they
received from the community stroke service and/or social services after the stroke as ‘faultless’. They believed
that enough therapy had been provided and that their level of recovery was as good as they could expect.
They tended to describe rehabilitation as ‘tailing off’ as the patient recovered. This group included patients
with ongoing disability from the stroke that significantly restricted their activities, as well as patients who
had made a near-complete recovery. It also included control patients who reported having no professional
rehabilitation and/or point of contact with stroke services beyond ESD: they did not feel that these things
were needed, and if they had any residual impairments they perceived that they were managing well. Carers
in this group felt well supported by the health and social care professionals involved in the patients’ care.
However, in both samples, some patients and carers were dissatisfied with the intensity/duration of
therapy and some felt that they had been ‘left to manage’ without adequate follow-up from health-care
professionals. This included control patients who had accessed NHS community rehabilitation for several
weeks beyond ESD. Some patients and carers felt this way despite reporting, or intervention records
indicating, that they had follow-up contact from social services or EXTRAS. For instance, one control group
patient felt ‘abandoned’ by the community rehabilitation team but described ongoing reablement support
from social services. Some carers reported that patients’ motivation and confidence to practise an activity,
for example walking outdoors, decreased once ESD ended and patients had no further therapy or less
intense therapy. These carers thought that ‘more therapy’ would have helped to sustain patients’
motivation to practise activities of daily living, ultimately reducing dependence on the carer.
Although some patients and carers felt discouraged once therapy was withdrawn and there was no follow-up
contact (that they recalled), several patients in both the intervention and the control samples were not
discouraged and sustained activities that they understood would promote recovery or maintenance after ESD
or further therapy had ended (e.g. gym sessions, ‘brain training’ puzzles). Some of these activities/changes
were prompted by health-care professionals (it is unclear whether or not these were EXTRAS staff), whereas
others were reported to be self-directed.
Apart from some patients’ and carers’ wish for further physical therapy, other needs not met by usual care
were counselling for health anxiety that had been exacerbated by the stroke (an intervention patient did
not want to wait several weeks for an NHS psychology appointment so used a private provider) and the
opportunity for further discussion with a stroke health-care professional about their risk factors for a
further stroke or potential for further recovery (these were control patients). One control patient who
did not report specific needs said he would have liked reassurance via follow-up contact:
I think they [stroke team staff] should spend a little bit more time with you. Even to the effect of
phoning you up and just saying, ‘How are you going? Any problems or anything we can do?’.
A courtesy call, that’s the main thing. I don’t think they should be spending a lot of their time
coming in and out, no. I’ve got everything.
C10, control patient
Staff experiences of EXTRAS
This section describes staff experiences of and views about delivering EXTRAS. Across the study centres,
staff reported a mixture of factors that promoted (‘promoters’) and factors that challenged (‘challenges’)
the delivery of EXTRAS and/or influenced their appraisal of it. These have been identified and framed by
drawing on NPT67 to analyse the 22 staff interviews. In the NPT framework, the work that people do
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around implementing an intervention can be described using four areas of work (‘constructs’) and activities
within these areas of work (‘components’). These are shown in Appendix 2, Table 63.
We report promoters and challenges identified by staff under relevant components of NPT. The interview
data did not include a promoter and challenger for every component. Inclusion of a promoter or challenge
does not imply that it was experienced by most staff or study centres, only that staff perceived it to have
potentially influenced intervention fidelity or the effectiveness of EXTRAS.
Coherence or sense-making
Differentiation
Promoters
l Perception that EXTRAS addressed an unmet need for ongoing contact and support, especially in areas
with limited access to follow-up.
l Observation that EXTRAS reviews were comprehensive, whereas reviews in usual care tended to focus
on medical matters or a single issue, for example mobility.
l Perception that goal-setting and action-planning was patient led and aimed to encourage self-
management. This was not always practised in usual care (e.g. action plans for goals set in usual care
might focus on what the therapists would do in therapy sessions, rather than what the patient would
do independently of the therapy sessions).
Challenge
l Observation by respondents in six services that similar reviews (at 6 months) and/or other ongoing contact,
such as a stroke co-ordinator, that offered a route to referral were already offered to patients in their area.
Communal specification
Promoter
l Following training, staff understood that the objectives of EXTRAS corresponded to its key components.
Individual specification
Promoters
l Attending training provided by the trial co-ordinating centre. Occasionally, staff acted outside their
remit for the trial (conducted an additional review or follow-up call for a patient; conducted
physiotherapy reviews when a need was identified), but staff were aware that this was not expected.
l Prior experience in reviewing patients and in goal-setting.
Challenges
Some staff were uncertain about:
l Whether or not they always needed to ask about all domains of need in the review when they were
confident that the patient had no needs in one or more domains. Staff tended to tailor the review
based on their familiarity with the specific patient.
l How to document the goal-setting and action-planning.
l When to arrange a home visit instead of a telephone call (some felt that a home visit might be more
appropriate for reasons other than patients’ difficulties with cognition, speech or hearing).
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Internalisation
Promoters
l Confidence that enhanced follow-up (beyond usual care) would benefit some/all patients based on their
understanding of existing research evidence.
l Perception that they could use the review data as evidence of unmet needs to inform future service provision.
Cognitive participation or relational work
Initiation
Promoter
l Each study centre had a named EXTRAS lead.
Challenge
l At a few study centres, when the original lead staff member left their post the handover of the
research/intervention was not smooth.
Enrolment
Promoter
l Perception of the intervention as an extension of ESD services.
Challenge
l View of staff or their managers that the intervention should be delivered by a community-based team
rather than a hospital-based ESD team.
Legitimation
Challenge
l Disapproval of any patient receiving the intervention only by telephone. A few staff thought that at least
one visit was necessary to understand how a patient coped in their home environment, and to identify
safety risks or carer strain. This was felt to be necessary so that advice given and goals set were appropriate.
Face-to-face interactions were felt to be important for encouraging discussion if patients were reticent:
Yes, I think if you are face to face with people, you can tease things out. You can see things, you
can introduce an idea, a suggestion to try to get them to open up. You can use all your counselling
skills for something like that, which over a phone is difficult, because you can only go on what
you’re hearing over the phone and only feedback on what they are giving you.
Study location 15, EXTRAS staff
Activation
Promoter
l Belief in the importance of the research for stroke care in general, even if staff did not anticipate that
EXTRAS would make a difference to patients locally.
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Challenges
l Sense of frustration if unable to contact therapists involved in a patient’s care to co-ordinate
action plans.
l View that being an ‘advice’ or ‘support’ service for those patients without rehabilitation goals was a
poor use of their time.
l Emotional discomfort or (in one case) the sense that the intervention was unethical if staff were unable
to offer appropriate support for an identified rehabilitation need:
The problem is, we felt that we were offering them something that we didn’t have. So we were
identifying they had rehab needs which we had to do as part of the trial, and then we were
coming to do a goal, action plan or whatever. It could have been like we would recommend this
person might be referred to neuropsychology, well we haven’t got one. So it was a little bit like
dangling the carrot and then not being able to give them it. So sometimes from an ethical point of
view, we felt a little bit uncomfortable [. . .] sometimes it was really awkward because we just sort
of said, ‘Well obviously we have identified there is a need there’, but we could not refer them on
to anybody.
Study location 8A, EXTRAS staff
Collective action or operational work
Relational integration
Challenge
l The perception that staff responsible for recruitment had ‘selected’ too many high-functioning patients
who did not have rehabilitation goals.
Interactional workability
Promoters
l Positive working relationships within the service and with other services – this was important for
referring appropriately and communicating goals/action plans to others treating the patient.
l Having sufficient time during the review contact to ‘tease out’ problems and explore solutions
with patients.
Challenges
l Time: each review plus the associated paperwork and actions took an average of 2 hours.
l Needing to prioritise clinical work over EXTRAS, so some reviews were missed.
l Frequent difficulties in contacting patients and needing to rearrange appointments, adding to the
burden on staff.
Contextual integration
Challenge
l Staff not being allocated protected time for providing EXTRAS.
PATIENT, CARER AND STAFF INTERVIEWS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
64
Skill-set workability
Promoters
l There was good communication between EXTRAS and other services involved in rehabilitating patients:
[. . .] just three or four patients from EXTRAS have come to us, but anyway they’ve been on the
books so it didn’t make much difference, actually. It was just like, after [intervention staff] used to
see [a patient] she [informed my team], ‘The patient has highlighted this need’. And the patient
was already on my books, I used to tell [intervention staff], ‘Yes, we have addressed those things’.
Study location 5, community staff
l Having knowledge about relevant local services and referral routes into these.
l Staff being allocated patients that they knew from ESD, or at least being matched according to their
discipline and the patient’s primary need.
Challenges
l Poor communication between EXTRAS and other services involved in rehabilitating patients. There was
the potential for unrealistic or inappropriate goals to be set in reviews:
[. . .] to be able to set goals when somebody’s still having ongoing therapy is extremely hard and
also, doing it blind, so over the phone you’re setting goals. You have no idea which are appropriate
or not [. . .] because 18 months down the line, you’ve got no idea what’s been tried and failed,
because we really struggle to have contact with physios that were seeing them in outpatients. [. . .]
I know we’re led by the patients, but if they don’t answer questions [about their active therapy,
abilities] as we need them to, then we’re possibly giving inappropriate advice.
Study location 12, EXTRAS staff
l Discomfort discussing with patients matters outside the staff member’s own discipline.
l Staff changes within EXTRAS – it was not always possible to hand over the conduct of reviews to
someone who knew the patient.
Reflexive monitoring or appraisal work
Individual appraisal and collective appraisal
Promoters
l Individual staff perceived benefits for patients: being a ‘sounding board’ for concerns; reducing isolation
by connecting patients and carers to services; offering an opportunity for the patient to reflect on their
status and achievements and ‘realise they were doing OK’; and supporting patients to ‘push themselves’
and gain confidence in their abilities:
I think from a kind of psychological point of view they were benefiting because I think they felt that,
‘Oh this is contact and it is still contact from the stroke team’, and that we were still caring and
listening to them. [. . .] they felt that they were getting some benefit even if it was just somebody sitting
down having a chat. Because sometimes it might not have even been around the goals or the action
plan, it might have been just the fact you are sitting having a chat, or you are giving them some advice.
Study location 8A, EXTRAS staff
l Individual staff perceived that early intervention in psychological or emotional issues probably
prevented referrals.
l Individual staff valued the opportunity to identify and address risks (safety/falls) or higher cognitive
problems that only became apparent several months after a patient’s stroke.
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Challenges
Individual staff observed that some patients:
l Did not share staff’s understanding of the reviews’ purpose and viewed them as a ‘check-up’ rather
than a ‘goal-setting exercise’.
l Did not want to/were not able to fully participate in goal-setting because of cognitive impairment, limited
insight into their own abilities or lack of motivation. Patients sometimes agreed to goals and then, when
these were evaluated at the next review, admitted that they were not personally meaningful.
l Became dependent on the review for help with problem-solving or for motivation (e.g. asking for
reviews between or beyond the scheduled reviews).
l Did not benefit in terms of outcomes:
[. . .] when I did their very last reviews, [patients] were very grateful; they wanted to thank the team for
all the support that they had had and one of them was quite sorry that the calls would be finishing.
[. . .] But from an outcome point of view, I didn’t feel anything had necessarily changed for them.
Study location 15, EXTRAS staff
l Found the review appointments inconvenient (one respondent reported consensus on this among
EXTRAS staff at her study centre), tiring or even distressing if they did not remember that they were a
trial participant or did not want to be reminded about their stroke.
At one study centre, the respondent said that staff agreed that later reviews (12-month and especially 18-month
reviews) were less useful. Few patients had new goals and needs became predominantly non-stroke related, for
example comorbidity, age-related decline in mobility or senses, or family problems.
Reconfiguration
Promoter
l Perceptions that the review content was useful, especially around emotional and social issues. In at
least two study centres, this resulted in changes to usual care being implemented after the study had
finished, that is incorporating some of the questions into 6-month reviews or planning a 6-week
telephone review based on the EXTRAS format.
Impact of EXTRAS on community rehabilitation staff and their services
According to the interviewed community rehabilitation staff, EXTRAS had little impact on community staff
and their services. The intervention data reported in Chapter 5 confirm that a very small number of new
referrals were made at any study centre.
At some study centres, more contact than usual was reported between EXTRAS staff and community
rehabilitation staff to discuss patient goals or referrals. This was not perceived as a substantial burden as
patient numbers were small.
Patient and carer experiences of EXTRAS
Patients tended to have poor recall of EXTRAS. The interviews took place at least 6 months after their
last EXTRAS review. Some patients whose records showed that they completed reviews and set goals
did not remember participating in any reviews and/or did not remember goal-setting . Patients’ responses
sometimes indicated that they confused EXTRAS reviews with the study outcome assessments. None of
the carers reported having participated in an EXTRAS review (this is confirmed by the study records).
PATIENT, CARER AND STAFF INTERVIEWS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
66
Carers’ knowledge of the reviews was based on what the patient had told them, so they tended to share
the patient’s view of the service.
Patients who remembered their reviews and were able to reflect on their experience of them, were
typically relatively young and had recovered well. They reported that:
l arrangements were convenient
l reviewers were personable and ‘helpful’ in terms of advice given
l reviews were reassuring and thorough in covering potential post-stroke issues
l repeated reviews over an extended period were targets/milestones for ‘weaning off’ support
(e.g. improving mobility to not need a walking stick).
Patients who had made a near-full recovery within the first 6 months or so of their stroke tended to feel
that the later reviews were not necessary for them.
A few patients described their reviews as a series of reviewer’s questions rather than as opportunities to
discuss current rehabilitation issues and personal goals. Most of these patients expressed satisfaction with
this approach. No patient or carer reported any disadvantage of participation.
Three patients in the intervention group complained about a lack of follow-up, yet records showed that
they had received EXTRAS reviews and had set goals. Two of these patients perceived an unmet need for
further therapy. One had completed all five reviews but said that he had not been contacted by any
health-care professional since ESD and was unhappy that his mobility had deteriorated since discharge
from hospital. He recalled ‘filling in a questionnaire’ that seemed to describe the study outcome
assessment rather than a review:
Well you get the feeling from the hospital’s point of view, that once you’re discharged you’ve, goodbye
cheerio. [. . .] I signed up for this [the study] in hospital. The girl that presented it, I thought I was going
to have more and more OT [occupational therapy] attention throughout a long period. But all it seems
to be is just a talking shop, and filling in a questionnaire; ‘How do you feel about this, that and the
other?’. As far as I’m concerned nothing has ever come about it, you know?
I7, intervention patient
The other patient was uncertain whether or not she had participated in reviews:
I think they [unidentified health-care professional] just rang us up and asked us different things.
That’s about it, I can’t remember anyone actually visiting us. I’m not saying they haven’t, but I can’t
remember. [. . .] Because I think if they had [provided ongoing rehabilitation], I’d have got this back
[arm function].
I3, intervention patient
The patients who recalled goal-setting in the reviews said that it motivated them. The evaluation of their
goals was an opportunity to reflect on their progress and have a sense of achievement:
[. . .] it felt like a continuing care, even if it is just a phone call. I hadn’t realised, I hadn’t thought about
it like that actually. It felt very important [. . .] it helped me see the improvement that I was making.
I1, intervention patient
These patients said that they had achieved what they wanted to in terms of their recovery.
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Discussion
The interview study has several findings that add to our understanding of how and in what context the
service was delivered, and that help to interpret the intervention data.
1. EXTRAS was not clearly distinct from usual care in some study centres.
Overall, staff bought into the general rationale for EXTRAS when they commenced the trial, but a minority
were not convinced that it was needed in their location as they felt that patients’ needs were already
being addressed and that goals were being set in community rehabilitation. In some areas, local services
already offered patients and carers an ongoing point of contact with a stroke-specialist health-care
professional or volunteer support officer; furthermore, in most areas, patients could be referred back
(usually via their GP) into a community rehabilitation service several months or even years after their
stroke. Nevertheless, several staff acknowledged that in their localities there were gaps in meeting some
longer-term needs, particularly psychological/emotional needs and higher-level cognitive impairment.
Some thought that an extended community stroke service could help to close those gaps, but this
would not necessarily use the EXTRAS design (e.g. it could be provided by a service other than ESD).
One of the aims of the intervention was to provide a route to referral, but study centres made very few
new referrals as a result of EXTRAS reviews. Interviewed staff indicated that this was mostly because
patients’ needs were already being addressed in community rehabilitation or occasionally because there
was a lack of suitable services to refer to. Consequently, the impact of EXTRAS on individual community
rehabilitation services appeared to be negligible.
The control group participants did not all experience an abrupt end to ongoing rehabilitation and care
after ESD, which was initially identified as a motivation for this trial in the protocol. A few control group
patients and carers described having been followed up by health and/or social care professionals for as
long as they needed. In addition, although some patients and carers in both groups expressed an unmet
need for follow-up or further health care, others reported that they had had no need for further support
after ESD and did not feel concerned when therapy finished: this reflects a finding of another interview
study with community-dwelling stroke survivors in the UK.69
The intervention patients and carers interviewed were not consistently more satisfied with their care than
the control sample, although some found that the intervention was helpful in terms of reassurance or
motivation to continue their self-practice. In contrast, the trial outcomes data show that the intervention
group was more likely to be satisfied with services. This was a relatively small interview sample and some
of the intervention sample did not recall having received the intervention. Interviews were conducted
> 6 months after the last EXTRAS review so as not to affect the 24-month outcome assessment.
2. EXTRAS was delivered with good fidelity to the protocol.
Evidence from the interview study corresponds to the intervention data findings that the fidelity of
intervention delivery was good, that is that EXTRAS was delivered as per protocol. However, some staff at
some study centres tailored the delivery of the EXTRAS review based on their prior knowledge of patients’
current rehabilitation status and issues, which meant that they did not ask questions they perceived to
be irrelevant. Staff were trained to deliver EXTRAS reviews and most had prior experience in conducting
reviews and/or goal-setting with stroke patients. The intervention was designed to be delivered by senior
members of ESD teams. In one study centre, several reviews were conducted by someone other than a
member of the ESD team owing to a lack of capacity in the ESD team: that reviewer was based in a service
that worked closely with ESD and saw patients as they transitioned from ESD. This arrangement made it
possible for the trial to run at that study centre, and as the centre randomised only a small number of
patients it seems unlikely that this exception would have affected overall trial outcomes.
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Patients were offered a regular structured review with ongoing support, advice and encouragement. The
intervention was designed to include carers, but carers were rarely involved in the reviews. According to
staff, the main reason for carers’ lack of involvement was that most reviews were conducted by telephone
with the patient only: carers could more readily be involved if reviews were conducted as home visits.
3. The context of the early supported discharge services affected delivery of EXTRAS.
Staff turnover meant that handover to other staff in the trial (if the lead staff member left) or handover of
patients was not always smooth, and there were sometimes time pressures where staff needed to prioritise
clinical duties over EXTRAS reviews. Nevertheless, the intervention data show that staff unavailability or
miscommunication regarding which patients were due to have a review did not significantly reduce the
rate of completion of reviews.
Positive working relationships within the service and with other services, and knowledge of local
non-statutory services, were perceived as important in being able to deliver the intervention. Conversely,
poor communication with other rehabilitation services meant that at some study centres the reviewers did
not know patients’ current rehabilitation plans and this made it difficult to co-ordinate care and to set goals.
4. Staff perceived some problems with the design of and patient recruitment to EXTRAS.
The primary outcome for the trial was the NEADL Scale at 24 months post randomisation. EXTRAS did
focus on EADL as well as emotional/psychosocial aspects of recovery. However, intervention staff were not
directly providing therapy, supervising practice of EADL activities or routinely conducting face-to-face
patient assessments. Some staff, therefore, believed that any benefit was likely to be psychological or
emotional and did not perceive that EXTRAS would have an effect on physical outcomes. The support,
advice, encouragement and reassurance offered to patients was perceived by staff to be the component
of EXTRAS from which patients were most likely to have benefited. Their view seems to be supported by
post hoc analysis of trial outcome data, which found fewer cases in the intervention group of anxiety at
24 months and depression at 12 months. Staff did consider that it was important that stroke survivors
received emotional/psychosocial support; however, some staff thought that patients’ need for this support
could be met without using so much of therapists’ time, for example by voluntary sector support services
or a stroke co-ordinator/specialist nurse.
Staff believed that the ongoing telephone contact from a stroke service was generally appreciated by
patients and carers but was inappropriate for some patients because of their cognitive problems. EXTRAS
did not have sufficient flexibility (resources) to offer domiciliary assessments routinely but the protocol did
enable face-to-face assessments to be undertaken at the discretion of a reviewer. Staff described clinical
rehabilitation activity in the community as being under various competing pressures, particularly because of
administrative and ‘information exchange’ activities. The time spent in information exchange has also been
found to limit therapy in stroke units.69,70
Staff gave other reasons for anticipating that the intervention would not be more effective on the NEADL
Scale than usual care. Some thought that the ‘wrong patients’ had been recruited at their study centre:
patients without significant rehabilitation needs who recovered quickly and patients with cognitive
difficulties who staff perceived could not engage in goal-setting. The goal-setting component of the
intervention raised issues for some staff who conducted the reviews. Staff described wanting to take a
patient-led approach because they believed that if patients set goals that were personally meaningful
then they would have more intrinsic motivation to achieve them. However, some staff also expressed
concern about goals being appropriate and achievable if they had not recently (or ever) seen the patient
in their home environment and were not sure what was being addressed in any community rehabilitation
the patient was receiving. In some circumstances, it may not be desirable for goals to be patient led if,
for example, patients lack insight or safety is a concern.71,72 As reviews were not directly observed,
it is unknown what proportion of goal-setting was patient led rather than therapist led. Other research
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suggests that therapists are not always good judges of whether rehabilitation is patient led or therapist led,73
and tend to overestimate the collaborative nature of goal-setting in stroke rehabilitation.74
Apart from the issue of setting appropriate goals by telephone, staff reflected that goal-setting was not
appropriate for all patients (whether in the intervention or usual care study group). Some staff described
this as patients ‘not engaging with’ goal-setting or not being ‘motivated’ to complete action plans. The
concept of ‘patient motivation’ has been critically evaluated in the literature;75 ‘unmotivated’ patients may
in fact be unclear on their role or feel that they do not have the knowledge necessary to take the lead.74
The problem of role is apparent in this interview study: patients did not always share staff’s understanding
of the purpose of the review. Some patients saw the reviews as check-ups and ‘not about goal-setting’.
In the interview sample, patients who remembered that they had been encouraged to set goals found
it helpful. If they instead described the reviews as check-ups, some valued this, but some did not because
it did not result in more therapy or a better understanding of their prognosis.
Strengths and limitations of the interview study
We conducted interviews with at least one EXTRAS staff member at all of the study centres (in one case
the respondent was not a member of an ESD team) and with community rehabilitation staff at most
locations. This enabled us to gather views about EXTRAS from staff working in a range of settings and
with varying levels of professional experience.
A smaller sample of patients and carers was recruited than envisaged in the protocol. There was some
evidence of patients having ‘research fatigue’76 by the point of recruitment to this interview study; some
who declined the interview said that they felt that they had contributed enough or had nothing further to
say. As with all voluntary research participation, there is the potential for non-response bias. However,
each sample did produce a range of opinions about the intervention and usual care.
The intervention patient sample was disproportionately male (80%) compared with the trial participants
overall (60% male). The control patient sample (50% male) was more similar to trial participants overall.
The interviews with patients, carers and staff, however, did not indicate that there was a sex difference in
response to the intervention.
Most patients in the intervention sample were not able to discuss EXTRAS in much detail (if at all). Those
who did recall the intervention in more detail tended to be younger and had made a good recovery;
in that sense they were not representative of the wider intervention group. The interviews took place
after the patients’ and carers’ 24-month outcome assessment, that is at least 6 months after the final
rehabilitation review, to avoid influencing participation in the outcome assessment. It was difficult for
respondents to recall the reviews, which were telephone conversations, after so much time had elapsed.
To have a more comprehensive understanding of patients’ and carers’ perceptions of what was helpful or
not about the rehabilitation reviews, it may have been better to schedule the interviews shortly after the
final review and risk a small proportion of patients/carers not wishing to complete the 24-month outcome
assessment. Given that these patients and carers agreed to an interview of up to 1 hour, it is possible that
they would still feel engaged enough with the study to complete the (shorter) outcome assessment some
months after the interview.
None of the carers (of intervention group patients) who participated in an interview had taken part in any
of the rehabilitation reviews. Our sampling approach excluded patients with cognitive or communication
impairments of a degree that they could not consent to or participate in an interview. This also excluded the
carers of those patients, who were perhaps more likely (than carers of patients without these impairments)
to have participated in a review alongside or on behalf of the patient. Carers participated in only 10% of
reviews overall and, given the other (temporal and geographical) restrictions on sampling, this targeting may
not have proved helpful in practice.
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Conclusion
The interpretation of the interview study findings concurs with the intervention data findings in pointing to
the intervention concept and design, rather than fidelity of delivery, as being an important reason for the
neutral result of the trial on the primary outcome and primary analyses. The support and advice offered
by the intervention was perceived to be beneficial for patients’ emotional health, but review, goal-setting
and evaluation without direct therapeutic intervention (whether or not the patient was still receiving therapy
in usual care) was not perceived to be necessarily effective in improving EADL. The recruitment of some
study centres that already offered extended contact with a community stroke service may also have limited
the potential intervention effect. Some staff thought that the patient case mix was likely to reduce the
potential of seeing an intervention effect as some patients had mild symptoms and recovered quickly,
whereas others had a cognitive impairment that made them unsuitable to receive a telephone review.
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Chapter 7 Routine rehabilitation service mapping
Aim and objectives
During the trial, a mapping exercise was undertaken to determine the routine rehabilitation and follow-up
services provided for stroke patients by each participating study centre, or by other organisations within
the vicinity of the study centre to which patients had access.
The objectives were:
l to describe the characteristics of ESD services at each participating study centre
l to identify the services to which patients may be signposted or referred for ongoing rehabilitation and
support in the longer term, after ESD.
Methods
Between May and September 2016, a RA (ES) conducted structured telephone interviews with a senior
member of each participating ESD team. Following an e-mail invitation, the interview questions were sent to
staff in advance and they were asked to read through the document in case any clarification was needed
and to obtain any readily available data relevant to the questions.
Interviews were digitally recorded and data were entered into a pro forma Microsoft Excel® (Microsoft
Corporation, Redmond, WA, USA) sheet for analysis. Prior to the start of the interview, all participants
provided consent to take part. Although there were 19 study centres taking part in the EXTRAS trial,
20 interviews were undertaken. This was because ESD was provided by two teams at one of the study centres.
Information about the ESD service was sought, including the criteria that patients needed to meet to be
eligible for the ESD service, the professional disciplines within the team, the service provision (e.g. duration
of rehabilitation) and the options available at discharge from ESD.
Information was also sought about routine stroke reviews undertaken post hospital discharge. The English
National Stroke Strategy 2007–201777 recommends that stroke patients should be reviewed at 6 weeks
and 6 months post discharge from hospital to assess their health and social needs and to optimise
secondary prevention.77 This is supported by a National Institute for Health and Care Excellence (NICE)
Quality Standard78 that requires provision of a structured health and social care review at 6 months and
1 year after stroke, and annually thereafter.78 Interviewees were asked about the local arrangements for
providing these reviews.
The interview also contained several prompt questions to identify and describe the community services that
were available to address one or more of the needs of stroke survivors after the ESD service was withdrawn.
Fourteen domains of need were included: (1) mobility and movement, (2) communication, (3) everyday
activities, (4) emotional and psychosocial issues, (5) impaired cognition, (6) nutrition, (7) visual disturbance,
(8) incontinence management, (9) support with relationships and sex, (10) pain management, (11) return to
work/volunteering, (12) return to driving, (13) healthier lifestyles and (14) support services (e.g. stroke-
specific information and advice). Interviewees were also asked if any services had been introduced or had
been withdrawn over the course of the trial.
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Results: characteristics of early supported discharge services at
participating study centres
Early supported discharge services were multidisciplinary teams (MDTs) that were provided as either a
stand-alone ESD service for stroke patients (n = 11, 55%) or an integrated ESD and community stroke
service (n = 9, 45%); that is, the same service provides both ESD and less intensive community stroke
rehabilitation.
The criteria that patients had to meet to be eligible to receive the ESD services are shown in Tables 21 and 22.
A total of 19 (95%) ESD services cared exclusively for stroke patients. One service provided ESD to both stroke
patients and those with brain injury. Services varied in terms of the patients’ level of independence in transfers
and in how recent the stroke must have been for the patient to be accepted into the service. Some services
required patients to have agreed rehabilitation goals by the time they were seen by ESD staff. A total of
11 (55%) ESD teams used other criteria to identify patients who could receive their service, for example
continence managed.
Table 23 illustrates the professional disciplines in the ESD teams, the service provision and the options for
rehabilitation after ESD. All ESD teams that participated in the trial had physiotherapy and occupational
therapy professionals. Two services did not have SLTs but accepted patients with speech disorders who
were treated by a separate service. Within the ESD teams, most of the direct patient care was provided by
rehabilitation assistants/associate practitioners/technical instructors, who followed plans set by therapists.
Provision of nursing and psychology expertise within the ESD team was not universal and was available
in 16 (80%) and 8 (40%) of the services, respectively. When nursing was not part of the ESD service,
most teams had access to community nursing services, but the availability of psychological services was
very limited.
A total of 14 (70%) of the ESD services operated 7 days per week, four (20%) services operated 5 days
per week and two (10%) operated 6 days per week. All services provided stroke rehabilitation at home
within 48 hours of patient discharge from the hospital as this was a criterion for being an EXTRAS site.
A total of 13 out of 14 services that were provided 7 days per week were able to visit patients at home
within 24 hours of hospital discharge.
Most (n = 18/20, 90%) of the services provided rehabilitation that they considered to be an ESD service
(i.e. intense rehabilitation following early discharge from hospital) for a time-limited period. The maximum
treatment period ranged from 2 to 12 weeks. Most commonly, the treatment period was 6 weeks (n = 15/20,
75% of services), with some flexibility on this limit in some services. However, two services did not have a limit
for how long they treated patients, instead discharging patients once agreed goals had been met or once
patients were judged to have no further rehabilitation potential.
After ESD rehabilitation was completed, if patients were judged to have further rehabilitation potential,
the next stage of the pathway varied according to the local service model and disciplines required.
Patients could be:
l referred to other stroke-specialist, neurospecialist or generic community services and discharged from
the service that delivered ESD (n = 12, 60%)
l referred to other community services but could continue with ESD therapists in specific circumstances,
such as if they needed an occupational therapist and no community occupational therapist was
available, or if there was thought to be a risk of deterioration during a long wait for community services
(n = 2, 10%)
l stepped down to the community strand of the service (n = 6, 30%).
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TABLE 21 Participating ESD services’ eligibility criteria 1
Location
Eligibility criteria
Flexible with criteria
Confirmed
diagnosis of
stroke
Medically
stable
Transfers independently/
assistance of one person
Identified
rehabilitation
goals
Aged
≥ 18 years
Able to provide
informed consent
Limit to time
since stroke
Other criteria
(see Table 22)
1 Yes but see
functional stroke
mimic patients
Yes No: accept if transfers with
assistance of two people
and safe between visits
Yes Yes No: best interest
basis if cognitive
impairment
No Yes No
2 Yes Yes Yes Yes Yes Yes Yes: up to 12 weeks
from date of stroke
No No
3 Yes Yes Yes Yes Yes Yes No Yes No
4 Yes Yes Yes Yes Yes No: next of kin
accepted
No Yes Yes: around assistance
of two people to transfer
5 Yes Yes No: transfers must be
manageable
Yes Yes No: best interest
basis if cognitive
impairment
No Yes Yes: if caseload allows
6 Yes Yes Yes Yes Yes No: next of kin
accepted
Yes: within 14 days
of stroke onset
Yes No
7 Yes Yes Yes Yes Yes Yes No No No
8A Yes Yes Yes No Yes Yes No Yes No
8B Yes Yes No: will accept if unable
to transfer with assistance
of one person
No Yes Yes No Yes Yes: if caseload allows
9A Yes Yes Yes Yes Yes Yes Yes: within 14 days
of stroke onset
No Yes: if caseload allows
9B Yes Yes No: up to with assistance
with two people
No Yes No: best interest
basis if cognitive
impairment
No Yes No
10 Yes Yes Yes Yes Yes No No Yes Yes: if caseload allows
11 Yes Yes Yes Yes Yes Yes No No Yes
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TABLE 21 Participating ESD services’ eligibility criteria 1 (continued )
Location
Eligibility criteria
Flexible with criteria
Confirmed
diagnosis of
stroke
Medically
stable
Transfers independently/
assistance of one person
Identified
rehabilitation
goals
Aged
≥ 18 years
Able to provide
informed consent
Limit to time
since stroke
Other criteria
(see Table 22)
12 Yes Yes Yes No Yes Yes Yes: 30 days post
onset
No No
13 Yes or acquired
brain injury
Yes Yes Yes Yes No: next of kin
accepted
No Yes Yes
14 Yes Yes Yes Yes Yes No: next of kin
accepted
Yes: within 14 days
of stroke onset
No No
15 Yes Yes Yes Yes Yes Yes No No Yes
16 Yes Yes No No Yes No: next of kin
accepted
No No Yes
17 Yes but see
patients with
stroke mimics
Yes Yes Yes Yes Yes No Yes Yes
18 Yes Yes Yes Yes Yes Yes No Yes No
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Results: post hospital discharge routine stroke reviews
Figure 15 shows whether or not routine reviews were offered to stroke patients in study locations at
around 6 weeks, 6 months, 12 months and annually thereafter, after discharge from hospital. Seventeen
(85%) locations offered 6-week reviews. These were provided by a consultant (n = 13), ESD team (n = 1),
specialist nurse (n = 1), stroke co-ordinator (n = 1) and the Stroke Association (n = 1). Seventeen locations
(85%) offered 6-month reviews; however, in one location, 6-month reviews were available for only city-
based patients. Six-month reviews were provided by a nurse (n = 8), the Stroke Association (n = 3), ESD
team (n = 2), stroke co-ordinator (n = 2), community stroke team (n = 1) and consultant (n = 1). The type of
nurse who provided the 6-month review was a stroke specialist nurse (n = 3), a district nurse (n = 1) and for
the other locations the type of nurse was not specified.
Staff interviewed in this mapping exercise had less knowledge about the provision of the 12-month and
the subsequent annual reviews. Respondents were aware that a 12-month review service was offered at
seven locations, not offered in nine locations and for the remaining four locations it was unknown if a
12-month review was offered. Reviews were provided by GPs (n = 4), combined GP and Stroke Association
(n = 1) Stroke Association (n = 1) and stroke co-ordinator (n = 1). Ongoing annual reviews were reported as
not being available in 13 (65%) locations, unknown in four locations, and, in the two locations where these
were offered, they were not universally available, being offered by only some general practices.
In the first year after discharge from hospital, two study locations offered one review, 12 locations offered
two reviews and five offered three reviews (however, note that at four locations, it is not known if a
12-month review was offered). One of the study locations did not routinely offer any reviews at the time
of data collection but was due to start offering 6-week reviews later that year.
Although not a specific question on the structured interview pro forma, review of the data collected
indicated that at 13 study locations a ‘stroke co-ordinator’ was available. These staff were commissioned
under various arrangements and had different remits. As above, in some areas they conducted post-
discharge routine reviews. In other areas, they provided information and support to patients, and in some
areas they appeared to be a point of contact should the patient wish to get in touch.
TABLE 22 Participating ESD services’ eligibility criteria 2: ‘other criteria’
Criterion Number of ESD teams (N= 20), n (%)
Continence managed 8 (40)
Home environment suitable/risk assessed 3 (15)
Nutrition managed 3 (15)
Cognitively able to cope at home 2 (10)
Medication managed 2 (10)
Risks minimised between visits 2 (10)
Able to communicate basic needs/raise alert 1 (5)
Able to cope with intensity of rehabilitation (physically/cognitively) 2 (10)
Care package arranged if needed 1 (5)
Lived in own home prior to stroke (not care home) 1 (5)
Low carer strain 1 (5)
Tissue viability 1 (5)
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TABLE 23 Professional disciplines, service provision and options for rehabilitation after ESD at participating ESD services
Location
ESD disciplines Provision
Rehabilitation after
ESDPT OT SLT
Rehabilitation
assistants Psychology Nursing Other
Maximum interval
from hospital
discharge to ESD
assessment/visit
(hours)
Service
availability
(days per
week)
Duration of
treatment in this
service (initial,
most intensive
period)
1 Yes Yes Yes Yes No Yes 24 7 2 weeks (some
flexibility to extend)
Separate community
services
2 Yes Yes Yes Yes Yes Yes Stroke care co-ordinator 48 5 6 weeks (some
flexibility to extend)
Separate community
services – ESD may
continue while patient
on waiting list
3 Yes Yes Yes Yes
(technicians)
No Yes Administrator 24 5 6 weeks Separate community
services
4 Yes Yes Yes Yes (associate
practitioners)
Yes Yes 24 7 6 weeks Step down to community
strand within same
service as ESD – no wait
5 Yes Yes Yes Yes No Yes Dietitian 48 7 10 weeks Separate community
services
6 Yes Yes Yes Yes Yes Yes Technical instructor,
social worker, stroke
information co-ordinator
24 7 6 weeks Step down to community
strand within same
service as ESD – no wait
7 Yes Yes Yes Yes Yes Yes 24 7 6 weeks (some
flexibility to extend)
Separate community
services
8A Yes Yes Yes Yes No Yes Stroke care co-ordinator
(nurse)
24 7 No time limit Separate community
services – ESD continues
to see patients who
need OT
8B Yes Yes Yes Yes No (access
to old-age
psychiatry)
No (access to
district nurse)
24 7 6 weeks (some
flexibility to extend)
Separate community
services – no wait
9A Yes Yes Yes Yes No Yes Stroke service team lead 24 7 6 weeks Step down to community
strand within same
service as ESD – no wait
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Location
ESD disciplines Provision
Rehabilitation after
ESDPT OT SLT
Rehabilitation
assistants Psychology Nursing Other
Maximum interval
from hospital
discharge to ESD
assessment/visit
(hours)
Service
availability
(days per
week)
Duration of
treatment in this
service (initial,
most intensive
period)
9B Yes Yes No Yes (associate
practitioners)
No Yes Health-care support
workers
24 7 No time limit Separate community
services
10 Yes Yes Yes Yes Yes Yes 24 6 6 weeks (some
flexibility to extend)
Separate community
services
11 Yes Yes Yes Yes No
(access to
psychology)a
Yes 24 7 6 weeks (some
flexibility to extend)
Separate community
services
12 Yes Yes Yes Yes Yes Yes 24 6 6 weeks Separate community
services
13 Yes Yes Yes Yes Yes Yes Stroke co-ordinator 24 7 6 weeks (some
flexibility to extend)
Step down to community
strand within same
service as ESD
14 Yes Yes Yes Yes (technical
instructors)
No Yes Stroke co-ordinator
(nurse)
48 5 6 weeks Step down to community
strand within same
service as ESD
15 Yes Yes Yes Yes Yes Yes 24 7 6 weeks Separate community
services
16 Yes Yes No Yes No No 48 5 6 weeks (some
flexibility to extend)
Separate community
services
17 Yes Yes Yes Yes No No (access to
stroke nurse and
nutrition nurse)
24 7 6 weeks (some
flexibility to extend,
except strict limit
for OT)
Separate community
services
18 Yes Yes Yes Yes No No (access to
nurse)
24 7 12 weeks Step down to community
strand within same
service as ESD
OT, occupational therapist; PT, physiotherapist.
a ESD team 11 expected to have a stroke-specific psychologist in place later in the EXTRAS delivery period.
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Results: community services available to stroke patients post early
supported discharge
Data collected about community service availability in terms of the 14 domains of need investigated are
summarised in Figure 16. A green entry indicates that a service(s) was available, a black entry indicates
that a service(s) was available but may not have been accessible by all patients treated by the ESD team
because of differing geographical boundaries for care, an amber entry indicates that available services
provided some limited care for this need and a red entry indicates no service provision.
Although many community services were available to support post-stroke needs in the different study
locations, several area respondents reported limited or no provision for emotional issues, relationship issues,
pain management and return to work. In addition, access to the available services could be complex. Data
about eligibility criteria were available for 116 out of 280 community services described in this mapping
exercise: 23 out of the 116 (20%) had criteria that excluded some stroke patients. Examples included
patients aged < 65 years who were excluded from psychology or psychiatry because the service was for
elderly patients; individuals with aphasia and/or who were housebound who were excluded from counselling
services as the service was by telephone or in an outpatient clinic. In 13 (65%) locations there was at least
one community service that would not be available to patients who lived in care homes.
Services varied in terms of stroke specificity, waiting times and duration of access. A summary of these
data for services addressing five key domains is illustrated in Table 24. In each of these five domains,
where waiting list information was available, approximate waiting times ranged from 1 to 26 weeks
between services waiting times could also vary within services as patients were prioritised according to
urgency of need. Details of the stroke specificity of services addressing all domains can be found in
Appendix 2, Tables 64–67.
In terms of referral to community services, this could be undertaken directly by the ESD for most services.
For some services, referrals needed to be made via the patient’s GP (e.g. specialist clinics for spasticity
and/or pain) or via a consultant (e.g. neuro-outpatient service). In some areas, referrals could be made by
a stroke co-ordinator. Most community services would, however, accept referrals at any time after stroke.
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FIGURE 15 Post hospital discharge routine stroke reviews in study locations.
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FIGURE 16 Summary of availability of community services to meet needs post stroke in study locations.
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Using the data obtained about the community services available in each study location, a series of diagrams
have been drawn to illustrate the referral options available at the end of ESD. Figure 17 shows study
location 1, which had an integrated ESD and community stroke team, and Figure 18 shows study
location 5, which had a stand-alone ESD team. Diagrams for other locations can be found in Appendix 2,
Figures 22–39.
Discussion
This mapping exercise has provided information about ESD services, availability of post hospital discharge
routine stroke reviews and community services in participating study centre locations.
To take part in the study, ESD services had to be MDTs that provided rehabilitation at home within 48 hours
of patient discharge from hospital for a time-limited period or had clear criteria for discharge of patients
from the service. All participating ESD teams continued to meet these criteria at the time of the mapping
exercise in 2016.
Although all participating ESD services met the criteria necessary to take part in the study, there were
some differences in their organisation and operation. The types of patients accepted differed, for example
in terms of required level of independence and time after stroke. Some teams were stand-alone ESD teams
and other teams were a combined ESD and community stroke service. The duration of rehabilitation
provided also varied. Some teams provided only 2 weeks of ESD rehabilitation whereas other teams had
no fixed time limit but discharged patients once agreed goals were met or there was judged to be no
further rehabilitation potential.
When compared with available national data on ESD services, the study ESD services were very similar,
except more study teams operated 7 days per week (see Appendix 2, Table 68).
Most, but not all, study locations provided 6-week and 6-month reviews post hospital discharge. Because
some data are missing about the provision of 12-month or later reviews, it is more difficult to be certain
TABLE 24 Service specificity, waiting list use and duration of access to community services to meet needs post
stroke in study locations
Mobility and
movement
(n= 54)
Communication
(n= 27)
Everyday
activities
(n= 32)
Emotional and
psychosocial
issues (n= 31)
Impaired
cognition
(n= 30)
Specificity, n (%)
Generic service 16 (30) 12 (44) 3 (41) 18 (58) 4 (13)
Neurological specific 28 (52) 7 (26) 11 (34) 8 (26) 16 (53)
Stroke specific 10 (19) 8 (30) 8 (25) 5 (16) 10 (33)
Waiting lists, n (%)
No waiting list 4 (7) 3 (11) 5 (16) 2 (6) 5 (17)
Waiting list used 29 (54) 19 (70) 17 (53) 15 (48) 15 (50)
Do not know 21 (39) 5 (19) 10 (31) 14 (45) 10 (33)
Duration of access, n (%)
Open-ended duration 29 (54) 16 (59) 22 (69) 10 (32) 15 (50)
Limited duration 6 (11) 4 (15) 5 (16) 7 (23) 5 (17)
Do not know duration 19 (35) 7 (26) 5 (16) 14 (45) 10 (33)
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ESD
< 2 weeks
Community therapy
service: PT, OT,
others
Community brain
injury service:
outpatient PT, OT, SLT,
neuropsychology,
rehabilitation
support workers, for
MDT needs
Voluntary sector
Stroke Association:
co-ordinators
(including 6-month
reviews),
communication
support group, peer
support
Driving assessment
centre
Day hospital
Community stroke
service: OT, PT, SLT,
nurses – open ended
Falls prevention
Psychological
interventions
(if MDT needs)
Intermediate care
services: PT, OT,
nurses
HSCP
Other community services:
cardiovascular and other supported exercise groups,
smoking cessation
Vocational
rehabilitation centre
Single disciplines:
community dietitian,
orthoptics,
continence specialist
nurse/advisor,
IAPT,
pain clinic 
HSCPs
SPoA
FIGURE 17 Referral options available at the end of ESD at study location 1. The arrows indicate that patients can self-refer back into the service. HSCP, health and social care
professional; IAPT, Improving Access to Psychological Therapies; OT, occupational therapist; PT, physiotherapist; SPoA, single point of access.
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Integrated ESD and CSTa
PT, OT, SLT, rehabilitation
assistants, nurse, dietitian
< 10 weeks 
Neuro-outpatient
PT 
Single disciplines:
community dietitian,
ophthalmology,
continence service,
IAPT,
orthotics,
adult domiciliary PT,
musculoskeletal physiotherapy,
speech and swallowing team
Voluntary sector
Other community
services:
healthy lifestyle
service,
smoking cessation
Spasticity service
Community
neurorehabilitation
centre day servicea
PT, OT,
psychology,
dietitian, MDT
needs
Consultant
HSCP
Community
neurorehabilitation
teama
PT, OT,
psychology,
dietitian, MDT
needs
• Stroke Association
• Life after stroke support
• Carers support organisation
• Driving assessment centre
• Relate
FIGURE 18 Referral options available at the end of ESD at study location 5. The arrows indicate that patients can self-refer back into the service. a, Part of community
neurorehabilitation service. CST, community stroke team; HSCPs, health and social care professionals; IAPT, Improving Access to Psychological Therapies; OT, occupational
therapist; PT, physiotherapist.
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about similarities or differences. However, it appears that fewer than half of the study locations were
providing 12-month reviews and possibly only two locations provided a later review. Overall, the majority of
study locations provided two post hospital discharge reviews in the first year after the patient left hospital
and there was very limited provision for such reviews thereafter. In most areas, the first of these two reviews
was undertaken at 6 weeks post discharge. As most ESD services were still providing support at 6 weeks,
reviews undertaken at this time would probably be conducted while patients were still in ESD care. This
indicates that routine structured follow-up after discharge from ESD services was limited. This is of importance
because EXTRAS commenced once ESD services ended and, therefore, was unlikely to significantly overlap
with regular routine follow-up services. Although 13 study locations had stroke co-ordinators, their roles
outside contributing to these routine reviews appeared to be variable; data provided by respondents did not
suggest that they were involved in further regular contact.
National data indicate that 49% of hospitals offered all patients a 6-month review, 43% offered a 6-month
review to only some patients and the remaining 8% of hospitals did not offer a review to any patients.79
This suggests that study locations were performing better in this regard.
The data collected about community services indicate that, in general, most study locations had services to
meet the majority of the needs explored. Exceptions to this were emotional needs, support with relationships,
pain management and return to work, where several locations had limited provision for these issues. However,
access to and operation of the services were very variable and some had lengthy waiting lists. For example,
patients could be waiting to access services such as physiotherapy, speech and language therapy or psychology
for up to 26 weeks in some places. This variability in community services was not surprising and is in keeping
with various publications from both before and during the trial.
Variability in community service availability and operation in the study locations suggests that care for
individuals post ESD was likely to differ. This has implications for both the control and the intervention
groups in the trial. Control group patients may have received different usual care and intervention group
patients may have received both different usual care and different care in relation to EXTRAS, which
interacted with existing services. However, location differences were expected and a priori it was planned
that all trial analyses would be adjusted for study centre.
This mapping exercise has some limitations. The data were collected from interviews with a senior member
of each ESD team participating in the trial. Although these staff were likely to be very knowledgeable
about their individual ESD service, their awareness of post hospital discharge reviews and community
service availability/operation was likely to have been more limited. Knowledge may also have been variable
depending on how an individual ESD team interacted with surrounding services. Indeed, some respondents
expressed uncertainty about describing the community services available and how they operated. This was
more noticeable with respondents who worked in ESD services where patients were discharged to community
services and ESD staff generally had no further contact with patients beyond the duration of their ESD
treatment. It would probably have been preferable to obtain mapping information from individuals working
within community services, but this would have been a considerably larger study and would have required
additional resources.
The diagrams illustrating the summary of community service availability and referral options after ESD were
assimilated by one researcher who pulled together the provided interview information. In retrospect, it may
have been useful to share these diagrams with the individual teams to check and improve accuracy, but
time did not allow for this to occur.
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Chapter 8 Health economic evaluation
Summary
The economic evaluation of the trial was undertaken to assess the value of an extended stroke rehabilitation
service provided for 18 months after ESD.
Cost per unit change in the NEADL Scale and QALYs for EXTRAS were assessed. Costs (in 2017 prices) are
presented from a health and social care perspective and uncertainty is presented as a cost-effectiveness
acceptability curve (CEAC) and as deterministic sensitivity analyses.
Over 2 years, EXTRAS was associated with lower costs than usual care (–£311, 95% CI –£3392 to £2787
less per person). Patients randomised to receive EXTRAS used, on average, more health-care services but
less social care services, mainly in the form of reduced home help and allowances. There was a 68%
chance that EXTRAS was cost saving. The CIs around the difference between the mean NEADL Scale
scores for the intervention and the control groups ruled out a clinically important difference. However,
in terms of the NEADL Scale, there was an 84% chance that EXTRAS would be cost saving.
EXTRAS provided more QALYs than usual care (0.07, 95% CI 0.01 to 0.12). Given the gain in QALYs and
the findings on cost differences, EXTRAS has a 90% chance of being considered cost-effective at 2 years
should society be willing to pay £20,000 per QALY. Sensitivity analyses, removal of outliers, alternative
EQ-5D-5L tariffs and removing imputed values did not alter this finding.
Despite no evidence of a meaningful difference in the primary outcome (NEADL Scale score) between the
study groups, provision of EXTRAS had a 68% chance of being cost saving in terms of QALYs. The changing
resource use pattern suggests that it is likely that provision of EXTRAS resulted in cost saving overall, but
there were likely to be extra costs to health services, which were offset by savings in social care. QALYs were
greater for patients who received EXTRAS. The QALY estimates arguably may capture wider impacts of
rehabilitation services beyond those captured by the NEADL Scale on patient outcomes. Given the impact on
costs and QALYs, there is a very high chance that EXTRAS would be considered cost-effective at conventional
thresholds for society’s willingness to pay (WTP) for a QALY.
Outline
EXTRAS provided regular contact between the patient and a senior ESD team member, usually by telephone,
at 1, 3, 6, 12 and 18 months post discharge from ESD. Each assessment consisted of a semistructured
interview to identify the patient’s progress, current rehabilitation needs and service provision. There
was then joint rehabilitation goal-setting and action-planning, which could consist of verbal advice and
encouragement; discussion with others involved in the patient’s care; signposting to local activities or
voluntary services; or referral to other services. The evaluation took an NHS and social care perspective to
judge whether or not EXTRAS was cost-effective, as judged by the incremental cost per QALY compared
with usual care after ESD services. A within-trial economic evaluation of costs per QALY over the 24 months
of the trial with a secondary analysis of cost per incremental increase in the primary outcome (the NEADL
Scale) was undertaken. The population was that of the main trial and their characteristics are shown in Table 1.
We also assessed the effect of EXTRAS on carers’ health-related quality of life (HRQoL) and QALYs.
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Methods
Overview
The evaluation was a within-trial analysis conducted over a 24-month time horizon, without extrapolation
or modelling. The EQ-5D-5L was used to estimate QALYs.43,80 The cost–utility analysis was reported as the
incremental cost per QALY gained over the 24-month trial period. QALYs were generated from individual
participant responses to the EQ-5D-5L.43 These responses were converted into utility values using the
appropriate tariffs for England (UK tariffs were not available).80 A CEA was also carried out, with results
reported as the incremental cost per unit gain in the NEADL Scale score during the trial period. Changes in
NEADL Scale scores were generated for each participant in both study groups.
Costs were based on the NHS and social care resources used by participants in each group of the trial.
These data were collected during the trial at individual participant level. Prices were obtained from NHS
Reference Costs 2015–1681 and the Personal Social Services Research Unit (PSSRU).82
Where relevant, stochastic sensitivity analysis, as recommended by NICE in Guide to the Method of
Technology Appraisal,83 was conducted. The analyses were conducted on an intention-to-treat basis.
In line with the good practice guidelines,83 both cost and health outcomes were discounted at the rate of
3.5% per annum in year 2, which is the recommended discount rate. The following equation was used for
generating a discounted outcome:
discounted outcome = original outcome / (1 + R)n, (1)
where R is the discount rate used and n is the number of years.
All health economic outcomes are reported using descriptive statistics appropriate to the type of data:
continuous variables or counts are reported as means and standard deviations (SDs) or medians and IQRs,
as appropriate to the distribution of the data. Dichotomous variables are reported as absolute numbers
and percentages. Differences in mean resource use, NEADL Scale scores and QALYs are reported, together
with bootstrapped 95% CIs.
The EQ-5D-5L was used to estimate QALYs.43,80 The EQ-5D-5L was completed by each participant at three
time points: baseline, 12 months and 24 months. As noted above, responses to the EQ-5D-5L were
converted into utility values using appropriate tariffs. The utility values were then converted into QALYs
using the area under the curve approach.84
All analyses were undertaken using Stata version 15.
Health-care resource use
Resource utilisation was recorded at baseline, 12 months and 24 months using an adapted version of the
CSRI.37–39 The following types of resource were included in each group of the trial.
EXTRAS:
l implementation costs along with the costs of senior ESD member involvement
l health and social care resources utilised by each patient over the 24-month trial period
l hospital resources utilised from post randomisation to death for patients who died within the
trial period.
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Usual care:
l health-care resources utilised by each patient over the 24-month trial period
l hospital and social care resources utilised from post randomisation to death for patients who died
within the trial period.
For patients who died during the 24-month follow-up period, post-randomisation costs were based on use
of hospital services until their death.
Costs: valuing resources
Unit costs for the resources used were obtained from routine sources, for example the PSSRU82 and the
NHS Reference Costs,81 when appropriate. Costs were those required to support one patient, which were
estimated as the average amount of resources used weighted by their unit costs. Costs were taken from
the most recent available price year (2016/17). Where the most recent cost data were not available,
available costs were adjusted to 2016/17 prices using the appropriate inflation index.83
EXTRAS reviews were provided at five time points: 1, 3, 6, 12 and 18 months post randomisation. Each
assessment required 2 hours of therapist time, which was costed at £44 per hour.82 The hourly cost was
assumed to be the cost per working hour of NHS band 6 staff. The cost of training professionals was not
considered in the analysis. Costs in the second year were discounted,83 which equates to a total intervention
cost of £437 per patient, using a 3.5% discount factor.
Outcome measures
Changes in HRQoL were derived from responses to the EQ-5D-5L at baseline, 12 months and 24 months.43,80
The EQ-5D-5L measures the health of the patient (utility) at that point in time over five dimensions (mobility,
self-care, usual activities, pain/discomfort and anxiety/depression), with each dimension having five levels;
therefore, a total of 3125 health states can be defined. Responses were valued using the England population
tariffs.80 The analysis utilised the EQ-5D-5L responses collected at baseline, 12 months and 24 months to
generate within-trial differences in HRQoL expressed as QALYs for each patient using the area under the
curve approach.85 One QALY is equivalent to 1 year lived with full health.
Using the QALY estimates derived for each participant, the mean QALY score for each group was calculated.
Differences in the patient characteristics between the two groups at baseline in terms of baseline utility,
centre, age and sex were accounted for when estimating QALY differences between groups. Information
about self-assessed health status was also collected using the VAS component as part of EQ-5D-5L. The VAS
asks respondents to rate their health on the day of completion on a scale of between 0 and 100, where
0 represents the worst imaginable state of health and 100 represents the best imaginable state of health.
Missing data
Complete-case analyses, using only cases with complete records of health outcomes and resource utilisation,
are likely to suffer from biases as there may be reasons why respondents were unable to provide data.
Therefore, our primary CEA used imputation methods to impute missing data. Missing variables were
tested for any pattern of missingness across both trial groups. When a cost item, or component of HRQoL,
was missing at random it is acceptable to exclude the missing cases if the regression controls for all of
the variables associated with the probability of missingness. In the event of partially completed measures,
the mean number of missing items was reported. Simple imputation based on means was used because
of the small numbers of missing data and this was tested with sensitivity analyses. In the case of EQ-5D-5L,
imputation was carried out at the utility score level. The missing resource use data were assumed to be
missing completely at random and the reported total costs are based on the non-imputed missing resource
use data. The available case analysis approach,86 which is considered more efficient than the complete-case
analysis, was followed for resource utilisation.
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Regression analysis
Differences in costs were estimated using a general linear model with a gamma distribution, with an
identity link function controlling for characteristics such as baseline costs, centre, age and sex to allow for
any heterogeneity between the intervention and control group populations.
Health outcomes were estimated by a linear regression based on an area under the curve technique,
controlling for baseline utility, age and sex to allow for any heterogeneity between treatment and control
populations.
Cost-effectiveness analysis
Costs for each participant were used to generate the average cost per participant in each group of the
trial, and thereby the incremental costs. QALYs estimated for each participant were used to generate the
average QALYs gained in each of the trial groups, along with the incremental QALYs. The same approach
was applied to the NEADL Scale scores. Possible imprecision around costs and QALYs was estimated as
95% CIs using parametric bootstrapping.87 An incremental cost-effectiveness ratio (ICER) was calculated as
the ratio of the difference in mean costs divided by the difference in mean effects between the intervention
and the control groups of the trial.
The primary analyses were based on data where imputation was used for missing NEADL Scale and QALY
data. Sensitivity analyses were conducted using non-imputed data (i.e. complete cases: patients with
complete outcome data), with the removal of any outliers in the cost and using an alternative variation
tariff for EQ-5D-5L. The net benefit when society was willing to pay £20,000 per QALY was estimated.
Net benefit involves putting a monetary value on any QALY differences by multiplying the mean QALY per
person by the value for a QALY. Net costs are then subtracted from this to give a net benefit value that is
reported in monetary terms.
Uncertainty and sensitivity analyses
The EXTRAS trial was not powered on health economic outcomes and may, therefore, be underpowered for
these outcomes. Therefore, estimation rather than hypothesis testing is appropriate when reporting results.
The focus of the analyses is on estimating cost-effectiveness, even when either the potential cost or the
effect differences lack conventional statistical significance. This is a standard way of conducting economic
evaluations and consistent with the approach adopted by NICE.
As well as a sensitivity analysis around the imputation of missing values, sensitivity analyses were performed
around key parameters affecting incremental cost-effectiveness. These are presented as a series of one-way
sensitivity analyses to test the impact of changes in one specific parameter on the results, for example
exploration of the impact of using alternative unit costs of resource utilisation.
A stochastic sensitivity analysis was also undertaken to explore the impact of uncertainties relating to
within-trial estimates of costs, effect and cost-effectiveness. As noted earlier, a parametric bootstrapping
technique was used to address the uncertainties around costs and effects and the results were used to
plot the cost-effectiveness plane and estimate the CIs in the costs and effects in both groups of the trial.
CEACs88 were used to visualise the probability that EXTRAS was cost-effective over a range of maximum
monetary values the decision-maker/NHS is willing to pay for a particular unit change in outcome.
Carers’ health-related quality of life
EQ-5D-5L responses were also collected from the carers of trial participants at baseline, 12 months and
24 months. The purpose of estimating any effect there might be on carers’ quality of life is that this could
be a factor for decision-makers to consider in relation to future provision of EXTRAS. As for patients,
an area under the curve method, controlling for baseline utility, was used to estimate QALYs and QALY
differences. Information about self-assessed health status was also collected from the VAS included as part
of the EQ-5D-5L. These data are not formally integrated into the cost-effectiveness or cost–utility analysis;
rather, they are used to aid interpretation of findings.
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Deviations from the study protocol
In the light of the results of the primary outcome, the plan for the economic evaluation was revisited
and two changes were made to the plan described in the study protocol. First, it was decided that the
extrapolation of long-term outcomes was not relevant because no significant difference was found
between randomisation groups at 24 months and, as such, no long-term differences would arise. Second,
it was decided to restrict the scope of the analyses to an NHS and Personal Social Services perspective.
Extending the scope of the evaluation towards a more societal one was intended to provide decision-
makers with additional information about the effects of EXTRAS. Given no significant change was found
in the primary outcome, we did not feel that this information would be of value to decision-makers.
Results
Overview
A total of 573 patients were randomised; 285 patients were randomised to receive EXTRAS and 288 were
randomised to receive usual care. Details of assessments conducted, deaths and withdrawals are shown in the
Consolidated Standards of Reporting Trials flow chart (see Figure 2). A 24-month assessment was conducted
for 219 out of 285 (76.8%) patients in the intervention group and 23 out of 285 (8.1%) patients in this group
died during the trial period. For patients randomised to receive usual care, 231 out of 288 (80.2%) patients
completed a 24-month assessment and 32 out of 288 (11.1%) patients died.
Imputed data
During the trial period, a small number of the patients who completed the assessments (the population
informing the primary economics analysis) did not complete the EQ-5D-5L. Only 10 utility scores were
imputed (see Appendix 2, Table 69) and there were no apparent differences in response rates between
the study groups.
Costs and outcomes
Table 25 shows the results of the primary economic evaluation using the imputed data set. The imputed
data set for the CEA is the subset of participants with completed resource utilisation forms until death or
trial ending. Utility values were imputed for this group. A total of 235 participants who were in receipt of
EXTRAS and 259 participants who received usual care contributed data to this evaluation. Table 25 shows
the adjusted means for costs, by health care and social care, and total costs and their adjusted differences.
Likewise, adjusted utilities at each time point are shown along with their differences and resulting QALYs.
The mean cost of health and social care resources used by patients in the intervention group was less
than those who received usual care (–£311, 95% CI –£3292 to £2787 less per person). The reduced mean
costs were due to reduced social care use but were partially offset by increased health-care use. Increased
health-care use was mainly a result of increased outpatient costs, day patient costs and primary health-care
costs, whereas reduced social care use was a result of the reduction in home help (personal care, home
services, shopping) and allowances. In all cases, the 95% CI around the difference includes zero. The CIs are
sufficiently wide to include economically important differences that could favour either study group.
A breakdown of the health-care and social care costs between the randomisation groups is shown in
Appendix 2, Table 70. Standard resource item costs are shown in Appendix 2, Table 71. It is not possible to
show all of the resource costs because some were disease specific. For example, for the inpatient cost of a
particular patient-reported condition we used the weighted average of the costs in the NHS Reference Costs,81
and for another condition for another patient, the respective average cost for that condition was used.
The utility and QALY differences, however, did show a statistically significant difference between the groups,
with patients in the intervention group experiencing between 0.01 and 0.12 additional QALYs over 2 years.
At the mean value, 0.07, this equates to 25 additional days in ‘full health’ over the 24-month trial follow-up
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period. A breakdown of EQ-5D-5L by dimension and trial group at baseline, 12 months and 24 months for
patients who contributed to the CEA is given in Appendix 2, Tables 72–74.
Tables 78–80 in Appendix 2 show a breakdown of the EQ-5D-5L by dimension and trial group at baseline,
12 months and 24 months for all patients who provided EQ-5D-5L data. Tables 81 and 82 show a
breakdown of the utilisation of major resource items for all patients who completed the CSRI at each time
point. Note that these tables do not match the numbers included in the cost-effectiveness analyses that
required CSRI data at all time points until death or trial end.
Figures 19 and 20 show the cost-effectiveness plane and CEAC, respectively. Both figures illustrate the
uncertainty around the estimates of cost-effectiveness. On the bootstrapped cost-effectiveness plane, points
on the negative vertical axis favour EXTRAS as cost saving (68%) and positive values favour usual care (32%).
Positive values (98.5%) on the horizontal (QALY) axis favour EXTRAS and negative values favour usual care
(1.5%). The average ICER falls in the south-east quadrant of the cost-effectiveness plane, suggesting that,
on average, EXTRAS dominates usual care. The ellipse depicts the 95% CI around the ratio of costs to
QALYs. The proportions are reflected in the CEAC where at a zero value for society’s WTP for a 1-QALY gain,
the CEAC is shown to cross the vertical axis at 68%, rising to 90% at £20,000 per QALY. The CEAC shows
the probability that EXTRAS would be deemed cost-effective across a range of values for WTP for 1 QALY.
As WTP for 1 QALY increases, so does the probability that EXTRAS would be judged cost-effective.
TABLE 25 Summary economic outcomes at 2 years, based on imputed missing values
Outcome
Intervention (n= 235),
mean (95% CI)
Control (n= 259),
mean (95% CI)
Adjusted difference:a
EXTRAS minus usual
care, mean (95% CI)
Costs (£)
Health care 5667 (3175 to 8711) 5943 (4839 to 6495) 963 (–160 to 2087)
Social care 7708 (5998 to 11,077) 9656 (7797 to 11,514) –1788 (–4381 to 806)
Intervention 437 – 437
Total 13,375 (11,381 to 15,369) 15,599 (12,018 to
19,180)
–311 (–3392 to 2787)b
EQ-5D-5L43,80
Baseline 0.60 (0.56 to 0.63) 0.60 (0.55 to 0.62) 0.01 (NA)
Utility year 1 0.58 (0.54 to 0.62) 0.52 (0.48 to 0.56) 0.05 (0.00 to 0.09)
Utility year 2 0.53 (0.49 to 0.58) 0.48 (0.44 to 0.53) 0.04 (0.01 to 0.07)
Total as QALY 1.12 (1.06 to 1.19) 1.04 (0.98 to 1.10) 0.07 (0.01 to 0.12)
Mean net benefit at £20,000 WTP for
QALY
£1711
Mean cost-effectiveness ratio On average EXTRAS dominates usual care
Probability of being cost-effective at
£20,000 WTP per QALY
90%
Probability that EXTRAS is cost saving 68%
NA, not applicable.
a Age, sex, baseline utility/costs, standard errors clustered by site.
b Totals subject to estimation differences.
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A summary of the self-reported quality of life on the VAS score in EQ-5D-5L (for patients who contributed
to the CEA) is shown in Table 26. There was no significant difference between the self-reported health
scores at baseline, 12 months and 24 months between trial groups.
Nottingham Extended Activities of Daily Living Scale scores
The economic analysis considered only those patients who reported completing the CSRI forms at 24 months.
Among these, there were only two patients missing data in the intervention group and one in the usual care
group. CIs around the mean difference in NEADL Scale score (1.98, 95% CI –0.17 to 4.14) rule out a clinically
important difference on this measure (Table 27). The results did not change when the analysis was carried out
using the complete data (1.94, 95% CI –0.3 to 4.18). Figure 21 shows the cost-effectiveness plane for the
NEADL Scale scores. In terms of the NEADL Scale, there was an 84% chance that EXTRAS would be cost saving.
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FIGURE 20 Cost-effectiveness acceptability curve.
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TABLE 26 Patients’ self-reported health (EQ-5D-5L VAS scores) at different time points between trial groups
Time point Mean SD Minimum Maximum
Baseline
Usual care 64.40 20.80 0 100
EXTRAS 67.34 19.20 5 100
12 months
Usual care 64.52 21.45 0 100
EXTRAS 68.39 20.81 5 100
24 months
Usual care 63.71 22.20 0 100
EXTRAS 67.62 21.67 5 100
Changes from baseline, mean (95% CI)
Usual care –0.69 (–4.57 to 3.18)
EXTRAS 0.28 (–3.55 to 4.12)
TABLE 27 Total costs and NEADL Scale scores in the trial groups at 2 years
Intervention,
mean (95% CI)
Usual care,
mean (95% CI)
Adjusted difference,
mean (95% CI)
Imputed data set n = 219 n = 231 –
NEADL Scale score 39.96 (37.56 to 42.37) 37.19 (34.78 to 39.59) 1.98 (–0.17 to 4.14)
Total costs (£) 13,749 (11,701 to 15,797) 16,881 (12,908 to 20,854) –1265 (–4223 to 1693)
Complete cases n = 217 n = 230 –
NEADL Scale score 39.87 (37.45 to 42.29) 37.33 (34.93 to 39.72) 1.94 (–0.3 to 4.18)
Total costs (£) 13,739 (11,677 to 15,802) 16,615 (12,660 to 20,571) –1001 (–4043 to 2041)
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FIGURE 21 Cost-effectiveness plane: NEADL Scale.
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Sensitivity analyses
In the light of the findings of the primary health economic analysis that EXTRAS was very likely to be deemed
cost-effective according to current thresholds, three sensitivity analyses were carried out. These were:
1. on the non-imputed data set
2. with the removal of any cost outliers
3. using an alternative valuation tariff for the EQ-5D-5L.
Despite the relatively few imputed values used to generate QALYs, it was important to establish the effect
that imputation had on estimates. Likewise, it was also important to establish the effect that any cost
outliers (in this analysis those with costs of ≥ £100,000 were excluded) might have on our estimates.
In the non-parametric analysis of costs, it was noted that a group of patients fell into this category and
it was necessary to determine whether or not they occurred disproportionately in one group of the trial.
Finally, the EQ-5D-5L crosswalk tariff89 was used as an alternative to the tariff used in the primary analysis to
establish what effect alternative valuations of the EQ-5D-5L health states might have on estimates of effect.
The results of the sensitivity analysis are shown in Table 28. In addition the CEAC and cost-effectiveness
planes are presented in Appendix 2, Figures 40–45. In all sensitivity analyses, the average ICER remained
in the south-east quadrant of the cost-effectiveness plane, suggesting that, on average, EXTRAS
dominated usual care.
In each case, the mean cost-effectiveness ratio did not change. It remained that, on average, EXTRAS was
associated with an increase in estimated HRQoL and reduced net health and social care costs.
TABLE 28 Primary analyses and sensitivity analyses
Analysis/metric Estimate
Primary analysis
Mean net benefit at £20,000 WTP for QALY £1711
Mean cost-effectiveness ratio On average EXTRAS dominates usual care
Probability of being cost-effective at £20,000 WTP per QALY 90%
No imputed data
Mean net benefit at £20,000 WTP for QALY £2238
Mean cost-effectiveness ratio On average EXTRAS dominates usual care
Probability of being cost-effective at £20,000 WTP per QALY 88%
Outliers excluded
Mean net benefit at £20,000 WTP for QALY £2692
Mean cost-effectiveness ratio On average EXTRAS dominates usual care
Probability of being cost-effective at £20,000 WTP per QALY 96%
Crosswalk EQ-5D-5L tariff
Mean net benefit at £20,000 WTP for QALY £1911
Mean cost-effectiveness ratio On average EXTRAS dominates usual care
Probability of being cost-effective at £20,000 WTP per QALY 96%
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Carers’ health-related quality of life
Information about carers’ HRQoL was also collected at baseline and at 12 and 24 months. The carers’
own valuations of their quality of life as captured by the EQ-5D-5L VAS are shown in Table 29. There was
no significant difference in the self-reported health scores of carers of patients at baseline and at 12 and
24 months in both groups of the trial.
The associated QALYs are shown in Table 30. Two estimates of QALY differences were made. The first
used the imputed data set, where predictive mean matching was used when a utility value existed for at
least one data point (baseline, 12 months or 24 months). Each estimate controlled for baseline utility. Only 135
carers (76 from the usual care group and 59 from the intervention group) completed the EQ-5D-5L at each
time point out of 185 carers considered for imputation. Missing data from nine from the usual care group and
41 from the intervention group were imputed. EQ-5D-5L scores by domain at each time point are given in
Appendix 2, Tables 75–77.
In each analysis, the 95% CI around the estimated differences in QALYs included zero but the CI may be
sufficiently wide to include clinically important differences favouring either group. Despite the small but
significant QALY gain for patients estimated in the primary economic analysis, there is no evidence that
this translated into HRQoL gains for their carers.
TABLE 29 Carers’ self-reported health (EQ-5D-5L VAS scores) at different time points between trial groups
Time point Mean SD Minimum Maximum
Baseline
Usual care 79.02 15.16 28 100
EXTRAS 76.11 18.58 10 100
12 months
Usual care 74.78 18.07 30 100
EXTRAS 72.45 19.55 10 100
24 months
Usual care 75.39 18.76 15 100
EXTRAS 78.02 16.12 30 100
Changes from baseline, mean (95% CI)
Usual care –3.64 (–9.16 to 1.88)
EXTRAS –0.73 (–6.48 to 5.03)
TABLE 30 Health-related quality of life (QALYs) of carers
Intervention Usual care Difference
Imputed data set n = 100 n = 85 –
Mean (95% CI) 1.52 (1.52 to 1.58) 1.57 (1.54 to 1.60) –0.05 (–0.14 to 0.04)
Complete cases n = 59 n = 76 –
Mean (95% CI) 1.52 (1.43 to 1.68) 1.60 (1.52 to 1.68) –0.08 (–0.20 to 0.04)
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Discussion
Despite no evidence of a meaningful difference in the primary outcome (NEADL Scale score) between study
groups, provision of EXTRAS had a 68% chance of being cost saving in terms of QALYs. The change in
resource use suggests that it is likely that EXTRAS would result in cost saving overall, but most likely with
extra costs to health services, which would be offset by savings in social care. Although from a societal
perspective how savings are made is relevant, in practice it raises the issue of cost shifting, whereby savings
may accrue to one service or organisation that may not be paying for the intervention, causing disincentives
and barriers to the adoption of a more cost-effective intervention.
Quality-adjusted life-years were greater for patients who were randomised to receive EXTRAS and this
outcome measure may arguably have captured wider impacts of the new service. Given the impact of
EXTRAS on costs and QALYs, there is a very high chance that this service would be considered cost-effective
at conventional thresholds for society’s WTP for 1 QALY (currently £20,000 per QALY).
It is possible in this case, as with the majority of economic evaluations undertaken alongside clinical trials,
that findings are subject to a type 1 error: a false-positive finding. However, the economic evaluation
estimates that EXTRAS was associated with HRQoL gains and net health-care and social care cost savings.
Sensitivity analyses confirmed this analysis as robust. Furthermore, focusing only on cost savings and the
NEADL Scale score implied that there was an 84% chance that EXTRAS would be considered cost-effective.
Other considerations, strengths and weaknesses
The economic evaluation of EXTRAS was based on data completed by a vast majority of participants in
the trial and the conclusions from the economic evaluation were supported by those from the sensitivity
analyses. We also conclude that the difference in estimated marginal QALY gains did not appear to be
driven by any differential rates of death between the two groups. However, the EXTRAS group appeared
to have more people reporting ‘no problems’ for all EQ-5D-5L domains at baseline and during follow-up.
This would potentially bias results against EXTRAS, as such cases represent a ceiling on possible gains in
HRQoL that could be derived from EXTRAS.
Within the analyses, we took account of clustering at the univariate level when estimating the association
between EXTRAS and the differences in costs and differences in QALYs. However, no bivariate adjustment
for clustering was made in the generation of the CEACs. It is methodologically unclear how such an analysis
could be performed, although it would have been possible to generate a CEAC per site and develop a
weighted cost-effectiveness ratio and CEAC, but as there was a relatively large number of sites with differing
numbers of patients at each site we felt that this was not a practical approach. The CEACs themselves were
produced from parametric bootstrapped samples. For this reason, they were affected by the distributions
used on the generalised linear models to estimate costs and QALYs. However, given the relatively large
sample sizes we felt that this parametric approach was appropriate despite the potential for non-normally
distributed data.
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Chapter 9 Discussion
Key findings
Primary outcome: extended activities of daily living
EXTRAS did not improve stroke patients’ performance in EADL following discharge from ESD services when
compared with usual care. The mean 24-month NEADL Scale score was 40.0 (SD 18.1) for intervention
group participants and 37.2 (SD 18.5) for those who received usual care, giving an unadjusted mean
difference of 2.8 (95% CI –0.6 to 6.2). The primary outcome, that is the mean difference in NEADL Scale
score at 24 months adjusted for baseline OHS, age and sex was 1.8 (95% CI –0.7 to 4.2).
Secondary outcomes: mood, health status, carer stress and satisfaction with services
Depression and anxiety are common after stroke. The mean anxiety and depression HADS scores were
lower for patients in the intervention group at 12 and 24 months, but the 95% CIs for the difference in
scores included zero.
Provision of the new service did not lead to significantly improved patient health status (OHS) or a
reduction in carer stress. Patients who received EXTRAS and their carers reported that they were more
satisfied with some aspects of their care than those who received usual care. For patients, these aspects
were overall satisfaction with care; staff met their needs; staff treated them with dignity and respect;
and they received sufficient help with mobility. Carers in the intervention group were more satisfied with
overall care and more felt that sufficient help had been provided for mobility issues.
Subgroup analyses
No association was found between the effectiveness of the intervention and the pre-stroke OHS score,
baseline NEADL Scale score and time in organised stroke care (defined as time as an inpatient and time in
ESD services), which were prespecified exploratory analyses.
Post hoc analysis
Post hoc analysis of the HADS score case versus non-case found that there were significantly fewer cases
of depression at 12 months in the intervention group (29% intervention group vs. 40% control group;
adjusted OR 0.59, 95% CI 0.39 to 0.90) and significantly fewer cases of anxiety at 24 months (28%
intervention group vs. 38% control group; adjusted OR 0.64, 95% CI 0.41 to 0.99).
Adverse events
A total of 504 SAEs were identified for 573 participants over 24 months. There were no significant
differences in the number of SAEs between those who received EXTRAS and those who received usual
care. None of the SAEs was attributed to the intervention.
Health economic evaluation
Stroke survivors who were randomised to receive EXTRAS had a better HRQoL and experienced 0.07
additional QALYs (95% CI 0.01 to 0.12). The mean cost of resource utilisation was lower in the
intervention group (–£311, 95% CI –£3292 to £2787), with a 68% chance of being cost saving. The
changing resource use pattern suggests that it is likely that additional costs to health services were offset
by savings in social care. At the standard WTP of £20,000 per QALY,90 there is a 90% probability that
EXTRAS is cost-effective for the NHS. No differences were seen for the HRQoL of carers.
Potential explanations of divergent results
Researchers and decision-makers will probably be most interested in the finding that, although there is
no evidence of any treatment effect on the primary outcome, the cost-effectiveness analyses are
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consistent with EXTRAS being associated with cost saving and HRQoL gain. This combination of results has
been reported in other settings, for example psychological treatments for obsessive–compulsive disorder,91
but we are not aware of any stroke rehabilitation trials that have reported this combination of findings.
One explanation of this finding is that the EQ-5D-5L captured wider impacts of EXTRAS than the NEADL
Scale. Another possibility is that although both the EQ-5D-5L and the NEADL Scale are ordinal scales, the
NEADL Scale lacks the cardinal property derived from patient and public preferences: a unit change in
utility measured by the EQ-5D-5L is of the same value to a patient, wherever it occurs on the scale. This is
not the case for the NEADL Scale.
In clinical trials, the primary outcome is chosen as it is believed to be the outcome of greatest importance.92
Our intervention sought to improve performance in EADL, but it did not. Secondary outcomes, including
health economic outcomes, are used to evaluate additional effects of an intervention that may be related to
the primary question or other hypotheses. These effects are also important, but secondary outcome results
in the context of a negative or neutral primary outcome are generally regarded as hypothesis generating
rather than hypothesis testing. Nevertheless, there is consistency between the results of the health economic
analyses, some secondary outcomes and a post hoc analysis; our findings suggest that EXTRAS may improve
stroke survivors’ quality of life (QALYs) and mood (anxiety and depression cases on the HADS) and some
aspects of satisfaction with services. In addition, qualitative interviews analysed prior to the randomised
trial results becoming available reported that staff who delivered the reviews felt that, as EXTRAS provided
support and advice without direct therapeutic intervention, it was more likely to have an impact on mood
and general well-being rather than to improve performance in EADL.
The EXTRAS trial results in the context of other studies
Systematic reviews of stroke units and ESD services have shown that ‘organised stroke care’ is clinically
effective and cost-effective.14,15 However, it is unclear how best to provide rehabilitation and support to
meet the needs of stroke patients and carers beyond ESD services. A number of studies have identified that
stroke survivors have a wide range of longer-term physical, psychological and social needs.6,8–10,12,25,60,93,94
A recent systematic review and meta-ethnography study12 reported that ‘stroke survivors and care givers feel
abandoned because they have been marginalised by services and they do not have the knowledge or skills
to re-engage’.
Trials that evaluated community-based interventions that sought to address either single or multiple
longer-term needs have used a range of approaches and outcomes and are of variable quality. Individual
community-based rehabilitation studies and subsequent meta-analyses have been largely neutral across a
range of interventions and outcomes. Few studies included a health economic evaluation.30,95 Given our
findings, it is possible that potential benefits of some of these interventions could have been overlooked
as the trials did not measure QALYs.
Therapy-based services
Like many previous studies, EXTRAS did not lead to improved performance in EADL. When designing the
EXTRAS trial in 2010, we were encouraged by the results of a 2003 Cochrane review24 (14 trials, 1617
participants) that reported that therapy-based services (excluding ESD services) provided to stroke patients
soon after discharge from the hospital reduced the odds of a poor outcome (OR 0.72, 95% CI 0.57 to
0.92) and increased performance in personal activities of daily living compared with usual care. However, a
2008 Cochrane review21 (five trials, 487 participants) found inconclusive evidence that similar interventions
provided 1 year or more after stroke were effective and the authors concluded that ‘this review highlights
the dearth of evidence investigating long-term therapy-based rehabilitation interventions for patients with
stroke’. The findings of the 2008 Cochrane review led to the NIHR HTA commissioned call that funded
the EXTRAS trial (see the project web page: www.journalslibrary.nihr.ac.uk/programmes/hta/103701/#/;
accessed 9 April 2020).
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Stroke liaison workers and stroke care co-ordinators
EXTRAS aimed to help individuals to maximise their recovery in the context of their day-to-day activities
and/or adjust to their residual disability. Our intervention was broader than trying to improve performance in
EADL, as we sought to address the full range of long-term needs experienced by stroke survivors. Therefore,
EXTRAS has some similarities to the interventions provided by stroke liaison workers who are health-care
workers or volunteers who provide education, social support and liaison with services. A 2010 Cochrane
review23 of trials that evaluated stroke liaison worker services (16 studies, 4759 participants) found no
benefit in terms of perceived health, mood, activities or participation. As with EXTRAS, intervention
participants were more satisfied with some aspects of service provision. Patients with mild to moderate
disability (Barthel activities of daily living score96 of 15–19) who were supported by a stroke liaison worker
were reported to have reduced death and disability (OR 0.62, 95% CI 0.44 to 0.87). We did not measure
the Barthel activities of daily living score in the EXTRAS trial, but our study population is not directly comparable
with this subgroup as some of the EXTRAS participants would have had a Barthel activities of daily living score
of < 15, that is they had more severe disability.
The Longer Term Stroke (LoTS) Care trial30 was published after the start of the EXTRAS trial. This large
cluster randomised controlled trial (32 sites, 800 patients, 208 carers) evaluated a system of care where
stroke care co-ordinators, who were community-based health-care professionals with experience in stroke
care, were trained to follow a structured assessment and treatment plan working with patients and carers
after discharge from hospital. Neither patients nor carers in the intervention group had improved outcomes
(including quality of life and EADL) when compared with usual care. The total health-care and social care
costs were similar between both randomisation groups.
Self-management interventions
Self-management interventions seek to encourage people with chronic conditions to take an active part in
their own care;69,97–99 this was one of the components of our intervention. Approaches to self-management
include problem-solving, goal-setting, shared decision-making, self-monitoring and coping with the
condition. A 2016 Cochrane review29 of self-management programmes for people with stroke (14 studies,
1863 participants) reported that these programmes improved quality of life [standardised mean difference
(SMD) random effects 0.34, 95% CI 0.05 to 0.62] and improved self-efficacy (SMD random effects 0.33,
95% CI 0.04 to 0.61) but that they had no effect on activities of daily living or mood. Studies have shown
that self-management programmes are likely to be cost-effective for some long-term conditions, for
example diabetes mellitus,100,101 but studies evaluating the cost-effectiveness of self-management for
stroke survivors are lacking.29
The EXTRAS intervention
Development and content of EXTRAS
The intervention was developed following an evidence review and the domains were comprehensive in
covering the range of priorities for stroke patients and carers.6,8,9,22,25,60,77,102 Stroke therapists, patients
and carers were involved in designing and piloting study materials. A domain potentially missing from
the reviews was fatigue. Fatigue was not included as a specific domain, as at the time of designing the
intervention the importance of this symptom had not been fully appreciated.103 Reviews were multifaceted,
reflecting current clinical practice. Manuals and detailed study documentation were produced along with
a training programme for participating ESD staff, enabling the intervention to be replicated in clinical
practice. The duration of the intervention was purposely much longer than most previous studies, as
patients and carers have recommended that care and support should be ongoing in the longer term.12
In our qualitative study, ESD team members felt that provision of ongoing contact and support was an
important component of stroke care, which was not provided in many settings. Some felt that the EXTRAS
trial would provide valuable data to inform the development of community-based stroke services.
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Delivery of EXTRAS
EXTRAS was embedded within NHS care and was delivered as it would be in clinical practice. We have
described EXTRAS according to the TIDieR checklist and guide, enabling the intervention to be replicated
and compared with other interventions.49 We have detailed quantitative and qualitative data about how
EXTRAS was delivered, which have helped us to interpret our divergent results.
One of the potential criticisms of our approach to providing a new community stroke service is that reviews
were primarily undertaken by telephone. Telephone reviews were selected not only because they were
more affordable, but also because they were likely to be less disruptive to a participant’s daily routine than
a clinic visit. In addition, they optimised the use of the reviewer’s time as no travel was needed. We did
not use video or more sophisticated technology, as many participants would have not had access to or
experience of using them.
As EXTRAS reviews were undertaken by telephone, we felt that it was important that they were carried
out by a stroke specialist with experience of community rehabilitation who knew the patient, who had
expertise in goal-setting and who had detailed knowledge of local services. It was important that the
reviewer had the skills and expertise to work in partnership with the patient to identify ongoing needs and
determine ways to address them. Reviewers came from a range of health-professional backgrounds and
their experience within an ESD team would have equipped them to take a holistic approach, as well as
using the knowledge of their discipline. Reviewers were also able to seek support, information and advice
from other members of the ESD team and those currently involved in the patient’s care. However, our
process evaluation found that not all of the EXTRAS reviewers were comfortable in addressing issues
beyond their own discipline, and some reported difficulties contacting others involved in the patient’s
care. Some ESD team members felt that EXTRAS reviews could be carried out by voluntary sector support
services or a stroke co-ordinator or specialist nurse.
There was an option within the EXTRAS protocol to undertake face-to-face reviews but this was used
infrequently. Some ESD team members felt that some patients would have benefited from one or more
home visits over the 18-month review period, as this would have enabled them to see how the patient
coped within their environment, assess any safety risks and discuss issues with carers. Face-to-face reviews
were thought to be more appropriate than telephone reviews if the patient had residual physical or
cognitive problems, or if he/she found it difficult to participate in telephone reviews.
Completion of EXTRAS reviews was good, with between 81% and 91% of expected reviews being
undertaken at each of the five time points. Although reviews could be undertaken by any member of the
ESD team, they were predominantly undertaken by physiotherapists (56%) or occupational therapists
(28%). Reduced mobility was the most common problem raised, followed by hobbies and leisure. It was
envisaged that goals and action plans would be jointly set by reviewers and patients but we did not assess
whether or not this partnership occurred. It may be that some of the priorities selected reflected the skills
and interests of the reviewer.
Action plans could include providing advice or encouragement; self-practice; liaising with services currently
involved in the patient’s care; or making a new referral. The most common action taken by a reviewer was
to provide the patient with advice (71–75% of action plans, depending on review stage) and this could be
linked to an action for the patient, for example practise an activity relating to an agreed goal (22–34% of
action plans). The EXTRAS reviewers felt that patient-led goal-setting and action-planning were important
components of the intervention and that these activities were not always undertaken or patient led in usual
care. They felt that EXTRAS promoted self-management. Some patients had little recollection of goal-setting
and some did not recall that reviews had taken place. Qualitative interviews took place 6 months after the
18-month EXTRAS review (to enable prior completion of the 24-month outcome assessment), so it is not
surprising that some people had poor recall. In addition, 30% of EXTRAS participants did not identify any
issues at their 18-month review, compared with 4% at their 1-month review. It may be inferred from the
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limited recall of reviews that the intervention was not meaningful or important to patients, or, more
positively, that the intervention was not burdensome.
A potential criticism of EXTRAS is the lack of provision of direct rehabilitation interventions following a
review (e.g. referrals for therapy). Action plans and referrals were at the discretion of the ESD staff who
delivered EXTRAS reviews and data were not captured about the clinical reasoning processes behind these
decisions. It is possible that a number of factors were influencing the choices made, including judgement
about a perceived lack of effect from further direct intervention for the stroke survivor or knowledge about
the lack or limited availability of local rehabilitation services.
As the availability of some longer-term rehabilitation services was limited in some areas, this could have led
to needs being identified at EXTRAS reviews that could not be addressed and this could have negatively
affected study participants. Alternatively, being informed about the help and support that was and was
not available may have helped some participants to revise their expectations and adjust to the situation. In
our process evaluation, ESD staff who were interviewed did not widely report that they felt that referral for
rehabilitation was limited or not possible in their area, although one interviewee did highlight a lack of
psychological services.
One explanation for the lack of a treatment effect on the primary outcome is that direct therapeutic
intervention may be required to improve performance in EADL. However, it appears that more general
support and advice has an effect on overall well-being and satisfaction. This could be an effect of stroke-
specific support and advice or a more non-specific effect from talking regularly to an individual about
ongoing issues. It is likely that stroke-specific expertise is an important component, as previous studies
of support services have been neutral.23
There was some overlap between EXTRAS and existing services, for example 6-month reviews; however,
few of the EXTRAS study centres offered routine reviews at ≥ 12 months after stroke. Nationally, only
28% of stroke survivors receive a 6-month review, despite NICE guidance.78,104 Nevertheless, if EXTRAS is
adopted into clinical practice, any overlap will need to be addressed.
One of the concerns raised by ESD teams who expressed an interest in participating in the trial was that
EXTRAS reviews could lead to an increased workload for health and social care services, but this was not
the case. Similar concerns were also raised when ESD services were first evaluated; however, ESD services
were also found to be cost saving.105 During the EXTRAS trial, only 117 unique referrals were intended to
be made by reviewers to other services and these intended referrals formed < 10% of action plans at each
review. The effect on individual services was minute; overall, 20 new referrals were intended to be made
to physiotherapy, 16 to occupational therapy, six to a community rehabilitation team, nine to speech and
language therapy and nine to social services.
Usual care
Participants in the control group received usual care post ESD. Usual care is perhaps a misnomer, as NHS
and social care are not standardised and, therefore, the care received by participants in the control group
is likely to have varied according to local service provision. Similarly, the availability of services to which
EXTRAS patients could be referred following each review will also have varied between study centres.
Our service mapping found that structured reviews of patients’ health and social care needs beyond
6 months were rarely provided, despite recommendations from the NHS National Stroke Strategy and
NICE.77,78 Provision of services to meet the longer-term needs of stroke patients was variable, and access
could be complex and confusing. In our process evaluation, some ESD team members reported that their
area already had comprehensive co-ordinated services to meet the longer-term needs of stroke survivors,
whereas others felt that community-based rehabilitation was un-co-ordinated, often with long waiting
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times, or unavailable. Interviewees highlighted the lack of service provision and support for some of the
‘hidden consequences’ of stroke, such as anxiety and fatigue. Some participants who received usual care
reported that their care had been faultless, whereas others commented on a lack of therapy and they felt
that they had been ‘left to manage’ without follow-up from health-care professionals.
Research studies and national audit results consistently report that stroke patients receive very little longer-
term rehabilitation.12,60,104 However, a number of EXTRAS participants were in receipt of long-term therapy:
47% of patients in the intervention group and 48% of patients in the control group saw a physiotherapist in
the 12 months following discharge from ESD services, and 26% and 23%, respectively, saw a physiotherapist
in the subsequent 12 months. In total, 31% of patients in the intervention group reported that they had seen
an occupational therapist in the 12 months post ESD, compared with 33% of the usual-care group. Over the
following 12 months, contact with an occupational therapist was 14% for the intervention group and 11%
for the control group. Contact with a SLT was 16% for the intervention group and 19% for the usual care
group over the first 12 months post randomisation and 5% for both intervention and control groups over the
following 12 months.
Methodological considerations
The EXTRAS trial is one of the largest randomised controlled trials of a new community stroke service
undertaken to date. Multicentre studies of community rehabilitation are uncommon and to participate in
the EXTRAS trial each study site was required to identify funding/resource to establish a new service
specifically for the trial.
Study setting
All participants received stroke unit and ESD care prior to participating in the trial, in accordance with best
practice.16,20 Sites were from a range of urban and rural settings around the UK and were keen to further
develop stroke care in their area, so these were likely to be progressive services. Most study sites reported
that EXTRAS was an important addition to their stroke service that would lead to improvements in patient
care, but a few felt that EXTRAS would not offer benefit over and above their current service provision.
Participants
Our inclusion criteria were broad and inclusive. Participants were typical of stroke survivors treated by ESD
services.14 We did not collect screening data because of the additional workload for recruiting staff and
we do not have data about the proportion of ESD service patients who participated in the trial at each site.
Participant numbers differed between study centres, which could represent a selection bias. However, this
is more likely to be a reflection of the duration of recruitment (longest 32 months, shortest 6 months), the
size of the stroke service, the availability of staff to identify and consent patients and the availability of ESD
team members to provide the intervention. The availability of ESD members was a particular consideration
for recruitment at each individual site. Some ESD staff felt that provision of EXTRAS was unlikely to benefit
patients with mild symptoms or cognitive deficits.
When designing the study, we anticipated that most participants would have a relative or carer who would
be invited to participate in the study. Only 194 out of 573 (34%) stroke survivors had a relative or carer
taking part in the study. Various unsuccessful attempts were made to increase the number of relatives/
carers participating in the study.
Outcomes
The primary outcome for this study was performance in activities of daily living measured by the NEADL
Scale. This scale assesses mobility, kitchen tasks, domestic tasks and leisure activities. Although labelled
slightly differently, the EXTRAS reviews covered all of these domains. Mobility was identified as a priority
issue for 55% of participants at 1 month and 35% at 18 months. Mealtimes were a priority for 30% of
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participants at 1 month and 15% at 18 months, and these values were 24% and 3% for domestic activities,
and 37% and 24% for hobbies and interests, respectively.
Being able to undertake everyday activities is only one of a range of outcomes that are valued by stroke
patients and carers, and the EXTRAS intervention purposely aimed to cover a wide range of potential
rehabilitation and other ongoing needs. Therefore, a broad range of secondary outcome measures were
selected, covering health status, mood, quality of life and experience of services. The outcome measures
used in the EXTRAS trial are widely used in stroke and rehabilitation research and are well validated, and
the satisfaction scale has been used in national service improvement initiatives.
In retrospect, it could be argued that a more global outcome measure rather than EADL would be a more
appropriate primary outcome. Some staff interviewed in our process evaluation felt that EXTRAS would not
lead to improvements in EADL, as it did not involve face-to-face assessments, provide therapy or involve
supervised practice of EADL. The ESD team members felt that the reviews were comprehensive but were
more likely to affect emotional and social issues, rather than physical recovery.
Economic evaluation
As with the majority of economic evaluations conducted as part of a randomised controlled trial,
comparisons of the cost and cost-effectiveness outcomes in the EXTRAS trial are secondary outcomes
and power calculations were not undertaken.106 It is likely that the economic analyses are underpowered.
For this reason, health economic analyses focus on estimation rather than hypothesis testing. The width of
the CIs around these results suggest that care must be taken when interpreting these findings. The CIs
around the QALY difference suggest that EXTRAS was associated with an improvement in HRQoL for
patients. The magnitude of the gains, although small, would be judged as economically significant.107
Sources of bias
We carried out the EXTRAS trial in accordance with current best practice.65,108 The trial was conducted
in line with a published protocol32 and reported according to international standards.49,109,110 A statistical
analysis plan and health economics analysis plan were finalised prior to data lock. Thanks to the efforts of
study participants, local research network staff, ESD teams and co-ordinating centre team members, one of
the strengths of the EXTRAS trial is the completeness and high quality of the data. Our findings are robust
and there is a low risk of bias.111
When designing the trial, we did consider including an attention control study group or another
intervention group that provided face-to-face EXTRAS reviews, but either of these options would have
significantly increased the sample size and complexity of the study.
Randomisation was by an independent web-based service with allocation concealment.
All but one of the outcomes (number of cases of anxiety and depression) have been reported according
to statistical and health economic analysis plans. The number of cases of anxiety and depression analysis
(HADS caseness) was undertaken post hoc and therefore these results should be treated with caution.
As with many rehabilitation studies, it was not possible to blind study participants or those delivering the
intervention to the participants’ study group. However, outcome assessments were usually undertaken by a
member of the co-ordinating centre who was blinded to treatment allocation. Outcome assessor blinding
rates were reported and are acceptable. As it was not possible to blind study participants to their study
group, this could have led to disappointment for those who were randomised to usual care and, in turn,
poorer outcomes because of resentful demoralisation.112 We did not record the views of control group
participants to determine if this was an issue.
Overall, the attrition rates in the EXTRAS trial are acceptable. However, there was differential attrition
between patient study groups at 24 months. In the intervention group, 66 out of 285 (23%) patients did
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not provide data for the 24-month assessment and in the control group this was 57 out of 288 (20%).
Removing those patients who did not provide data because they were known to be deceased, the dropout
is 43 out of 262 (16%) in the intervention group and 25 out of 256 (10%) in the control group. The
differential attrition rate between study groups could potentially have biased our results. The increased
attrition rate in the intervention group may be due to trial fatigue because of the number of clinical
assessments that had been completed during the intervention period, and this was mentioned by some
participants who were invited to participate in the interview study. It could be also be argued that some of
the dropout could be a result of those in the intervention group being dissatisfied with the care that they
had received (or not received). Alternatively, the intervention may have helped individuals to adjust to life
after stroke and move on.
One patient who was randomised to usual care received the intervention in error. However, contamination or
competitive therapy bias was otherwise unlikely, as ESD teams had limited capacity for additional work. Most
sites would agree to recruit only two participants per month because of the capacity to provide the EXTRAS
intervention. Although this low recruitment rate probably contributed to the high fidelity to the intervention
seen in the study, it may have meant that reviewers were inexperienced and we evaluated the new service
on a learning curve. Evaluation of EXTRAS after a learning period may have been a preferable approach.
However, as EXTRAS was a research intervention, this design would probably have been challenging to
implement.
Patient and public involvement
In 2011, the Care Quality Commission25 reported that stroke patients and carers identified the need
for ongoing rehabilitation, provision of information and contact with a named person as priorities for
improving stroke services. EXTRAS was developed based on the expressed needs of stroke survivors
identified in the Stroke Association UK Survivor Needs Survey,8 the Care Quality Commission report25
and other research evidence relating to the longer-term needs of stroke patients.
Stroke survivors and carers were involved in developing our outline and full NIHR HTA proposals. Prior to
each submission, our application was discussed with the Lay Member Panel of the NIHR Stroke Research
Network and the North-east Stroke Patient and Carer Panel. They were very positive about the proposed
new service and evaluation. They agreed that it was reasonable to undertake telephone rather than
face-to-face reviews.
Patients and carers were actively involved in the development of the intervention materials. This was
discussed with the patient and carer groups who were involved in developing the research proposal and
we also sought the opinions of individual patients who were being cared for by Northumbria Healthcare
NHS Foundation Trust stroke service and their patient experience team.
The NIHR Stroke Research Network Lay Member Panel and the North-east Patient and Carer Panel
commented on the study information sheets and data collection forms. The topic guide for qualitative
interviews with patients and carers was piloted with the King’s College London Stroke Research Patients
and Family Group. Stroke survivors and carers provided advice and practice interviews with the outcome
assessor about how to conduct telephone and face-to-face assessments. Dysphasia-friendly study materials
were produced by Speakeasy (Bury, UK), and stroke survivors and carers were involved in the development
of these materials. We feel that patient and carer involvement facilitated recruitment to the study. Their
involvement ensured that study documents and assessments were appropriate and acceptable.
The study was adopted by the NIHR Stroke Research Network and we provided updates to their Lay Member
Panel until 2015, when research networks were reorganised and the panel ceased to exist. Many local NIHR
Clinical Research Network: Stroke networks have established patient and carer panels that comment on
issues relating to adopted studies, but we did not set up a system to enable regular contact with these
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panels. During the course of the trial, we intermittently presented progress to the North-east Patient and
Carer Panel. In particular, we discussed ways to increase the recruitment of carers.
A service user (RC) was part of the investigator team and was involved in the study from its design at grant
application stage to reviewing this final report. He was involved in regular investigator group meetings,
commented on the study design and documents, and was involved in the final data interpretation. Another
service user (David Burgess) was a member of the TSC and advised on a number of issues, particularly the
recruitment of carers.
We did not have a documented patient and carer involvement and evaluation plan and, in retrospect, this
would have been helpful. Once recruitment and other parts of the study were progressing well, patient
and carer involvement was sparse. We should have systematically recorded the changes made to the study
based on patient and carer involvement. In future studies, we will follow GRIPP2 (Guidance for Reporting
Involvement of Patients and the Public) guidance113 and will also consider establishing a patient and carer
panel specifically for the study.
We have not yet shared our findings with patient and carer groups, but we will do so once this report is
published. We will seek their advice about the wider dissemination of results and we will work with the
Stroke Association and with the North-east Patient and Carer Panel to look at ways to ensure that the
results reach a broad audience.
It is important that study participants are informed about the results of the EXTRAS trial. Once the trial is
published, study results will be presented at local meetings to study participants who will also be sent a
summary of the results of the study and a copy of the final NIHR report (for those who wish to receive it).
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Chapter 10 Conclusions
EXTRAS did not improve stroke survivors’ performance in EADL. The lack of effect on the primary outcomeis likely to be because of the concept of EXTRAS rather than the fidelity of the intervention. Patients and
carers in the intervention group were more satisfied with their overall care, but carer strain and carer quality
of life were not influenced by EXTRAS. The post hoc analysis found fewer cases of anxiety and depression in
the intervention group than in the usual care group. The impact on patient costs and QALYs resulted in a
high chance that EXTRAS could be considered cost-effective at the current conventional thresholds of the
NHS/UK society’s WTP for 1 QALY, despite there being no difference in the primary outcome.
Self-management was an important part of EXTRAS, as we sought to improve the stroke survivors’
knowledge, skills and confidence to manage their condition in the context of their day-to-day activities.114
The EXTRAS reviews offered stroke survivors an opportunity to have regular contact with a stroke specialist
who supported them to reflect on their situation and to be realistic about their progress and expectations,
as well as to become more knowledgeable about stroke and the help that was and was not available.
Implications for health and social care
The main challenge of this study is the interpretation of the results, given the apparent divergence between
the primary outcome and the health economic outcomes. Although there is no evidence of any treatment
effect on the primary outcome, the cost-effectiveness analyses are consistent with EXTRAS being associated
with cost saving and quality-of-life gain. Our findings suggest that EXTRAS may be an affordable addition
to improve stroke care.
Recommendations for further research
The EXTRAS trial has demonstrated that a large multicentre trial to evaluate a new innovative community
stroke service is achievable. Robust development and evaluation of stroke units and ESD services, supported
by national audit, have led to major improvements in stroke care over the last 20 years. There remains an
urgent need to develop, provide and evaluate community services to meet the long-term and ongoing
needs of stroke survivors and carers. Unless this is achieved, community-based rehabilitation will continue
to lag behind other aspects of stroke care.
Further research is required to identify whether or not community-based interventions tailored to the
individual needs of stroke survivors can improve performance in EADL, and to understand the mechanisms
by which quality of life is improved and costs are reduced by provision of intermittent longer-term
specialist review.
The James Lind Alliance (Southampton, UK) has identified 10 top priorities relating to life after stroke115
and many of these priorities influence performance in EADL. For example, recovery of upper limb function
and improving mobility, cognition and speech. These priorities are currently being reviewed by the James
Lind Alliance Priority Setting Partnership and the Stroke Association, but addressing the longer-term
consequences of stroke is likely to remain a priority.
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Appendix 1 Description of EXTRAS using the
TIDieR checklist
TABLE 31 Description of EXTRAS using the TIDieR checklist
Item Description
1. Brief name: ‘provide the name or phrase that
describes the intervention’
Extended stroke rehabilitation service (EXTRAS)
2. Why: ‘describe any rationale, theory, or goal
of the elements essential to the intervention’
The EXTRAS consisted of rehabilitation reviews conducted by a
senior member of the ESD team at 1, 3, 6, 12 and 18 months post
discharge from routine ESD (trial randomisation). Each review
consisted of a semistructured interview to identify rehabilitation
issues, goal-setting and action-planning
The elements of this service are established rehabilitation practice
3. What materials: ‘describe any physical or
informational materials used in the intervention,
including those provided to participants or
used in intervention delivery or in training of
intervention providers. Provide information
on where the materials can be accessed’
A study-specific manual described how to conduct the reviews and
included guidance on exploring rehabilitation needs, goal-setting
and appropriate interventions to meet a patient’s needs
Study-specific paperwork was completed for each review and required
documentation of identified needs, goals set and action plans made
Staff delivering the reviews received specific training
Participants received an appointment card that documented review
dates and also contained a short checklist of rehabilitation issues to be
covered in each review
Following a review, participants received a summary of the interview
and recommendations for rehabilitation by post
4. What (procedures): ‘describe each of the
procedures, activities and/or processes used in
the intervention, including any enabling support
activities’
The EXTRAS reviews were intended to be conducted by telephone.
However, if participation in a telephone interview was not possible,
a home visit could be undertaken. Each review consisted of:
Identification of rehabilitation needs. A semistructured interview was
conducted to determine the patient’s progress, current rehabilitation
needs and service provision. The interview addressed daily activities
(mobility, personal care, mealtimes, domestic activities), social
participation (work and volunteering, hobbies and interests, driving
and transport) and wider issues (communication, memory and
concentration, mood, medical issues, pain) that may be problematic
for stroke survivors. The views of both the patient and carer (where
appropriate) could be sought. The interview topics were based on
the literature about long-term needs after stroke, including the UK
Stroke Survivor Needs Survey 7 and input from stroke survivors,
carers and health-care professionals
Joint rehabilitation goal-setting. From the identified progress and
rehabilitation needs, up to five individual rehabilitation goals could
be set by the patient (and carer) in collaboration with the senior
ESD team member who conducted the review. The focus of joint
goal-setting was intended to be on increasing participation in
everyday activities. From the second review, progress towards
goals set previously was assessed prior to further goal-setting.
Achievement of goals was recorded using a Goal Attainment Scale48
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TABLE 31 Description of EXTRAS using the TIDieR checklist (continued )
Item Description
Action-planning. The patient (and carer) agreed an action plan for
each rehabilitation goal. Action plans could include:
Verbal advice and encouragement
Discussion with the stroke team, rehabilitation team, primary care
team or social services involved in care
Signposting to local activities, community organisations or voluntary
services
Referral to stroke services, rehabilitation services or primary care
services for further assessment and treatment if required according
to local guidelines and/or service provision
5. Who provided: ‘for each category of intervention
provider (for example, psychologist, nursing
assistant) describe their expertise, background
and any specific training given’
Senior members of ESD teams delivered the reviews. The choice of
ESD team staff member (e.g. physiotherapist, occupational therapist,
nurse) to conduct each individual review was at the discretion of
each participating centre
On opening a study centre, all senior ESD staff taking part in delivery
of the new service received face-to-face training from the trial
co-ordinating centre team. As delivery of the intervention for this
study was conducted for almost 5 years (recruitment commenced in
late 2012 and delivery of the intervention ceased in mid-2017),
inevitable staffing changes took place in ESD teams. New members
of staff received cascade training from existing trained staff and/or
further training visits from the trial co-ordinating centre were
undertaken
6. How: ‘describe the modes of delivery (such as face
to face or by some other mechanism, such as
internet or telephone) of the intervention and
whether it was provided individually or in a group’
One-to-one telephone interviews were intended. However, if
participation in a telephone interview was not possible, a home visit
could be undertaken
7. Where: ‘describe the type of location(s) where
the intervention occurred’
Telephone calls were made from ESD team facilities
8. When and howmuch: ‘describe the number of
times the intervention was delivered and over what
period of time including the number of sessions,
their schedule, duration, intensity or dose’
Five reviews were conducted over 18 months. These took place at 1,
3, 6, 12 and 18 months post discharge from routine ESD services.
Review duration was individual and according to the length of time
it took to complete
9. Tailoring: ‘if intervention was planned to be
personalised or adapted, then describe what,
why, when and how’
Every review was personalised as individual needs were identified,
goals set and actions planned
10. Modifications: ‘if intervention was modified
during the course of the study, describe the
changes what, why, when and how’
No modifications were made
11. How well (planned): ‘if intervention adherence
or fidelity was assessed, describe how and by
whom, and if any strategies were used to
maintain or improve fidelity, describe them’
Each review was documented onto study-specific paperwork that
asked for rehabilitation issues, goals set and action plans made to be
recorded
The paperwork for all five reviews was provided as a booklet and at
the start of each time point space was provided to document a
reason if the review could not be undertaken
Data from the study paperwork was uploaded onto an online
database and the study co-ordination centre used this to send
monthly reports to all participating teams highlighting overdue or
missing reviews
12. How well (actual): ‘If intervention adherence
or fidelity was assessed, describe the extent to
which the intervention was delivered as planned’
Details of delivery of the intervention are provided in Chapter 5
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Appendix 2 Supplementary data
TABLE 32 Reasons why recruited patients were not randomised
Reasons recruited patients were not randomised Number of patients (N= 101), n
Patient decision to withdraw 49
Deterioration in cognition or health 5
Did not want further rehabilitation 13
No reason provided 18
Too many other commitments/time commitment 10
Too many questions/questions too challenging 3
Study centre staff decision to withdraw 20
Staff considered patient no longer appropriate because of a deterioration
in health
8
Staff considered patient no longer appropriate because of the cognitive function
of patient and/or carer
8
Patient recruited in error as they did not fulfil eligibility criteria
(not a diagnosis of stroke)
4
Other decision 28
Patient moving away from study centre area 2
Patient discharged from routine ESD and baseline assessment/randomisation not
conducted in error
9
Patient unavailable/uncontactable for baseline assessment and randomisation 6
Staff unavailable to conduct baseline assessment and randomisation 6
Patient recruited in error did not fulfil eligibility criteria (not discharged
with ESD team)
5
Patient died 4
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TABLE 33 Patient recruitment and randomisation per study centre
Study centre Opening date
Number of patients
recruited (n)
Number of patients randomised
Total, n (%) Intervention (n) Control (n)
North Tyneside 5 November 2012 42 36 (86) 17 19
Wansbeck 5 November 2012 35 24 (69) 12 12
Leeds 3 December 2012 132 81 (61) 41 40
Newcastle 2 January 2013 36 27 (75) 14 13
Pennine 12 February 2013 23 15 (65) 8 7
South Tyneside 1 August 2013 28 27 (96) 14 13
Cornwall 28 August 2013 68 61 (90) 29 32
Southampton 7 October 2013 21 21 (100) 11 10
Plymouth 24 October 2013 60 60 (100) 30 30
Portsmouth 7 November 2013 29 27 (93) 14 13
Norfolk 29 November 2013 57 56 (98) 28 28
Staffordshire 5 December 2013 21 18 (86) 9 9
Bournemouth 25 February 2014 32 32 (100) 16 16
Hull 10 March 2014 8 8 (100) 3 5
York 21 May 2014 11 11 (100) 5 6
Sherwood Forest 4 July 2014 24 22 (92) 11 11
Somerset 25 July 2014 19 19 (100) 9 10
Wigan 7 August 2014 10 10 (100) 5 5
Cardiff 23 December 2014 18 18 (100) 9 9
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TABLE 34 Reasons for missing follow-up outcome data
Group
Withdrawn at or before
the 12-month assessment
Assessment not conducted
at 12 months
Withdrawn between
12 and 24 months
Assessment not conducted
at 24 months
Intervention Total: N = 13
l Patient moving out of study
area: n = 1
l Patient requested, no reason
provided: n = 3
l Patient reported finding the study
confusing: n = 1
l Patient unwell and unable to
continue: n = 5
l Patient reported fully recovered
and did not want to
continue: n = 1
l Patient reported too busy to
continue: n = 2
Total: N = 23
l Patient unwell and unable to do
assessment: n = 5
l Patient uncontactable or did not respond
to phone/e-mail/questionnaire
attempts: n = 18
Total: N = 7
l Patient reported that
appointment times were not
convenient: n = 1
l Patient unwell and unable to
continue: n = 6
Total: N = 23
l Patient declined to complete
assessment: n = 3
l Patient unwell and unable to do
assessment: n = 2
l Patient uncontactable or did not
respond to phone/e-mail/
questionnaire attempts: n = 18
Control Total: N = 8
l Carer required to assist patient
to do study and could no longer
do so: n = 1
l Patient request, no reason
provided: n = 2
l Patient unwell and unable to
continue: n = 5
Total: N = 14
l Patient unwell and unable to do
assessment: n = 2
l Patient uncontactable or did not respond
to phone/e-mail/questionnaire
attempts: n = 12
Total: N = 1
l Patient unwell and unable to
continue: n = 1
Total: N = 16
l Patient declined to complete
assessment: n = 4
l Patient unwell and unable to do
assessment: n = 1
l Patient uncontactable or did not
respond to phone/e-mail/
questionnaire attempts: n = 11
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TABLE 35 Comparison of characteristics of patients who were randomised into the trial and those who dropped
out of the trial before randomisation
Characteristic Randomised Not randomised
Sex, n (%) n = 573 n = 99
Male 342 (59.7) 50 (50.5)
Female 231 (40.3) 49 (49.4)
Age (years) n = 573 n = 99
Median (IQR) 71 (61–78) 75 (66–82)
Pre-stroke NEADL Scale score n = 573 n = 99
Mean (SD) 60.4 (9.6) 54.8 (13.7)
Pre-stroke OHS score, n (%) n = 572 n = 99
0 349 (61.0) 50 (50.5)
1 108 (18.9) 20 (20.2)
2 82 (14.3) 17 (17.2)
3 29 (5.1) 11 (11.1)
4 4 (0.7) 1 (1.01)
5 0 (0.0) 0 (0.0)
Stroke type, n (%) n = 573 n = 99
Cerebral infarct 503 (87.8) 92 (92.9)
Intracerebral haemorrhage 59 (10.3) 5 (5.1)
Subarachnoid haemorrhage 10 (1.8) 1 (1.0)
Unknown 1 (0.2) 1 (1.0)
Stroke subtype, n (%) n = 570 n = 99
TACS 115 (20.2) 20 (20.2)
PACS 258 (45.3) 41 (41.4)
LACS 100 (17.5) 24 (24.2)
POCS 96 (16.8) 14 (14.1)
Uncertain 1 (0.2) 0 (0.00)
First ever stroke, n (%) n = 573 n = 99
Yes 462 (80.6) 78 (78.8)
NIHSS score at recruitment (scored 0–42) n = 563 n = 99
Median (IQR) 2 (1–4) 2 (2–4)
LACS, lacunar stroke; PACS, partial anterior circulation stroke; POCS, posterior circulation stroke; TACS, total anterior
circulation stroke.
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TABLE 36 Distribution of subscales of NEADL Scale scores at each time point
Subscale
Pre stroke Baseline 12 months 24 months
Intervention,
mean (SD)
Control,
mean (SD)
Intervention,
mean (SD)
Control,
mean (SD)
Intervention,
mean (SD)
Control,
mean (SD)
Intervention,
mean (SD)
Control,
mean (SD)
n = 285 n = 288 n = 283 n = 285 n = 239 n = 248 n = 219 n = 231
Mobility (0–18) 16.7 (3.1) 16.1 (3.8) 10.5 (5.5) 10.3 (5.5) 11.0 (5.6) 10.3 (5.7) 10.7 (5.8) 9.8 (6.0)
n = 285 n = 288 n = 283 n = 286 n = 239 n = 247 n = 219 n = 231
Kitchen (0–15) 14.7 (1.5) 14.5 (2.1) 12.1 (4.0) 11.8 (4.3) 11.6 (4.3) 10.9 (4.4) 11.3 (4.4) 10.8 (4.8)
n = 285 n = 288 n = 283 n = 285 n = 239 n = 248 n = 219 n = 231
Domestic tasks
(0–15)
13.7 (2.8) 13.5 (3.3) 8.0 (5.2) 7.8 (5.2) 8.1 (5.2) 7.4 (5.0) 7.8 (5.1) 7.1 (5.0)
n = 285 n = 288 n = 281 n = 284 n = 239 n = 248 n = 219 n = 231
Leisure activities
(0–18)
16.0 (3.1) 15.6 (3.4) 9.3 (4.2) 9.3 (4.1) 10.0 (4.8) 9.5 (4.5) 10.2 (5.0) 9.6 (4.9)
n = 285 n = 288 n = 281 n = 282 n = 239 n = 247 n = 219 n = 231
Total (0–66) 61.0 (8.6) 59.7 (10.6) 39.8 (16.1) 39.1 (16.1) 40.6 (17.7) 38.3 (17.0) 40.0 (18.1) 37.2 (18.5)
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TABLE 37 Detailed breakdown of patients’ experiences of services at 12 months
About the services, to what extent do you agree that: Intervention, n (%) Control, n (%)
Staff were welcoming and friendly n = 238 n = 246
Strongly disagree 1 (0.4) 3 (1.2)
Disagree 1 (0.4) 3 (1.2)
Agree 83 (34.9) 112 (45.5)
Strongly agree 147 (61.8) 118 (48.0)
Does not apply 6 (2.5) 10 (4.1)
Missing 1 2
Staff treated you with dignity and respect n = 238 n = 246
Strongly disagree 1 (0.4) 3 (1.2)
Disagree 3 (1.3) 4 (1.6)
Agree 81 (34.0) 107 (43.5)
Strongly agree 146 (61.3) 123 (50.0)
Does not apply 7 (2.9) 9 (3.7)
Missing 1 2
Staff assessed your needs n = 237 n = 246
Strongly disagree 1 (0.4) 2 (0.8)
Disagree 9 (3.8) 6 (2.4)
Agree 93 (39.2) 130 (52.9)
Strongly agree 126 (53.2) 99 (40.2)
Does not apply 8 (3.4) 9 (3.7)
Missing 2 2
Staff met your needs n = 238 n = 246
Strongly disagree 0 (0.0) 2 (0.8)
Disagree 14 (5.9) 13 (5.3)
Agree 97 (40.8) 134 (54.5)
Strongly agree 120 (50.4) 88 (35.8)
Does not apply 7 (2.9) 9 (3.7)
Missing 1 2
You have been involved as much as you wanted to be in decisions
about your care n = 238 n = 246
Strongly disagree 1 (0.4) 3 (1.2)
Disagree 19 (8.0) 17 (6.9)
Agree 102 (42.9) 121 (49.2)
Strongly agree 109 (45.8) 92 (37.4)
Does not apply 7 (2.9) 13 (5.3)
Missing 1 2
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TABLE 37 Detailed breakdown of patients’ experiences of services at 12 months (continued )
About the services, to what extent do you agree that: Intervention, n (%) Control, n (%)
You were able to discuss your preferences, beliefs and concerns
as part of your care n = 238 n = 244
Strongly disagree 1 (0.4) 3 (1.2)
Disagree 15 (6.3) 14 (5.7)
Agree 107 (45.0) 129 (52.9)
Strongly agree 104 (43.7) 79 (32.4)
Does not apply 11 (4.6) 19 (7.8)
Missing 1 4
You were told who to contact if you had any worries or concerns n = 238 n = 244
Strongly disagree 2 (0.8) 2 (0.8)
Disagree 11 (4.6) 13 (5.3)
Agree 106 (44.5) 144 (59.0)
Strongly agree 114 (47.9) 74 (30.3)
Does not apply 5 (2.1) 11 (4.5)
Missing 1 4
You were confident that the staff you saw had the right skills and
knowledge to help you n = 236 n = 246
Strongly disagree 1 (0.4) 4 (1.6)
Disagree 6 (2.5) 10 (4.1)
Agree 100 (42.4) 136 (55.3)
Strongly agree 123 (52.1) 87 (35.4)
Does not apply 6 (2.5) 9 (3.7)
Missing 3 2
You were treated fairly regardless of your age, race, sex, belief,
sexual orientation or disability n = 237 n = 246
Strongly disagree 1 (0.4) 2 (0.8)
Disagree 7 (3.0) 6 (2.4)
Agree 96 (40.5) 127 (51.6)
Strongly agree 127 (53.6) 101 (41.1)
Does not apply 6 (2.5) 10 (4.1)
Missing 2 2
You were given the information you wanted n = 237 n = 246
Strongly disagree 1 (0.4) 2 (0.8)
Disagree 11 (4.6) 13 (5.3)
Agree 113 (47.7) 140 (56.9)
Strongly agree 107 (45.2) 79 (32.1)
Does not apply 5 (2.1) 12 (4.9)
Missing 2 2
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TABLE 37 Detailed breakdown of patients’ experiences of services at 12 months (continued )
About the services, to what extent do you agree that: Intervention, n (%) Control, n (%)
You were able to see the same health-care professional/team
whenever possible n = 238 n = 246
Strongly disagree 2 (0.8) 3 (1.2)
Disagree 15 (6.3) 27 (11.0)
Agree 108 (45.6) 135 (54.9)
Strongly agree 103 (43.5) 68 (27.6)
Does not apply 9 (3.8) 13 (5.3)
Missing 1 2
If you had important questions to ask, you got answers that you
could understand n = 236 n = 245
Strongly disagree 2 (0.9) 0 (0.0)
Disagree 14 (5.9) 10 (4.1)
Agree 109 (46.2) 136 (55.5)
Strongly agree 103 (43.6) 76 (31.0)
Does not apply 8 (3.4) 23 (9.4)
Missing 3 3
If you needed more than one service, staff made sure they were
well co-ordinated n = 238 n = 246
Strongly disagree 3 (1.3) 3 (1.2)
Disagree 16 (6.7) 21 (8.6)
Agree 104 (43.7) 126 (51.4)
Strongly agree 92 (38.7) 63 (25.7)
Does not apply 23 (9.7) 32 (13.1)
Missing 1 2
If you needed more than one service, staff made sure that your
care information was clearly and accurately shared n = 238 n = 245
Strongly disagree 4 (1.7) 3 (1.2)
Disagree 13 (5.5) 19 (7.7)
Agree 104 (43.7) 129 (52.4)
Strongly agree 93 (39.1) 63 (25.6)
Does not apply 24 (10.1) 32 (13.0)
Missing 1 3
You were told who to contact if you had any ongoing health-care
needs n = 238 n = 246
Strongly disagree 1 (0.4) 2 (0.8)
Disagree 15 (6.3) 18 (7.3)
Agree 107 (45.0) 147 (59.8)
Strongly agree 110 (46.2) 68 (27.6)
Does not apply 5 (2.1) 11 (4.5)
Missing 1 2
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TABLE 37 Detailed breakdown of patients’ experiences of services at 12 months (continued )
About the services, to what extent do you agree that: Intervention, n (%) Control, n (%)
Overall, how satisfied are you with the services you received? n = 239 n = 246
Extremely satisfied 77 (32.2) 64 (26.0)
Very satisfied 112 (46.9) 102 (41.5)
Quite satisfied 39 (16.3) 61 (24.8)
Not very satisfied 9 (3.8) 16 (6.5)
Extremely unsatisfied 2 (0.8) 3 (1.2)
Missing 0 2
In the last 12 months, have you had enough help with speaking
difficulties from the NHS? n = 239 n = 246
Yes, definitely 48 (20.1) 54 (22.0)
Yes, to some extent 31 (13.0) 35 (14.2)
No I did not get enough help from the NHS 11 (4.6) 16 (6.5)
I did not have any speaking difficulties 149 (62.3) 141 (57.3)
Missing 0 2
In the last 12 months, have you had enough treatment to help
improve your mobility from the NHS? n = 239 n = 247
Yes, definitely 103 (43.1) 80 (32.4)
Yes, to some extent 64 (26.8) 86 (34.8)
No I did not get enough help from the NHS 35 (14.6) 52 (21.1)
I did not have any mobility difficulties 37 (15.5) 29 (11.7)
Missing 0 1
In the last 12 months, have you had enough help with emotional
problems from the NHS? n = 239 n = 246
Yes, definitely 38 (15.9) 52 (21.1)
Yes, to some extent 42 (17.6) 60 (24.4)
No I did not get enough help from the NHS 33 (13.8) 34 (13.8)
I did not have any emotional problems 126 (52.7) 100 (40.7)
Missing 0 2
TABLE 38 Detailed breakdown of patients’ experience of services at 24 months
About the services, to what extent do you agree that: Intervention, n (%) Control, n (%)
Staff were welcoming and friendly n = 216 n = 227
Strongly disagree 0 (0.0) 2 (0.9)
Disagree 2 (0.9) 2 (0.9)
Agree 51 (23.6) 65 (28.6)
Strongly agree 63 (29.2) 58 (25.6)
Does not apply 100 (46.3) 100 (44.1)
Missing 3 4
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TABLE 38 Detailed breakdown of patients’ experience of services at 24 months (continued )
About the services, to what extent do you agree that: Intervention, n (%) Control, n (%)
Staff treated you with dignity and respect n = 216 n = 225
Strongly disagree 0 (0.0) 0 (0.0)
Disagree 0 (0.0) 4 (1.8)
Agree 53 (24.5) 64 (28.4)
Strongly agree 64 (29.6) 58 (25.9)
Does not apply 99 (45.8) 99 (44.0)
Missing 3 6
Staff assessed your needs n = 216 n = 225
Strongly disagree 0 (0.0) 2 (0.9)
Disagree 4 (1.9) 7 (3.1)
Agree 56 (25.9) 61 (27.1)
Strongly agree 57 (26.4) 53 (23.6)
Does not apply 99 (45.8) 102 (45.3)
Missing 3 6
Staff met your needs n = 217 n = 226
Strongly disagree 0 (0.0) 2 (0.9)
Disagree 3 (1.4) 12 (5.3)
Agree 63 (29.0) 60 (26.6)
Strongly agree 51 (23.5) 51 (22.6)
Does not apply 100 (46.1) 101 (44.7)
Missing 2 5
You have been involved as much as you wanted to be in decisions
about your care n = 216 n = 226
Strongly disagree 0 (0.0) 1 (0.4)
Disagree 7 (3.2) 12 (5.3)
Agree 61 (28.2) 59 (26.1)
Strongly agree 49 (22.7) 49 (21.7)
Does not apply 99 (45.8) 105 (46.5)
Missing 3 5
You were able to discuss your preferences, beliefs and concerns
as part of your care n = 216 n = 226
Strongly disagree 0 (0.0) 1 (0.4)
Disagree 8 (3.7) 9 (4.0)
Agree 64 (29.6) 68 (30.1)
Strongly agree 42 (19.4) 44 (19.5)
Does not apply 102 (47.2) 104 (46.0)
Missing 3 5
You were told who to contact if you had any worries or concerns n = 216 n = 226
Strongly disagree 1 (0.5) 4 (1.8)
Disagree 6 (2.8) 5 (2.2)
Agree 58 (26.9) 66 (29.2)
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
134
TABLE 38 Detailed breakdown of patients’ experience of services at 24 months (continued )
About the services, to what extent do you agree that: Intervention, n (%) Control, n (%)
Strongly agree 52 (24.1) 50 (22.1)
Does not apply 99 (45.8) 101 (44.7)
Missing 3 5
You were confident that the staff you saw had the right skills
and knowledge to help you n = 216 n = 226
Strongly disagree 0 (0.0) 1 (0.4)
Disagree 3 (1.4) 6 (2.7)
Agree 62 (28.7) 68 (30.1)
Strongly agree 54 (25.0) 51 (22.6)
Does not apply 97 (44.9) 100 (44.3)
Missing 3 5
You were treated fairly regardless of your age, race, sex, belief,
sexual orientation or disability n = 216 n = 227
Strongly disagree 0 (0.0) 1 (0.4)
Disagree 1 (0.5) 3 (1.3)
Agree 58 (26.9) 68 (30.0)
Strongly agree 58 (26.9) 56 (24.7)
Does not apply 99 (45.8) 99 (43.6)
Missing 3 4
You were given the information you wanted n = 216 n = 227
Strongly disagree 0 (0.0) 0 (0.0)
Disagree 4 (1.9) 10 (4.4)
Agree 65 (30.1) 70 (30.8)
Strongly agree 49 (22.7) 45 (19.8)
Does not apply 98 (45.4) 102 (44.9)
Missing 3 4
You were able to see the same health-care professional/team
whenever possible n = 215 n = 226
Strongly disagree 0 (0.0) 4 (1.8)
Disagree 9 (4.2) 11 (4.9)
Agree 63 (29.3) 66 (29.2)
Strongly agree 40 (18.6) 41 (18.1)
Does not apply 103 (47.9) 104 (46.0)
Missing 4 5
If you had important questions to ask, you got answers that
you could understand n = 216 n = 226
Strongly disagree 0 (0.0) 1 (0.4)
Disagree 8 (3.7) 8 (3.5)
Agree 64 (29.6) 66 (29.2)
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TABLE 38 Detailed breakdown of patients’ experience of services at 24 months (continued )
About the services, to what extent do you agree that: Intervention, n (%) Control, n (%)
Strongly agree 43 (19.9) 47 (20.8)
Does not apply 101 (46.8) 104 (46.0)
Missing 3 5
If you needed more than one service, staff made sure they were
well co-ordinated n = 216 n = 227
Strongly disagree 1 (0.5) 2 (0.9)
Disagree 7 (3.2) 7 (3.1)
Agree 50 (23.2) 59 (26.0)
Strongly agree 41 (19.0) 36 (15.9)
Does not apply 117 (54.2) 123 (54.2)
Missing 3 4
If you needed more than one service, staff made sure that your
care information was clearly and accurately shared n = 216 n = 226
Strongly disagree 1 (0.5) 1 (0.4)
Disagree 8 (3.7) 9 (4.0)
Agree 52 (24.1) 58 (25.7)
Strongly agree 39 (18.1) 36 (15.9)
Does not apply 116 (53.7) 122 (54.0)
Missing 3 5
You were told who to contact if you had any ongoing
health-care needs n = 216 n = 226
Strongly disagree 1 (0.5) 3 (1.3)
Disagree 5 (2.3) 6 (2.6)
Agree 62 (28.6) 75 (32.9)
Strongly agree 48 (22.1) 40 (17.5)
Does not apply 101 (46.5) 104 (45.6)
Missing 3 5
Overall, how satisfied are you with the services you received? n = 213 n = 216
Extremely satisfied 56 (26.3) 45 (20.8)
Very satisfied 98 (46.0) 91 (42.1)
Quite satisfied 54 (25.4) 53 (24.5)
Not very satisfied 5 (2.4) 20 (9.3)
Extremely unsatisfied 0 (0.0) 7 (3.2)
Missing 6 15
In the last 12 months, have you had enough help with speaking
difficulties from the NHS? n = 215 n = 225
Yes, definitely 15 (7.0) 18 (8.0)
Yes, to some extent 14 (6.5) 17 (7.6)
No, I did not get enough help from the NHS 13 (6.1) 20 (8.9)
I did not have any speaking difficulties 173 (80.5) 170 (75.6)
Missing 4 6
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TABLE 38 Detailed breakdown of patients’ experience of services at 24 months (continued )
About the services, to what extent do you agree that: Intervention, n (%) Control, n (%)
In the last 12 months, have you had enough treatment to help
improve your mobility from the NHS? n = 215 n = 224
Yes, definitely 31 (14.4) 35 (15.6)
Yes, to some extent 64 (29.8) 46 (20.5)
No, I did not get enough help from the NHS 46 (21.4) 86 (38.4)
I did not have any mobility difficulties 74 (34.4) 57 (25.5)
Missing 4 7
In the last 12 months, have you had enough help with emotional
problems from the NHS? n = 216 n = 223
Yes, definitely 22 (10.2) 31 (13.9)
Yes, to some extent 30 (13.9) 28 (12.6)
No, I did not get enough help from the NHS 21 (9.7) 36 (16.1)
I did not have any emotional problems 143 (66.2) 128 (57.4)
Missing 3 8
TABLE 39 Patient outcome assessment blinding
12 months 24 months
Intervention
(n= 239)
Control
(n= 248)
Intervention
(n= 219)
Control
(n= 231)
Assessment by telephone or face to face, n (%) 212 (89) 204 (82) 195 (89) 186 (81)
Assessor reported certainty for randomisation group,
n (%)
Yes 37 (17) 7 (3) 17 (9) 2 (1)
No 173 (82) 197 (97) 178 (91) 184 (99)
Missing 2 (1)
Where assessor reported certainty, correct
randomisation group was recorded, n (%)
n = 37 n = 7 n = 17 n = 2
Yes 37 (17) 6 (3) 17 (9) 1 (1)
No 0 (0) 1 (0) 0 (0) 1 (1)
Assessments conducted blinded, n (%) 173 (82) 198 (97) 178 (91) 185 (99)
TABLE 40 Reasons for medical events being considered SAEs
Reason Intervention (N= 250) Control (N= 254)
Event resulted in death, n (%) 26 (10.4) 32 (12.6)
Event was life-threatening, n (%) 6 (2.4) 5 (2.0)
Event resulted in admission to hospital or prolongation of
hospitalisation, n (%)
163 (65.2) 168 (66.1)
Event resulted in persistent or significant disability or
incapacity, n (%)
14 (5.6) 9 (3.5)
Event was ‘otherwise considered significant’ by the
investigator, n (%)
41 (16.4) 40 (15.7)
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TABLE 41 Summarised SAEs that resulted in death
Intervention (N= 26), n Control (N= 32), n
Cardiovascular
Total 7 6
Cardiorespiratory failure 1
Coronary heart disease 1
Heart failurea 4a 2
Hypertensive heart disease 1
Ischaemic heart disease 1 1
Myocardial infarction 1
Peripheral vascular disease 1
Dermatological
Total 1
Cellulitis and septic shock 1
Gastrointestinal
Total 1 4
Bowel cancer 1 1
Gastric outlet obstruction and metastatic gastric cancer 1
Ischaemic bowel 1
Pancreatic cancer 1
Musculoskeletal
Total 2
Fracture: hip 1
Sarcomab 1b
Musculoskeletal/respiratory
Total 2
Fractured hip and chest infection/pneumoniab 2b
Neurological
Total 1 6
Stroke (new) 1 3
Subarachnoid haemorrhage 1
Subdural haematoma 2
Respiratory
Total 8 11
Acute respiratory distress syndrome postoperative 1
Chest infection/pneumoniaa 6a 6
Chronic obstructive pulmonary disease 1
Lung cancer 1
Metastatic lung cancer 1
Pulmonary embolus 1
Respiratory failure from bilateral pneumothoraces
from ribs following fall
1
Sarcoidosis 1
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TABLE 41 Summarised SAEs that resulted in death (continued )
Intervention (N= 26), n Control (N= 32), n
Urinary tract
Total 1 1
Urinary tract infection 1 1
Miscellaneous
Total 4 3
Complications of stroke 1
Death: cause could not be established 3 1
Frailty of old age 1
Old age 1
a One of these events commenced during study involvement but the date of death was after study end.
b These events commenced during study involvement but the date of death was after study end.
TABLE 42 Summarised SAEs that did not result in death
Intervention Control
Number of
participants who
experienced
event, n
Number
of events
(N= 224), n
Number of
participants who
experienced
event, n
Number
of events
(N= 222), n
Cardiovascular
Total 18 22 20 26
AF or other arrhythmia 5 4
Angina/ischaemic chest pain 3 3
Aortic valve replacement 1
Atrial septal defect repair 1
Cardiac resynchronisation therapy and
defibrillator insertion
1
Carotid sinus syncope 1
Foramen ovale closure 2
Heart failure 2 8
ICD insertion 1
Implantation of loop recorder 1
Insertion of left ventricular assistive device 1
Insertion of stent graft for thoracic aneurysm 1
Ischaemic toe 1
Leg angioplasty 1
Malignant hypertension 1
Myocardial infarction 3 2
Pacemaker insertion 1 2
Postural/orthostatic hypotension 2
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TABLE 42 Summarised SAEs that did not result in death (continued )
Intervention Control
Number of
participants who
experienced
event, n
Number
of events
(N= 224), n
Number of
participants who
experienced
event, n
Number
of events
(N= 222), n
Dermatological
Total 7 7 3 3
Abscess 2
Burns 1
Cellulitis 4
Infected diabetic foot ulcer 1
Infected sebaceous cyst 1
Leg ulcers 1
Endocrine
Total 3 3 2 2
Hyperglycaemia 2
SIADH 1 1
Thyroid lobectomy 1
ENT
Total 3 3
Ear infection 1
Labyrinthitis 1
Vertigo 1
Eye
Total 1 1
Cataract surgery 1
Gastrointestinal
Total 16 18 17 26
Alcoholic liver disease 1
Appendicitis 1
Biliary sepsis related pancreatic cancer 1
Bowel cancer surgery 2 2
Campylobacter diarrhoea 1
Cholangitis 1
Cholecystitis 1 1
Cholecystitis related to pancreatic cancer 1
Constipation 3
Diarrhoea secondary to chemotherapy 1
Diverticulitis 1
ERCP 1
Faecal impaction 1
Gastric cancer 1
Gastritis 1
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TABLE 42 Summarised SAEs that did not result in death (continued )
Intervention Control
Number of
participants who
experienced
event, n
Number
of events
(N= 224), n
Number of
participants who
experienced
event, n
Number
of events
(N= 222), n
Gastroenteritis 2 2
GI bleed 2
Haemorrhoids 1
Hernia repair 3 1
Laparoscopic cholecystectomy 1
Liver biopsy 1
Liver injury and bleed 1
New diagnosis pancreatic cancer 1
Oesophageal spasm 1
Oesophageal stricture 1
OGD 1
OGD and endoscopic mural resection 1
PR bleed 1
Recurrent ascites 1
Symptoms because of progressive
pancreatic cancer
1
Symptoms related to pancreatic cancer 1
Gynaecological
Total 1 1
Vaginal wall laxity 1
Haematological
Total 1 1 4 4
DVT 4 4
Follicular lymphoma 1
Musculoskeletal
Total 32 34 24 31
Accidental laceration 1
Disc generation and neural compromise 1
Dislocated hip 1
Dog bite to hand 1
Femoral reconstruction 1
Fracture: ankle 1 1
Fracture: clavicle 1
Fracture: femur 1 1
Fracture: finger 1
Fracture: hip 9 6
Fracture: hip and metacarpal 1
Fracture: humerus 3 1
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TABLE 42 Summarised SAEs that did not result in death (continued )
Intervention Control
Number of
participants who
experienced
event, n
Number
of events
(N= 224), n
Number of
participants who
experienced
event, n
Number
of events
(N= 222), n
Fracture: metatarsal 1
Fracture: pelvis 1
Fracture: pubic rami and wrist 1
Fracture: ribs and finger 1
Fracture: wedge L1 1
Fracture: wrist 3
Head/facial injury 1
Infected hip replacement and washout 1
Knee effusion 1
Knee haemarthrosis 1
Knee replacement 1 5
L4/5 decompression surgery 1
Limb pain following fall 1
Lumbar facet joint disease 1
Muscular leg pain 1
Musculoskeletal back pain 2
Musculoskeletal hip pain 1
Musculoskeletal leg pain 1
Nerve root entrapment 1
Pain post knee replacement 1
Pseudogout 1
Psoas abscess 1
Revision of infected hip replacement 1
Rheumatoid arthritis flare 1
Seroma related to recent hip replacement 1
Spinal decompression surgery 1
Neurological
Total 31 52 40 57
Balance and mobility issues because of old
stroke
1
Brain tumour removal 1
Cerebral amyloid and subarachnoid
haemorrhage
1
Cerebral arteriography 1
Decompensation/exacerbation of stroke 2 2
Focal neurology related to previous stroke 1
Head injury 2
Increased tone/spasticity 2 1
Insertion of cranioplasty plate 1
Memory loss/dementia 1 3
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
142
TABLE 42 Summarised SAEs that did not result in death (continued )
Intervention Control
Number of
participants who
experienced
event, n
Number
of events
(N= 224), n
Number of
participants who
experienced
event, n
Number
of events
(N= 222), n
Migraine 1
Neurological symptoms: cause unknown 1
Neuropathic pain post shingles 1
New stroke 15 14
Occipital fracture and subarachnoid bleed 1
Occipital fracture/subdural haematoma 1
Parkinson’s disease 1
Possible seizure 2
Seizure(s) 13 16
Stereotactic radiosurgery 1
Stereotactic surgery 1
Subdural haematoma 2
TIA 8 8
TIA or seizure 2 1
Unexplained neurological symptoms 1
Psychiatry
Total 3 3
Anxiety 1
Self-harm 1
Severe depression 1
Respiratory
Total 17 38 19 22
Breathlessness: under investigation 1
Bronchoscopy 1
Chest infection/pneumonia 22 16
Elective mediastinoscopy and biopsy 1
Exacerbation of asthma 1
Exacerbation of COAD 5 4
Pleural effusion 1
Pleural effusion and thorascopy 1
Pleural effusion drained (lymphoma) 3
Pulmonary embolus 2 1
Respiratory dyspnoea: cause not given 1
Urinary tract
Total 10 14 17 20
Bladder tumour resection 1
Collection post kidney transplant 1
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TABLE 42 Summarised SAEs that did not result in death (continued )
Intervention Control
Number of
participants who
experienced
event, n
Number
of events
(N= 224), n
Number of
participants who
experienced
event, n
Number
of events
(N= 222), n
Hydrocele repair 1
Kidney infection 1
Kidney transplant 1
Renal acidosis 1
Renal colic 1
Renal haematoma and ureter calculi post
lithotripsy
1
TURP 1 1
Urinary retention 2 2
UTI 8 12
Miscellaneous
Total 28 29 23 29
Abdominal pain: cause unknown 1
Anaphylaxis 1
Back pain: cause unknown 1
Basilic vein transposition 1
Blackout/collapse/unresponsive episode:
cause unclear
2 1
Bleed from PICC line 1
Bleeding: high INR 1
Chest pain: cause unknown 1
Collapse: low BP from medication 1
Dehydration 1
Drug-induced electrolyte imbalance 1
Fall: cause unclear – injury documented 1
Fall: cause unknown – injury documented 1
Fall: no cause documented – injury
documented
1
Fall: no cause documented – no injury
documented
1 2
Fall because of stroke weakness and shoulder
pain: no injury documented
1
Falls secondary to cardiovascular disease: no
injury documented
1
Functional weakness 1
Granulomatosis 1
Headache: muscular 1
Headache: no cause established 1 1
Headache and dizziness: no cause found 1
Hypotensive episode 1
Injury to finger and face following fall 1
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TABLE 42 Summarised SAEs that did not result in death (continued )
Intervention Control
Number of
participants who
experienced
event, n
Number
of events
(N= 224), n
Number of
participants who
experienced
event, n
Number
of events
(N= 222), n
Mastectomy 1
Mechanical fall: no injury documented 2
Micturition syncope 1
Musculoskeletal chest pain 1
Nausea and bradycardia following ERCP
anaesthesia
1
Neurological symptoms because of
fibromyalgia
1
Non-cardiac chest pain 3
Off legs: no cause found 1 1
Overdose 1
Pain after OGD 1
Pain from bone metastasis 1
Parotitis 1
Peripheral oedema because of hemiparesis 1
Postural hypotension 1
Sepsis: source not documented 1
Sepsis: source unknown 1
Syncopal episode 1
Tesio line insertion 1
Unsteadiness: cause unclear 1
Vasovagal 2 1
Vomiting: no cause documented 1
Vomiting: no cause established 1 1
AF, atrial fibrillation; BP, blood pressure; COAD, chronic obstructive airways disease; DVT, deep-vein thrombosis; ENT, ear,
nose and throat; ERCP, endoscopic retrograde cholangiopancreatography; GI, gastrointestinal; ICD, implantable cardioverter
defibrillator; INR, international normalised ratio; ODG, oesophagogastroduodenoscopy; PICC, peripherally inserted central
catheter; PR, perirectal; SIADH, syndrome of inappropriate antidiuretic hormone secretion; TIA, transient ischaemic attack;
TURP, transurethral resection of the prostate; UTI, urinary tract infection.
Note
Where SAE reports documented more than one clinical event (e.g. pneumonia and acute kidney injury), the main event/
reason for hospitalisation was the event summarised. Where the main event appeared unclear, adjudication took place to
agree the event to summarise.
TABLE 43 For randomised patients, the number of SAEs reported before randomisation
Number of SAEs reported per patient Number of patients (N= 573), n
0 557
1 14
2 1
3 1
Total SAEs 19
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TABLE 44 Reasons for medical events prior to randomisation being considered SAEs
Reason Number of events (N= 19), n
Event resulted in death 0
Event was life-threatening 2
Event resulted in admission to hospital or prolongation of hospitalisation 14
Event resulted in persistent or significant disability or incapacity 1
Event was ‘otherwise considered significant’ by the investigator 2
TABLE 45 For randomised patients, summarised SAEs before randomisation
Number of patients who experienced event, n Number of events (N= 19), n
Cardiovascular
Total 2 2
Heart failure 1
Hypotensive collapse 1
Eye
Total 1 1
Corneal ulcer 1
Gastrointestinal
Total 2 2
Choledocholithiasis 1
Diverticulitis 1
Haematological
Total 1 1
DVT 1
Musculoskeletal
Total 1 1
Fracture: hip 1
Neurological
Total 5 6
Cerebellitis 1
New stroke 2
Seizure(s) 3
Respiratory
Total 2 3
Chest infection/pneumonia 2
Pulmonary embolus 1
Urinary tract
Total 3 3
Bladder tumour resection 1
Urinary retention 1
UTI 1
DVT, deep vein thrombosis; UTI, urinary tract infection.
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TABLE 46 For patients who dropped out before randomisation, the number of SAEs reported
Number of SAEs per patient Number of patients (N= 101), n
0 87
1 8
2 5
4 1
Total SAEs 22
TABLE 47 Reasons for medical events being considered SAEs for patients who dropped out of the study before
randomisation
Reason Number of events (N= 22), n
Event resulted in death 4
Event was life-threatening 1
Event resulted in admission to hospital or prolongation of hospitalisation 14
Event resulted in persistent or significant disability or incapacity 0
Event was ‘otherwise considered significant’ by the investigator 3
TABLE 48 For non-randomised patients, summarised SAEs
Number of patients who
experienced event, n
Number of events
(N= 22), n
Cardiovascular
Total 5 5
Carotid endarterectomy 1
Heart failure 1
MI 1
Mitral value repair (Libman–Sacks endocarditis) 1
Pacemaker insertion 1
Gastrointestinal
Total 2 2
Gastritis or reflux 1
Ischaemic bowel 1
Heamatological
Total 1 1
DVT 1
Miscellaneous
Total 1 1
Overdose 1
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TABLE 48 For non-randomised patients, summarised SAEs (continued )
Number of patients who
experienced event, n
Number of events
(N= 22), n
Neurological
Total 4 4
Complications of stroke 1
New stroke 1
Seizure(s) 1
Stroke 1
Respiratory
Total 4 6
Chest infection/pneumonia 5
Pulmonary embolus 1
Urinary tract
Total 3 3
UTI 3
DVT, deep vein thrombosis; MI, myocardial infarction; UTI, urinary tract infection.
TABLE 49 Number of non-serious AEs per patient
Number of events (n)
Number of patients, n (%)
12 months 24 months
Intervention (N= 239) Control (N= 248) Intervention (N= 219) Control (N= 231)
0 173 (72.4) 191 (77.0) 166 (75.8) 181 (78.4)
1 56 (23.4) 43 (17.3) 39 (17.8) 37 (16.0)
2 8 (3.3) 12 (4.8) 11 (5.0) 11 (4.8)
3 1 (0.4) 1 (0.4) 2 (0.9) 1 (0.4)
4 1 (0.4) 0 (0.0) 1 (0.5) 1 (0.4)
5 0 (0.0) 1 (0.4) 0 (0.0) 0 (0.0)
Total events 79 75 71 66
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TABLE 50 Summarised non-serious AEs
12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Cardiovascular
Total 8 8 5 5 4 4 4 5
Angina 1 0 1 0
Atrial fibrillation/other
arrhythmia
0 3 1 0
Blood pressure issues 1 0 1 2
Heart attack 0 2 0 0
Heart failure 2 0 0 0
Heart monitoring 0 0 0 1
Hole in heart 1 0 0 0
Leaking valve 1 0 0 0
Pacemaker insertion/
replacement
1 0 0 1
Peripheral vascular disease 1 0 1 0
Suspected heart attack 0 0 0 1
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TABLE 50 Summarised non-serious AEs (continued )
12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Dermatological
Total 3 4 4 4 2 2 4 4
Callous on foot 0 0 0 1
Cellulitis 0 2 1 0
Facial rashes 0 0 0 1
Infection in feet 1 0 0 0
Injury to skin with poor
healing
0 1 0 0
Issues with skin graft for
BCC
1 0 0 0
Itchy skin because of
medication
0 0 1 0
Psoriasis 0 1 0 0
Rodent ulcer face 1 0 0 0
Rodent ulcer leg 1 0 0 0
Toe ulcers 0 0 0 1
Toenail removal 0 0 0 1
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12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Endocrine
Total 8 8 1 1 0 0 3 3
Diabetes mellitus 7 1 0 3
Swelling on thyroid 1 0 0 0
ENT
Total 3 4 0 0 1 2 2 2
Cancerous growth in ear 1 0 0 0
Ear infection 2 0 0 0
Nose bleeds 0 0 0 1
Tinnitus 0 0 1 0
Vertigo 1 0 1 1
Eye
Total 1 1 5 5 2 3 5 6
Blurred vision 0 0 0 1
Burst blood vessels in eye 0 1 0 1
Cataract/cataract surgery 0 2 1 2
Diabetic macular oedema 0 0 0 1
Diabetic maculopathy 0 1 0 0
Eyesight deterioration 0 0 1 0
Glaucoma 0 1 0 0
Macular degeneration 0 0 1 1
Reconstruction of eyelids 1 0 0 0
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TABLE 50 Summarised non-serious AEs (continued )
12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Gastrointestinal
Total 2 2 9 9 5 5 8 8
Bowel cancer 0 0 2 0
Bowel problems 0 0 0 1
Constipation 0 1 0 0
Diverticulitis 0 1 1 1
Gall stones 0 0 0 1
Hernia/hernia repair 2 4 2 2
Irritable bowel syndrome 0 0 0 1
Polyps/polyp removal 0 2 0 2
Rectal bleeding 0 1 0 0
Gynaecological
Total 1 1 1 1 1 1 2 2
Benign ovarian cyst 0 0 0 1
Cyst 0 0 1 0
Ovarian cyst 1 0 0 0
Possible endometrial cancer 0 0 0 1
Womb prolapse 0 1 0 0
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12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Haematological
Total 1 1 2 2 3 3 1 1
Anaemia 0 0 2 0
Blood clot 0 1 0 0
Blood clots in leg 0 1 0 0
Blood disorder 0 0 1 0
Low platelets 1 0 0 0
Monoclonal gammopathy of
unknown significance
0 0 0 1
Musculoskeletal
Total 8 8 4 4 9 9 4 4
Arthritis 3 2 3 1
Back injury 1 0 0 0
Baker’s cyst 1 0 1 0
Fibromyalgia flare 1 0 0 0
Fractured wrist 0 0 1 0
Frozen shoulder 1 1 0 0
Golfer’s elbow 0 0 0 1
Gout 0 1 1 0
Hip joint problems 0 0 0 1
Paget’s disease 1 0 0 0
Prolapsed disc 0 0 1 0
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TABLE 50 Summarised non-serious AEs (continued )
12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Sore muscles and joint 0 0 1 0
Spinal and knee injuries 0 0 0 1
Tennis elbow 0 0 1 0
Neurological
Total 19 21 12 12 16 18 8 8
Carpal tunnel operation 0 0 1 0
Central post-stroke pain 0 0 1 0
Memory loss/dementia 0 2 3 3
Nerve release surgery 0 0 1 0
Neurological symptoms?
Cause
1 0 0 0
Numbness over mouth and
face
0 0 0 1
Parkinson’s disease 2 0 1 0
Possible seizure/epilepsy 1 1 0 0
Possible TIA 1 0 0 0
Sciatica 0 1 3 0
Seizure(s) 7 4 5 1
Senile amyloidosis 0 0 1 0
Shingles 2 0 0 2
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12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Stroke 1 1 0 0
Surgery of nerve damage
to arm
0 1 0 0
TIA 6 2 1 0
Trigeminal neuralgia 0 0 0 1
Psychiatric
Total 5 5 1 1 1 1 3 3
Anxiety 2 0 0 2
Depression 2 1 0 1
Panic attacks 1 0 0 0
Suicidal thoughts 0 0 1 0
Respiratory
Total 3 3 5 5 3 3 3 3
Asthma 0 0 1 0
Breathing issues under
investigation
0 1 0 0
Breathlessness 2 0 0 0
COPD 1 0 0 0
Pneumonia/chest infection 0 4 1 3
Sleep apnoea 0 0 1 0
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TABLE 50 Summarised non-serious AEs (continued )
12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Urinary tract
Total 10 10 11 12 9 10 6 6
Angiomyolipoma of kidney 0 0 1 0
Bladder problem 0 2 0 0
Bladder problems under
investigation
0 1 0 0
Bladder prolapse 0 1 0 0
Erectile dysfunction 0 0 0 1
Haematuria under
investigation
1 0 0 0
Incontinence 1 0 1 0
Kidney cancer and surgery 0 0 1 0
Kidney problems 1 0 0 0
Kidney stone(s) 1 2 0 1
Metastatic kidney cancer 0 0 1 0
Prostate cancer 0 1 1 0
Prostate problem 1 2 1 2
Renal cancer 2 0 0 0
Urinary retention 1 0 0 0
UTI(s) 2 3 4 2
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12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Miscellaneous
Total 3 3 11 14 10 10 11 11
Back and joint pain: side
effects of statins
1 0 0 0
Blackout/collapse 1 3 2 2
Breast cancer surgery 0 0 1 0
Chemotherapy side effects 0 1 0 0
Cyst in abdomen 0 0 1 0
Cysts on liver and kidneys 0 0 0 1
Dehydration 0 0 0 1
Dizziness 0 1 0 0
Drug intolerances 0 1 0 0
Fall 0 0 0 1
Flu 0 1 0 0
Fluid retention and kidney
weakness
0 0 1 0
Growth removed 0 0 1 0
Head pains because of drug
side effect
0 1 0 0
Hypercholesterolaemia 0 0 0 1
Infection source not
documented
0 0 1 1
Joint/muscle/back pain 1 1 0 0
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TABLE 50 Summarised non-serious AEs (continued )
12 months 24 months
Intervention Control Intervention Control
Number of
participants who
experienced event
Number
of events
(N= 79)
Number of
participants who
experienced event
Number
of events
(N= 75)
Number of
participants who
experienced event
Number
of events
(N= 71)
Number of
participants who
experienced event
Number
of events
(N= 66)
Left side of mouth dribbles 0 1 0 0
Leg oedema 0 0 0 2
Pain from neck problems 0 0 0 1
Removal of metal plate
in foot
0 0 0 1
Swollen abdomen 0 1 0 0
Swollen leg(s) 0 2 0 0
Unsteady and falls 0 1 0 0
Unwell cause unclear 0 0 1 0
Vacant episodes 0 0 1 0
Virus 0 0 1 0
BCC, basal cell carcinoma; COPD, cardiac obstructive pulmonary disease; TIA, transient ischaemic attack; UTI, urinary tract infection.
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TABLE 51 Carer enrolment per study centre
Study centre Opening date Number of carers enrolled (N= 200), n
North Tyneside 5 November 2012 16
Wansbeck 5 November 2012 11
Leeds 3 December 2012 6
Newcastle 2 January 2013 11
Pennine 12 February 2013 1
South Tyneside 1 August 2013 11
Cornwall 28 August 2013 24
Southampton 7 October 2013 5
Plymouth 24 October 2013 30
Portsmouth 7 November 2013 8
Norfolk 29 November 2013 26
Staffordshire 5 December 2013 9
Bournemouth 25 February 2014 8
Hull 10 March 2014 1
York 21 May 2014 5
Sherwood Forest 4 July 2014 10
Somerset 25 July 2014 7
Wigan 7 August 2014 2
Cardiff 23 December 2014 9
TABLE 52 Summary of reasons provided for not inviting a carer to participate in the study
Reason why a carer was not invited n (%)
No carer identified 80 (58)
Carer or patient declined carer involvement 17 (12)
Carer unwell 5 (4)
Patient or researcher felt inappropriate to burden carer 18 (13)
No reason provided/reason unclear 19 (14)
TABLE 53 Detailed breakdown of carer experience of services at 12 and 24 months
About the services, to what extent do you agree that:
12 months, n (%) 24 months, n (%)
Intervention Control Intervention Control
Staff were welcoming and friendly
Strongly disagree
Disagree 1 (1.3) 1 (1.6)
Agree 26 (28.6) 33 (45.8) 23 (29.1) 16 (25.0)
Strongly agree 57 (62.6) 36 (50.0) 29 (36.7) 18 (28.1)
Does not apply 8 (8.8) 3 (4.2) 26 (32.9) 29 (45.3)
Missing 1 2 4 6
continued
DOI: 10.3310/hta24240 HEALTH TECHNOLOGY ASSESSMENT 2020 VOL. 24 NO. 24
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Shaw et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
159
TABLE 53 Detailed breakdown of carer experience of services at 12 and 24 months (continued )
About the services, to what extent do you agree that:
12 months, n (%) 24 months, n (%)
Intervention Control Intervention Control
Staff treated your relative/friend with dignity and respect
Strongly disagree
Disagree 1 (1.1) 1 (1.4) 1 (1.3) 0 (0)
Agree 24 (26.7) 33 (45.8) 22 (28.2) 18 (28.1)
Strongly agree 59 (65.6) 35 (48.6) 30 (38.5) 17 (26.6)
Does not apply 6 (6.7) 3 (4.2) 25 (32.1) 29 (45.3)
Missing 2 2 5 6
Staff assessed your relative/friend’s needs
Strongly disagree 1 (1.3) 2 (3.1)
Disagree 3 (3.3) 1 (1.4) 2 (2.6) 1 (1.6)
Agree 29 (32.2) 40 (55.6) 21 (27.3) 17 (26.6)
Strongly agree 52 (57.8) 28 (38.9) 27 (35.1) 15 (23.4)
Does not apply 6 (6.7) 3 (4.2) 26 (33.8) 29 (45.3)
Missing 2 2 6 5
Staff met your relative/friend’s needs
Strongly disagree 1 (1.3) 1 (1.6)
Disagree 6 (6.7) 2 (2.8) 4 (5.1) 6 (9.4)
Agree 29 (32.6) 40 (56.3) 23 (29.5) 13 (20.3)
Strongly agree 48 (53.9) 26 (36.6) 24 (30.8) 15 (23.4)
Does not apply 6 (6.7) 3 (4.2) 26 (33.3) 29 (45.3)
Missing 3 3 5 6
You have been involved as much as you wanted to be in decisions about their care
Strongly disagree 1 (1.1) 1 (1.4)
Disagree 5 (5.6) 2 (2.8) 4 (5.1) 4 (6.3)
Agree 31 (34.4) 35 (49.3) 21 (26.9) 14 (21.9)
Strongly agree 45 (50.0) 29 (40.9) 26 (33.3) 18 (28.1)
Does not apply 8 (8.9) 4 (5.6) 27 (34.6) 28 (43.8)
Missing 2 3 5 6
You were able to discuss your preferences, beliefs and concerns as part of their care
Strongly disagree 2 (2.3) 3 (4.2)
Disagree 7 (7.9) 4 (5.6) 2 (2.6) 3 (4.8)
Agree 32 (36.0) 36 (50.7) 23 (29.5) 16 (25.4)
Strongly agree 39 (43.8) 22 (31.0) 23 (29.5) 15 (23.8)
Does not apply 9 (10.1) 6 (8.5) 30 (38.5) 29 (46.0)
Missing 3 3 5 7
You were told who to contact if you had any worries or concerns
Strongly disagree 3 (3.3) 1 (1.4) 0 (0) 1 (1.6)
Disagree 7 (7.8) 4 (5.6) 3 (3.8) 6 (9.4)
Agree 36 (40.0) 41 (56.9) 30 (39.0) 15 (23.4)
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TABLE 53 Detailed breakdown of carer experience of services at 12 and 24 months (continued )
About the services, to what extent do you agree that:
12 months, n (%) 24 months, n (%)
Intervention Control Intervention Control
Strongly agree 39 (43.3) 24 (33.3) 22 (27.9) 14 (21.9)
Does not apply 5 (5.6) 2 (2.8) 24 (30.4) 28 (43.8)
Missing 2 2 4 6
You were confident that the staff who saw your relative/friend had the right skills and knowledge to help them
Strongly disagree 1 (1.1) 0 (0)
Disagree 2 (2.2) 2 (2.8) 3 (3.8) 0 (0)
Agree 35 (38.9) 38 (53.5) 28 (35.4) 20 (31.8)
Strongly agree 46 (51.1) 29 (40.9) 24 (30.4) 14 (22.2)
Does not apply 6 (6.7) 2 (2.8) 24 (30.4) 29 (46.0)
Missing 2 3 4 7
Your relative/friend was treated fairly regardless of their age, race, sex, belief, sexual orientation or disability
Strongly disagree
Disagree 2 (2.2) 0 (0) 2 (2.5) 2 (3.1)
Agree 25 (27.8) 32 (44.4) 24 (30.4) 19 (29.7)
Strongly agree 59 (65.6) 39 (54.2) 32 (40.5) 16 (25.0)
Does not apply 4 (4.4) 1 (1.4) 21 (26.6) 27 (42.2)
Missing 2 2 4 6
You were given the information you wanted
Strongly disagree 1 (1.1) 2 (2.9)
Disagree 5 (5.7) 3 (4.3) 4 (5.1) 3 (4.7)
Agree 33 (37.1) 38 (54.3) 24 (30.8) 18 (28.1)
Strongly agree 44 (49.4) 26 (37.1) 26 (33.3) 13 (20.3)
Does not apply 6 (6.7) 1 (1.4) 24 (30.8) 30 (46.9)
Missing 3 4 5 6
Your relative/friend was able to see the same health-care professional/team whenever possible
Strongly disagree 0 (0) 1 (1.6)
Disagree 9 (10.1) 9 (12.7) 3 (3.8) 4 (6.3)
Agree 35 (39.3) 37 (52.1) 25 (32.1) 20 (31.3)
Strongly agree 38 (42.7) 21 (29.6) 25 (32.1) 9 (14.1)
Does not apply 7 (7.9) 4 (5.6) 25 (32.1) 30 (46.9)
Missing 3 3 5 6
If you had important questions to ask, you got answers that you could understand
Strongly disagree 2 (2.2) 0 (0)
Disagree 2 (2.2) 6 (8.5) 2 (2.6) 1 (1.6)
Agree 37 (41.1) 34 (47. 9) 22 (28.2) 21 (33.3)
Strongly agree 40 (44.4) 27 (38.0) 25 (32.1) 11 (17.5)
Does not apply 9 (10.0) 4 (5.6) 29 (37.2) 30 (47.6)
Missing 2 3 5 7
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TABLE 53 Detailed breakdown of carer experience of services at 12 and 24 months (continued )
About the services, to what extent do you agree that:
12 months, n (%) 24 months, n (%)
Intervention Control Intervention Control
If your relative/friend needed more than one service, staff made sure they were well co-ordinated
Strongly disagree 2 (2.2) 1 (1.4)
Disagree 7 (7.9) 8 (11.4) 3 (3.9) 3 (4.8)
Agree 36 (40.5) 29 (41.4) 21 (27.3) 13 (20.6)
Strongly agree 34 (38.2) 22 (31.4) 20 (26.0) 12 (19.1)
Does not apply 10 (11.2) 10 (14.3) 33 (42.9) 35 (55.6)
Missing 3 4 6 7
If your relative/friend needed more than one service, staff made sure that your care information was clearly and
accurately shared
Strongly disagree 1 (1.1) 1 (1.4)
Disagree 5 (5.6) 6 (8.5) 4 (5.3) 3 (4.7)
Agree 40 (44.9) 33 (46.5) 21 (27.6) 14 (21.9)
Strongly agree 32 (36.0) 21 (29.6) 18 (23.7) 11 (17.2)
Does not apply 11 (12.4) 10 (14.1) 33 (43.4) 36 (56.3)
Missing 3 3 7 6
You were told who to contact if your relative/friend had any ongoing health-care needs
Strongly disagree 2 (2.2) 1 (1.4)
Disagree 8 (9.0) 5 (6.9) 6 (7.7) 4 (6.3)
Agree 43 (48.3) 38 (52.8) 24 (30.8) 19 (29.7)
Strongly agree 31 (34.8) 24 (33.3) 21 (26.9) 12 (18.8)
Does not apply 5 (5.6) 4 (5.6) 27 (34.6) 29 (45.3)
Missing 3 2 5 6
Overall, how satisfied are you with the services you received?
Extremely satisfied 35 (38.5) 18 (25.4) 22 (30.6) 7 (13.7)
Very satisfied 34 (37.4) 27 (38.0) 29 (40.3) 18 (35.3)
Quite satisfied 15 (16.5) 20 (28.2) 17 (23.6) 15 (29.4)
Not very satisfied 7 (7.7) 6 (8.5) 2 (2.8) 10 (19.6)
Extremely unsatisfied 2 (2.8) 1 (2.0)
Missing 1 3 11 19
In the last 12 months, has your relative/friend had enough help with speaking difficulties from the NHS?
Yes, definitely 14 (15.2) 11 (15.5) 7 (9.2) 5 (7.8)
Yes, to some extent 9 (9.8) 10 (14.1) 9 (11.8) 7 (10.9)
No, I did not get enough help from the NHS 8 (8.7) 5 (7.0) 6 (7.9) 5 (7.8)
I did not have any speaking difficulties 61 (66.3) 45 (63.4) 54 (71.1) 47 (73.4)
Missing 0 3 7 7
In the last 12 months, has your relative/friend had enough treatment to help improve your mobility from the NHS?
Yes, definitely 44 (48.9) 21 (29.2) 18 (24.7) 4 (6.6)
Yes, to some extent 21 (23.3) 22 (30.6) 21 (28.8) 14 (23.0)
No, I did not get enough help from the NHS 13 (14.4) 19 (26.4) 13 (17.8) 27 (44.3)
I did not have any mobility difficulties 12 (13.3) 10 (13.9) 21 (28.8) 16 (26.2)
Missing 2 2 10 9
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TABLE 53 Detailed breakdown of carer experience of services at 12 and 24 months (continued )
About the services, to what extent do you agree that:
12 months, n (%) 24 months, n (%)
Intervention Control Intervention Control
In the last 12 months, has your relative/friend had enough help with emotional problems from the NHS?
Yes, definitely 15 (17.1) 11 (15.9) 7 (9.5) 7 (11.5)
Yes, to some extent 31 (35.2) 19 (27.5) 17 (23.0) 15 (24.6)
No, I did not get enough help from the NHS 12 (13.6) 14 (20.3) 12 (16.2) 14 (23.0)
I did not have any emotional problems 30 (34.1) 25 (36.2) 38 (51.4) 25 (41.0)
Missing 4 5 9 9
TABLE 54 Number of EXTRAS reviews received compared with the number expected, allowing for deaths and
withdrawals
Number of reviews
Patients expected to
have a review, n (%)
Patients who received
a review, n (%)
0 3 (1) 12 (4)
1 6 (2) 15 (5)
2 7 (2) 21 (7)
3 7 (2) 24 (8)
4 13 (5) 39 (14)
5 249 (87) 174 (61)
TABLE 55 Reasons why EXTRAS reviews were not conducted, by review stage
Reason
Stage (N= 285 randomised) (n)
1 month 3 months 6 months 12 months 18 months
Total reviews not conducted, n (%) 27 (9) 40 (14) 54 (19) 74 (26) 75 (26)
Died (new case) 0 3 3 4 8
Died (prior case) 0 0 3 6 10
Withdrawn (new case) 3 3 4 3 5
Withdrawn (prior case) 0 3 6 10 13
Admitted to hospital/unwell 2 2 7 10 4
Refused review when contacted 3 6 3 4 4
Uncontactable 10 15 22 24 20
Staff decided the review was inappropriate 0 2 1 2 2
Staff unavailable to conduct the review 4 3 3 9 7
Miscommunication and staff unaware of
patient involvement in trial
2 0 0 0 0
No reason provided 3 3 2 2 2
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TABLE 56 Profession of staff who conducted EXTRAS reviews
Profession
Time point, n (%)
Total, n (%)
1 month
(N= 258)
3 months
(N= 245)
6 months
(N= 231)
12 months
(N= 211)
18 months
(N= 210)
All physiotherapist bands 138 (53) 140 (57) 132 (57) 120 (57) 119 (57) 649 (56)
Physiotherapist band 5 1 (0) 0 (0) 1 (0) 3 (1) 1 (0) 6 (1)
Physiotherapist band 6 59 (23) 65 (27) 46 (20) 27 (13) 26 (12) 223 (19)
Physiotherapist band 7 78 (30) 75 (31) 85 (37) 90 (43) 92 (44) 420 (36)
All occupational therapist bands 76 (29) 71 (29) 64 (28) 51 (24) 58 (28) 320 (28)
Occupational therapist band 5 6 (2) 6 (2) 5 (2) 2 (1) 2 (1) 21 (2)
Occupational therapist band 6 40 (16) 35 (14) 33 (14) 26 (12) 25 (12) 159 (14)
Occupational therapist band 7 28 (11) 29 (12) 25 (11) 20 (9) 25 (12) 127 (11)
Occupational therapist band 8 2 (1) 1 (0) 1 (0) 3 (1) 6 (3) 13 (1)
All SLT bands 13 (5) 11 (4) 12 (5) 13 (6) 9 (4) 58 (5)
SLT band 6 7 (3) 6 (2) 8 (3) 6 (3) 7 (3) 34 (3)
SLT band 7 2 (1) 3 (1) 2 (1) 4 (2) 1 (0) 12 (1)
SLT band 8A 0 (0) 0 (0) 0 (0) 1 (0) 0 (0) 1 (0)
SLT band 8C 4 (2) 2 (1) 2 (1) 2 (1) 1 (0) 11 (1)
All nurse bands 24 (9) 20 (8) 18 (8) 20 (9) 16 (8) 98 (8)
Nurse band 5 1 (0) 2 (1) 2 (1) 1 (0) 0 (0) 6 (1)
Nurse band 6 13 (5) 12 (5) 9 (4) 12 (6) 11 (5) 57 (5)
Nurse band 7 10 (4) 6 (2) 6 (3) 7 (3) 5 (2) 34 (3)
Nurse band 8 0 (0) 0 (0) 1 (0) 0 (0) 0 (0) 1 (0)
All dietitian bands 2 (1) 1 (0) 1 (0) 2 (1) 2 (1) 8 (1)
Dietitian band 5 1 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (0)
Dietitian band 6 1 (0) 1 (0) 1 (0) 2 (1) 2 (1) 7 (1)
All stroke co-ordinator bands 2 (1) 1 (0) 3 (1) 2 (1) 2 (1) 10 (1)
Not recorded 12 (1)
Total (n) 1155
TABLE 57 Patients with one or more priority rehabilitation issue(s) in different domains/activities
Time point, n (%)
1 month
(N= 187)
3 months
(N= 164)
6 months
(N= 145)
12 months
(N= 108)
18 months
(N= 74)
Mobility 103 (55) 76 (46) 61 (42) 43 (40) 26 (35)
Transfers 6 (3) 6 (4) 5 (3) 3 (3) 1 (1)
Walking indoors 28 (15) 19 (12) 23 (16) 13 (12) 5 (7)
Stairs 11 (6) 6 (4) 5 (3) 2 (2) 2 (3)
Walking outdoors 66 (35) 54 (33) 43 (30) 29 (27) 16 (22)
Falls 11 (6) 9 (5) 7 (5) 7 (6) 8 (11)
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TABLE 57 Patients with one or more priority rehabilitation issue(s) in different domains/activities (continued )
Time point, n (%)
1 month
(N= 187)
3 months
(N= 164)
6 months
(N= 145)
12 months
(N= 108)
18 months
(N= 74)
Personal care 35 (0) 27 (0) 14 (0) 9 (0) 3 (4)
Washing 17 (9) 10 (6) 7 (5) 2 (2) 2 (3)
Dressing 16 (9) 14 (9) 7 (5) 2 (2) 0 (0)
Toileting 6 (3) 6 (4) 5 (3) 4 (4) 2 (3)
Personal grooming 1 (1) 1 (1) 1 (1) 1 (1) 0 (0)
Mealtimes 56 (30) 41 (25) 25 (17) 12 (11) 11 (15)
Eating 20 (11) 11 (7) 8 (6) 2 (2) 5 (7)
Swallowing 5 (3) 3 (2) 2 (1) 2 (2) 1 (1)
Appetite/healthy eating 8 (4) 9 (5) 7 (5) 4 (4) 5 (7)
Meal/drink preparation 29 (16) 19 (12) 9 (6) 5 (5) 1 (1)
Domestic activities 45 (24) 42 (26) 23 (16) 17 (16) 2 (3)
Inside the home 19 (10) 17 (10) 6 (4) 5 (5) 0 (0)
Outside the home 15 (8) 20 (12) 15 (10) 10 (9) 1 (1)
Shopping 17 (9) 12 (7) 6 (4) 2 (2) 1 (1)
Work and volunteering 36 (19) 22 (13) 17 (12) 9 (8) 2 (3)
Return to work 27 (14) 17 (10) 13 (9) 7 (6) 2 (3)
Volunteering 10 (5) 8 (5) 4 (3) 3 (3) 0 (0)
Hobbies and interests 70 (37) 59 (36) 54 (37) 41 (38) 18 (24)
Quiet leisure 10 (5) 5 (3) 6 (4) 5 (5) 3 (4)
Active leisure 46 (25) 38 (23) 36 (25) 28 (26) 11 (15)
Social participation 22 (12) 21 (13) 17 (12) 11 (10) 5 (7)
Driving and transport 56 (30) 40 (24) 28 (19) 17 (16) 14 (19)
Driving 46 (25) 33 (20) 24 (17) 13 (12) 13 (18)
Travel on public transport 8 (4) 3 (2) 3 (2) 3 (3) 3 (4)
Getting in/out of car or on/off public
transport
6 (3) 6 (4) 3 (2) 3 (3) 0 (0)
Communication 43 (23) 25 (15) 21 (14) 13 (12) 6 (8)
Reading 14 (7) 6 (4) 3 (2) 4 (4) 2 (3)
Writing 25 (13) 19 (12) 16 (11) 8 (7) 3 (4)
Comprehension and understanding 4 (2) 2 (1) 1 (1) 3 (3) 0 (0)
Accounting and money management 4 (2) 2 (1) 1 (1) 0 (0) 0 (0)
Speech 2 (1) 0 (0) 1 (1) 1 (1) 0 (0)
Hearing 0 (0) 0 (0) 2 (1) 8 (7) 1 (1)
Memory and concentration 19 (10) 14 (9) 12 (8) 9 (8) 7 (9)
Memory 10 (5) 10 (6) 8 (6) 7 (6) 5 (7)
Concentration and attention 12 (6) 4 (2) 7 (5) 4 (4) 3 (4)
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TABLE 57 Patients with one or more priority rehabilitation issue(s) in different domains/activities (continued )
Time point, n (%)
1 month
(N= 187)
3 months
(N= 164)
6 months
(N= 145)
12 months
(N= 108)
18 months
(N= 74)
Mood, anxiety and depression 29 (16) 22 (13) 22 (15) 14 (13) 11 (15)
Low mood 19 (10) 19 (12) 18 (12) 13 (12) 9 (12)
Anxiety 11 (6) 5 (3) 3 (2) 3 (3) 5 (7)
Changes in personality 5 (3) 0 (0) 3 (2) 1 (1) 2 (3)
Medical issues 37 (20) 33 (20) 27 (19) 26 (24) 18 (24)
Recent hospital admission 0 (0) 0 (0) 3 (2) 2 (2) 1 (1)
Lifestyle management 10 (5) 13 (8) 13 (9) 15 (14) 6 (8)
Medication management 8 (4) 6 (4) 2 (1) 3 (3) 1 (1)
Contact with health-care professional) 9 (5) 6 (4) 6 (4) 9 (8) 5 (7)
Other relevant past medical history 13 (7) 11 (7) 8 (6) 4 (4) 7 (9)
Pain 28 (15) 23 (14) 15 (10) 15 (14) 9 (12)
Pre-existing pain 7 (4) 4 (2) 5 (3) 3 (3) 4 (5)
Musculoskeletal pain 20 (11) 13 (8) 9 (6) 11 (10) 4 (5)
Neuropathic pain 1 (1) 6 (4) 1 (1) 3 (3) 2 (3)
Other issues 10 (5) 12 (7) 13 (9) 5 (5) 4 (5)
Fatigue 1 (1) 1 (1) 0 (0) 0 (0) 0 (0)
Finance 5 (3) 2 (1) 1 (1) 0 (0) 0 (0)
Independent living 1 (1) 4 (2) 1 (1) 0 (0) 1 (1)
Relationships 0 (0) 0 (0) 0 (0) 1 (1) 0 (0)
Upper limb 3 (2) 3 (2) 5 (3) 2 (2) 2 (3)
Vision 0 (0) 3 (2) 6 (4) 2 (2) 0 (0)
TABLE 58 Conduct of action-planning, by review stage
Review stage
Goals/action
points set (n)
Goals/action points with
action plans, n (%)
1 month 742 723 (97)
3 months 547 532 (97)
6 months 427 416 (97)
12 months 313 306 (98)
18 months 146 144 (99)
Total 2175 2121 (98)
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TABLE 59 Services to which referrals were made during the trial
Service
Number of referrals madea
1 month
(n= 233)
3 months
(n= 200)
6 months
(n= 180)
12 months
(n= 142)
18 months
(n= 79)
Across
review
stagesb
Age UK, n (%) 0 (0) 1 (1) 0 (0) 1 (1) 0 (0) 1
Community rehabilitation team, n (%) 3 (1) 0 (0) 2 (1) 0 (0) 1 (1) 6
Dietitian, n (%) 1 (< 0.5) 0 (0) 0 (0) 0 (0) 0 (0) 1
District nursing, n (%) 0 (0) 0 (0) 1 (1) 0 (0) 0 (0) 1
Driving assessment centre, n (%) 1 (< 0.5) 1 (1) 1 (1) 1 (1) 1 (1) 4
Exercise group or referral scheme, n (%) 7 (3) 3 (2) 4 (2) 3 (2) 0 (0) 14
Falls team/group, n (%) 1 (< 0.5) 0 (0) 0 (0) 0 (0) 1 (1) 2
Gait analysis clinic, n (%) 0 (0) 1 (1) 0 (0) 0 (0) 0 (0) 1
General practitioner, n (%) 1 (< 0.5) 0 (0) 1 (1) 0 (0) 0 (0) 2
Health trainers, n (%) 0 (0) 0 (0) 1 (1) 0 (0) 0 (0) 1
Independent living team, n (%) 0 (0) 1 (1) 1 (1) 1 (1) 0 (0) 2
Library service, n (%) 1 (< 0.5) 0 (0) 0 (0) 0 (0) 0 (0) 1
Long-term conditions team, n (%) 0 (0) 0 (0) 0 (0) 1 (1) 0 (0) 1
Ophthalmology, n (%) 1 (< 0.5) 0 (0) 0 (0) 0 (0) 0 (0) 1
Orthotics, n (%) 1 (< 0.5) 1 (1) 0 (0) 0 (0) 2 (3) 4
Occupational therapist, n (%) 8 (3) 4 (2) 6 (3) 2 (1) 0 (0) 16
Psychologist, n (%) 2 (1) 0 (0) 2 (1) 3 (2) 0 (0) 6
Physiotherapist, n (%) 10 (4) 3 (2) 4 (2) 5 (4) 1 (1) 20
Sensory team/sight service, n (%) 2 (1) 1 (1) 0 (0) 0 (0) 0 (0) 3
Speech and language therapist, n (%) 6 (3) 1 (1) 1 (1) 1 (1) 0 (0) 9
Social services, n (%) 6 (3) 1 (1) 2 (1) 1 (1) 1 (1) 9
Stroke Association, n (%) 2 (1) 3 (2) 1 (1) 3 (2) 0 (0) 7
Stroke consultant, n (%) 0 (0) 1 (1) 0 (0) 1 (1) 0 (0) 2
Stroke nurse, n (%) 0 (0) 1 (1) 0 (0) 0 (0) 0 (0) 1
Vocational rehabilitation, n (%) 1 (< 0.5) 1 (1) 0 (0) 0 (0) 0 (0) 2
Total (n) 117
a n = patients with goals/action points recorded.
b Patients were occasionally referred to the same service more than once during the intervention. This column counts
this as a single referral. For example, a patient was referred to Age UK at the 3-month review and again at the
12-month review.
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TABLE 60 EXTRAS review conduct, by study centre
Study
centre
Reviews expected
to be conducted (n)a
Reviews conducted,
n (% of expected)
Reviews not
conducted
(excluding deaths/
withdrawals) (n)
Reasons reviews not conducted
(excluding deaths/withdrawals)
(number of reviews)
1 74 72 (97) 2 l Declined: 1
l Uncontactable: 1
2 45 42 (93) 3 l Uncontactable: 3
3 138 127 (92) 11 l Admitted to hospital/unwell: 3
l Declined: 1
l Uncontactable: 7
4 15 8 (53) 7 l Staff unavailable: 1
l Uncontactable: 6
5 181 149 (82) 32 l Admitted to hospital/unwell: 6
l Declined: 1
l Not known: 3
l Staff unavailable: 1
l Uncontactable: 21
6 62 54 (87) 8 l Admitted to hospital/unwell: 4
l Uncontactable: 4
7 136 135 (99) 1 l Admitted to hospital: 1
8 78 73 (94) 5 l Admitted to hospital: 1
l Staff considered review inappropriate: 1
l Uncontactable: 3
9 35 26 (74) 9 l Uncontactable: 9
10 150 122 (81) 28 l Admitted to hospital/unwell: 4
l Declined: 5
l Staff unavailable: 9
l Unavailable/uncontactable: 10
11 64 47 (73) 17 l Admitted to hospital/unwell: 3
l Declined: 5
l Staff unaware of recruitment: 1
l Staff considered review inappropriate: 1
l Staff unavailable: 5
l Uncontactable: 2
12 49 49 (100) 0 NA
13 44 42 (95) 2 l Admitted to hospital/unwell: 2
14 55 48 (87) 7 l Declined:1
l Uncontactable/unavailable: 6
15 61 58 (95) 3 l Uncontactable: 3
16 44 24 (55) 20 l Admitted to hospital/unwell: 1
l Not contacted because staff were not
aware of recruitment: 1
l Staff unavailable: 7
l Unavailable/uncontactable: 11
17 59 34 (58) 25 l Declined: 6
l Not known: 9
l Staff considered review inappropriate: 5
l Staff unavailable: 3
l Uncontactable: 2
18 25 25 (100) 0 NA
19 23 20 (87) 3 l Uncontactable: 3
NA, not applicable.
a Expected: accounting for deaths and withdrawals.
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TABLE 61 Continuity of staff for patients, by study centre
Study centre
Number of different reviewers who conducted reviews for an individual patient,
n (% of patients randomised)
1 member of staff 2 members of staff 3 members of staff 4 members of staff
1 11 (69) 5 (31) 0 0
2 7 (78) 2 (22) 0 0
3 1 (3) 18 (62) 10 (34) 0
4 0 2 (67) 1 (33) 0
5 9 (22) 21 (51) 10 (24) 1 (2)
6 6 (43) 7 (50) 1 (7) 0
7 25 (89) 3 (11) 0 0
8 10 (59) 5 (29) 2 (12) 0
9 2 (25) 2 (25) 4 (50) 0
10 12 (40) 15 (50) 3 (10) 0
11 3 (21) 7 (50) 3 (21) 1 (7)
12 3 (27) 7 (64) 1 (9) 0
13 4 (36) 5 (45) 2 (18) 0
14 6 (67) 3 (33) 0 0
15 1 (11) 8 (89) 0 0
16 7 (50) 7 (50) 0 0
17 5 (42) 7 (58) 0 0
18 3 (60) 1 (20) 1 (20) 0
19 2 (40) 3 (60) 0 0
TABLE 62 Number of staff involved in delivery of EXTRAS
Study centre
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
1 month
Number of staff 2 2 3 1 14 8 1 4 3 16 8 7 7 2 2 6 2 2 2
Number reviews per staff member
Minimum 8 4 8 3 1 1 28 3 1 1 1 1 1 2 1 1 4 2 1
Median 8 5 8 3 1 1 28 4 3 2 1 1 1 4 3 2 5 3 3
Maximum 8 5 13 3 7 4 28 5 4 3 2 2 3 6 4 3 5 3 4
3 months
Number of staff 2 2 3 1 10 7 1 4 4 14 9 6 6 2 1 5 2 2 2
Number reviews per staff member
Minimum 4 3 6 3 1 1 28 4 1 1 1 1 1 1 4 1 3 2 1
Median 7 4 11 3 3 1 28 4 2 2 1 2 2 5 4 3 4 3 2
Maximum 10 5 15 3 7 4 28 4 3 4 2 2 3 8 4 3 4 3 3
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TABLE 62 Number of staff involved in delivery of EXTRAS (continued )
Study centre
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
6 months
Number of staff 2 2 3 1 11 7 1 4 4 12 7 6 5 2 1 5 2 3 2
Number reviews per staff member
Minimum 5 4 6 1 1 1 27 2 1 1 1 1 1 1 4 1 3 1 1
Median 8 5 7 1 2 1 27 4 1 2 1 1 2 5 4 3 4 2 2
Maximum 10 5 13 1 10 4 27 4 2 6 2 2 2 8 4 3 4 2 3
12 months
Number of staff 2 2 3 1 10 7 1 3 1 9 6 6 5 1 1 4 2 2 2
Number reviews per staff member
Minimum 5 4 2 1 1 1 27 4 2 1 1 1 1 8 4 1 2 2 1
Median 7 4 3 1 3 1 27 5 2 2 1 2 2 8 4 3 3 3 2
Maximum 9 4 17 1 6 3 27 5 2 8 2 3 3 8 4 4 4 3 2
18 months
Number of staff 2 2 2 0 9 4 1 4 3 8 4 6 4 1 1 4 2 2 2
Number reviews per staff member
Minimum 4 4 6 0 1 1 25 2 1 1 1 1 1 8 7 1 2 1 1
Median 7 4 11 0 2 2 25 4 1 2 2 2 3 8 7 3 3 3 2
Maximum 9 4 16 0 10 3 25 4 2 11 3 3 3 8 7 4 3 4 3
TABLE 63 Normalisation process theory: generic constructs and components
NPT construct Components (work done by staff implementing the intervention)
Coherence or sense-making l Differentiation: they distinguish the intervention from current ways of working
l Communal specification: they collectively agree about the purpose of the intervention
l Individual specification: they individually understand what the intervention requires
of them
l Internalisation: they construct potential value of the intervention for their work
Cognitive participation or
relational work
l Initiation: key individuals drive the intervention forward
l Enrolment: they agree that the intervention should be part of their work
l Legitimation: they buy into the intervention
l Activation: they continue to support the intervention
Collective action or
operational work
l Relational integration: they maintain their trust in each other’s work and expertise
l Interactional workability: they perform the tasks required by the intervention
l Contextual integration: the intervention/research is adequately supported by its
host organisation
l Skill set workability: the work of the intervention is allocated appropriately
Reflexive monitoring or
appraisal work
l Systematisation: they access information about the effects of the intervention
l Communal appraisal: they collectively assess the intervention as worthwhile
l Individual appraisal: they individually assess the intervention as worthwhile
l Reconfiguration: they modify their work in response to their appraisal of
the intervention
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TABLE 64 Types of service available in each study location, by need domain (mobility and movement, communication, everyday activities and emotional and psychosocial issues)
Location
Mobility and movement Communication Everyday activities
Emotional and psychosocial issues
Any
Psychology/psychiatry IAPT/well-being/counselling
Any Generic Neurological Stroke Any Generic Neurological Stroke Any Generic Neurological Stroke Generic Neurological Stroke Generic Neurological Stroke
1 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
2 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
3 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
4 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
5 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
6 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
7 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
8A ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
8B ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
9A ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
9B ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
10 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
11 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
12 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
13 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
14 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
15 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
16 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
17 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
18 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Totals (n) 20 8 14 6 20 11 6 9 20 9 9 7 20 2 5 4 12 1 9
IAPT, Improving Access to Psychological Therapies.
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TABLE 65 Types of service available in each study location, by need domain (impaired cognition, nutrition, visual disturbance and incontinence management)
Location
Impaired cognition Nutrition Visual disturbance
Incontinence
management
Any Memory clinic
Other
Any Generic Neurological Stroke Any Generic Neurological Any (all generic)Generic Neurological Stroke
1 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
2 ✓ ✓ ✓ ✓ ✓ ✓ ✓
3 ✓ ✓ ✓ ✓ ✓ ✓ ✓
4 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
5 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
6 ✓ ✓ ✓ ✓ ✓ ✓ ✓
7 ✓ ✓ ✓ ✓ ✓ ✓ ✓
8A ✓ ✓ ✓ ✓ ✓ ✓ ✓
8B ✓ ✓ ✓ ✓ ✓ ✓ ✓
9A ✓ ✓ ✓ ✓ ✓ ✓ ✓
9B ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
10 ✓ ✓ ✓ ✓ ✓ ✓ ✓
11 ✓ ✓ ✓ ✓ ✓ ✓ ✓
12 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
13 ✓ ✓ ✓ ✓ ✓ ✓ ✓
14 ✓ ✓ ✓ ✓ ✓ ✓ ✓
15 ✓ ✓ ✓ ✓ ✓ ✓ ✓
16 ✓ ✓ ✓ ✓ ✓ ✓ ✓
17 ✓ ✓ ✓ ✓ ✓ ✓ ✓
18 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Totals (n) 20 5 3 8 8 20 16 2 3 20 30 19 20
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TABLE 66 Types of service available in each study location, by need domain (support with relationships and sex and pain management)
Location
Support with relationships and sex Pain management
Any
Psychology/psychiatry IAPT/well-being/counselling Medical
Any Generic Neurological StrokeGeneric Neurological Stroke Generic Neurological Stroke Neurological Stroke
1 ✓ ✓ ✓ ✓ ✓ ✓
2 ✓ ✓ ✓ ✓
3 ✓ ✓ ✓ ✓
4 ✓ ✓ No
5 ✓ ✓ ✓ ✓
6 ✓ ✓ ✓ ✓ ✓
7 ✓ ✓ ✓ ✓ ✓
8A ✓ ✓ ✓ ✓
8B Not known No
9A ✓ ✓ ✓ No
9B ✓ ✓ ✓ No
10 ✓ ✓ ✓ ✓ ✓
11 ✓ ✓ ✓ ✓
12 ✓ ✓ ✓ ✓
13 ✓ ✓ ✓ ✓
14 ✓ ✓ ✓ ✓ ✓ ✓
15 ✓ ✓ ✓ ✓
16 ✓ ✓ ✓ ✓ ✓ ✓
17 No ✓ ✓
18 ✓ ✓ ✓ ✓
Totals (n) 18 1 1 4 5 0 11 3 3 16 1 9 7
IAPT, Improving Access to Psychological Therapies.
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TABLE 67 Types of service available in each study location, by need domain (return to work/volunteering, return to driving, healthier lifestyles and support services)
Location
Return to work/volunteering Return to driving Healthier lifestyles Support services
Any
Vocational rehabilitation General occupational therapy support
Generic Stroke Any Generic Stroke Any Generic StrokeGeneric Neurological Stroke Stroke
1 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
2 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
3 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
4 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
5 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
6 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
7 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
8A ✓ ✓ ✓ ✓ ✓ ✓ ✓
8B ✓ ✓ ✓ Not known ✓ ✓ ✓
9A ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
9B ✓ ✓ ✓ ✓ ✓ ✓ ✓
10 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
11 ✓ ✓ ✓ No ✓ ✓ ✓ ✓ ✓
12 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
13 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
14 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
15 ✓ ✓ ✓ No ✓ ✓
16 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
17 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
18 ✓ ✓ ✓ ✓ ✓ ✓ ✓
Totals (n) 20 3 7 8 7 19 18 16 8 20 13 19
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ESD
< 6 weeks
Community PT
service 
Day hospital service for
    over 65s with MDT needs:
Neurological PT
outpatient
Voluntary sector:
• Spasticity clinic
• Memory team
• Pain service
HSCP
Other community services:
Single disciplines:
Ophthalmology GP
• Communication support
   group
• Stroke Association –
   co-ordinators, vocational
   rehabilitation, exercise
   group, young/other
   peer support
• Relate
• Driving assessment
   centre
• Supported exercise group
• Smoking cessation
• Community dietitian
• Orthoptics
• Low vision team
• Continence service
• Orthotics
• Stroke outpatient
   speech and language
   therapy
• PT, OT, SLT, clinical
   psychology, nurses,
   dietitian
• Open ended
• Falls management
   programmes
• Continence clinic    
FIGURE 22 Referral options available at the end of ESD at study location 2. HSCP, health and social care professional; OT, occupational therapist; PT, physiotherapist.
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ESD
< 6 weeks
Community
rehabilitation
therapies
PT, OT, SLT
Voluntary sector:
Other community
services:
Single disciplines:
GP
HSCP
Neurological specialist triage
Stroke care
co-ordinator
(6-month reviews, etc.)
Community neurological 
rehabilitation
therapies including
stroke specialist
PT, OT, SLT
Psychology
Community dietitian
• Stroke
   communication
   support group
• Carers’ support
• Driving assessment
   centre
• Age UK
• Ophthalmology
• Orthoptics
• Continence service
• Speech and
   language therapy
• Sensory impairment
   team
• Health promotion
   service including exercise
   referral, weight
   management
• Pain clinic
• Counselling service
FIGURE 23 Referral options available at the end of ESD at study location 3. HSCP, health and social care professional; OT, occupational therapist; PT, physiotherapist.
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Integrated ESD and CST
(PT, OT, SLT, rehabilitation
assistant, psychologist,
nurse)
Open ended 
Voluntary sector:
HSCP
Other community services: Single disciplines:
• Stroke Association exercise
   group, peer support
• Driving assessment centre
• Carers’ Centre
• Relate
• Exercise referral
• Smoking cessation
• Community dietitian
• Ophthalmology
• Orthoptics
• Continence advisor
FIGURE 24 Referral options available at the end of ESD at study location 4. CST, community stroke team;
HSCP, health and social care professional; OT, occupational therapist; PT, physiotherapist.
Integrated ESD and CST (and reablement)
PT, OT, SLT, rehabilitation assistants, 
psychology, nurse, technical instructor, 
social worker, information co-ordinator
2–6 weeks intensive, then step down for
< 12 weeks initially     
Single disciplines:
Voluntary sector:
HSCP
GP Community dietetics
Exercise referral
Consultant
Ophthalmology
Pain management
Consultant/therapist review Clinical psychology
Other community
services:
• Driving assessment
• Fitness after stroke
   programme
• Communication
   support
• Peer/family support
• Spasticity clinic
• Orthotics
• Bowel and bladder service
FIGURE 25 Referral options available at the end of ESD at study location 6. CST, community stroke team;
HSCP, health and social care professional; OT, occupational therapist; PT, physiotherapist.
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ESD
< 6 weeks
Community
neurorehabilitation
therapies (area 1)
PT, OT 
Complex neurological 
rehabilitation
outpatient service
including
vocational
rehabilitation
and pain clinic
PT, OT, SLT,
neuropsychologist
nurse, rehabilitation
assistant, MDT
needs
Voluntary sector: Other community
services:
Single disciplines:
GP
HSCP
Stroke specialist
nurse 6-month
review 
Community
dietitian 
Community
rehabilitation
therapies (area 2)
PT, OT
For psychology
• Stroke Association
   and Different
   Strokes support
   groups
• Carers’ support
• Age UK
• Driving assessment
   centre
• Orthotics
• Ophthalmology
• Continence service
• Speech and
   language therapy
• Exercise referral/
   health trainer
• Neurological pain 
   clinic
• Spasticity clinic
• Emotional
   well-being service
• Smoking cessation
FIGURE 26 Referral options available at the end of ESD at study location 7. HSCP, health and social care professional; OT, occupational therapist; PT, physiotherapist.
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ESD
Open ended
Community
neurorehabilitation
therapies
PT, OT, SLT 
Complex
neurorehabilitation
centre
PT, OT, counsellor,
psychiatry,
neuropsychology,
relationships,
sexual dysfunction
clinic, driving
assessment, spasticity
clinic, orthotics.
MDT needs 
Voluntary sector: Other community
services:
Single disciplines:
GP
HSCP
Community
dietitian
Memory clinic
Talking therapies 
Consultant
Ophthalmology
Stroke spasticity
clinic
HSCP
• Vocational
   rehabilitation
• Peer and carer
   support group
• Continence service
• Speech and
   language therapy
• Exercise referral/
   health trainer
• Sensory support
   team
• Peer support
   workers
• Smoking cessation
FIGURE 27 Referral options available at the end of ESD at study location 8A. HSCP, health and social care professional; OT, occupational therapist; PT, physiotherapist.
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ESD
> 6 weeks
Voluntary sector: Other community
services:
Single disciplines:
GP
HSCP
Community dietitian
Ophthalmologist
Spasticity clinic
Driving assessment
Community
rehabilitation and
reablement service
PT, OT, technical
instructors; link
to carers 
• Stroke Association and
   Red Cross peer support
   and communication
   groups
• Carers’ support
• Vocational rehabilitation 
   service
• Community speech
   and language
   therapy
• Aphasia specialists
• Psychiatry of old age
• Continence service
• Peer support
   workers
• Smoking cessation
FIGURE 28 Referral options available at the end of ESD at study location 8B. HSCP, health and social care professional; OT, occupational therapist; PT, physiotherapist.
A
PPEN
D
IX
2
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
180
Integrated ESD and
CST (PT, OT, SLT,
rehabilitation
assistant, nurse)
Open ended
Voluntary sector:
HSCP
Other community services: Single disciplines:
Memory clinic
Spasticity clinic
• Communication support group
• Driving assessment centre
• Carers’ Centre
• Age UK
• Exercise referral/health trainers
• Smoking cessation
• Community dietitian
• Orthoptics
• Continence service
• IAPT
• District nurse
   6-month review 
FIGURE 29 Referral options available at the end of ESD at study location 9A. CST, community stroke team;
HSCP, health and social care professional; OT, occupational therapist; PT, physiotherapist.
Sensory impairment
team
Memory clinic
Orthoptics
GP
HSCP
ESD
< 6 weeks 
Single disciplines:
• Community SLT
• Bladder and bowel
   service
• Community dietitian
• IAPT
Voluntary sector:
• Stroke Association life
   after stroke support
• Driving assessment
Community
neurorehabilitation team
PT, OT, SLT,
Spasticity clinic
FIGURE 30 Referral options available at the end of ESD at study location 9B. HSCP, health and social care
professional; OT, occupational therapist; PT, physiotherapist.
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Driving assessment
Stroke consultant
Community
dietetics
GP
Stroke Association
communication
groups
commissioned 
HSCP
HSCP
ESD
< 6 weeks
Community therapy
team
PT, OT 
Adult SLT
Neurological
therapy unit
PT, OT
Clinical
neuropsychology
Ophthalmology
Continence service
Well-being service
Voluntary sector:
• Stroke Association
   life after stroke
   support
• Carers’ support
• Connect
   communication
   support
FIGURE 31 Referral options available at the end of ESD at study location 10. HSCP, health and social care professional; OT, occupational therapist; PT, physiotherapist.
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Sensory impairment team
Community dietetics
Continence advisors
Pain clinic
IAPT
GP
HSCP
ESD
Open ended
Single disciplines:
Brain injury outreach team
PT, OT, vocational rehabilitation
Voluntary sector:
• Stroke Association life
   after stroke support
• Different Strokes 
• Community SLT
• Clinical neuropsychology
• OT outreach team
• Community neurological PT
• Continence aids (via SPoA)
• District nurses
• Orthoptics
FIGURE 32 Referral options available at the end of ESD at study location 11. HSCP, health and social care professional; IAPT, Improving Access to Psychological Therapies;
OT, occupational therapist; PT, physiotherapist; SPoA, single point of access.
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Other community services: 
Pain team
GP
HSCP
ESD
< 6 weeks
Single disciplines:
Neurological outpatient
service
PT, OT 
Voluntary sector:
Consultant
review 
Integrated care team
PT, OT, nursing, social
worker, mental health
worker
Not for psychology
For psychology
• Stroke Association life
   after stroke support
• Carers’ support
• Adult deaf and visual
   impairment team
• Driving assessment
• Vocational rehabilitation
• Spasticity clinic
• Strokability
• Smoking cessation
• Stroke self-management
   course
• Adult SLT
• Continence service
   (via SPoA)
• Community dietitian
• IAPT
• Clinical psychology
• Orthoptics 
FIGURE 33 Referral options available at the end of ESD at study location 12. HSCP, health and social care professional; IAPT, Improving Access to Psychological Therapies;
OT, occupational therapist; PT, physiotherapist; SPoA, single point of access.
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Community integrated
rehabilitation team
MDT 
Integrated ESD and CST
PT, OT, SLT, rehabilitation
assistants, psychology,
nurse, stroke co-ordinator
Open ended
Single disciplines:
Voluntary sector:
HSCP
GP
Pain clinic
Other community
services:
• Exercise referral
• Smoking cessation
• Adult SLT
• Community dietitian
• Continence service
• Orthotics
• Spasticity
• Orthoptics
• Stroke Association life
   after stroke support/course
• Age UK
• Communication support
• Driving assessment
   centres 
FIGURE 34 Referral options available at the end of ESD at study location 13. CST, community stroke team; HSCP, health and social care professional; OT, occupational
therapist; PT, physiotherapist.
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Intermediate care team
PT, OT, support workers,
home-care assistants
Integrated ESD and CST PT,
OT, SLT, nurse, technical
instrutors
< 6 weeks intensive, then
step down Single disciplines:
Voluntary sector:
GP Pain clinic
Consultant
Ophthalmology
Complex neurorehabilitation
centre
Driving assessment, spasticity
clinic, MDT needs 
Self-refer
Neurological outpatient service
OT, PT, SLT • Vocational rehabilitation
   service
• Stroke Association: life
   after stroke support,
   assistant psychologist
• Sight service 
• Bladder and bowel service
• Psychology
• Stroke dietitian
• Talking therapies
• Family support officer
FIGURE 35 Referral options available at the end of ESD at study location 14. CST, community stroke team;
OT, occupational therapist; PT, physiotherapist.
Integrated ESD and CST
PT, OT, SLT,
rehabilitation assistants,
psychology, nurse
< 6 weeks Single disciplines:
Voluntary sector:
GP
Ophthalmology
Specialist pain team
Community and outpatient 
neurorehabilitation teams
PT, OT, neuropsychology,
rehabilitation assistant,
dietitian
Vocational rehabilitation
service
Community rehabilitation and
reablement services, MDT HSCP
• Stroke Association
• Different Strokes
• Sight service
• Driving assessment centre 
• IAPT
• Adult SLT
• Communication group
• Continence service
• Spasticity service
• Orthotics
FIGURE 36 Referral options available at the end of ESD at study location 15. CST, community stroke team;
HSCP, health and social care professional; IAPT, Improving Access to Psychological Therapies; OT, occupational
therapist; PT, physiotherapist.
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Community dietitian
Continence service
GP
ESD
< 6 weeks
Single disciplines:
Reablement services
OT, rehabilitation
assistants, carers 
Voluntary sector:
Other community
services:
Spasticity and
splinting clinics
Consultant Orthoptics
HSCP
• Stroke Association
• Life after Stroke
   service;
   communication
   support
• Dove bereavement/
   loss support
• Carers’ support
• Community SLT
• IAPT
• Clinical psychology
• Podiatry (orthotics)
• Domiciliary OT
• Domiciliary PT
• Neuro-outpatient PT
• Stroke and cardiac
   rehabilitation exercise
   group
• Health promotion
   service
• Driving assessment
FIGURE 37 Referral options available at the end of ESD at study location 16. HSCP, health and social care professional; IAPT, Improving Access to Psychological Therapies;
OT, occupational therapist; PT, physiotherapist.
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Integrated ESD and CST
PT, OT, SLT, rehabilitation
assistants (access to stroke
nurse, nutrition nurse,
orthoptics)
Single disciplines:
Voluntary sector:
GP
Spasticity
Pain clinic
Community
neurorehabilitation
team
PT, OT, SLT, MDT
needs
Community rehabilitation
team, MDT 
HSCP
Reablement team
OT, carers 
GP/consultant
Consultant
Orthotics
Other community
services:
• Dietitian
• Continence service
• IAPT
• Orthoptist
• Stroke Association
   support officers,
   communication
   support
• Stroke support
   group
• Sensory team
• Supported employment
   service
• Driving assessment
• Health promotion
   services 
FIGURE 38 Referral options available at the end of ESD at study location 17. CST, community stroke team;
HSCP, health and social care professional; IAPT, Improving Access to Psychological Therapies; OT, occupational
therapist; PT, physiotherapist.
Integrated ESD and CST
PT, OT, SLT,
rehabilitation assistants,
dietitian (access to
nursing)
Open ended 
Single disciplines:
Voluntary sector:  
GP
Memory clinic
Pain clinic
Stroke outpatients service
PT, SLT 
HSCP
Consultant
Ophthalmology
Other community services:
• Visual impairment
   support
• Stroke Association
• Driving assessment
• Neurological orthotics
• Continence service
• IAPT
• Spasticity service
• Exercise groups
• Health promotion services
FIGURE 39 Referral options available at the end of ESD at study location 18. CST, community stroke team;
HSCP, health and social care professional; IAPT, Improving Access to Psychological Therapies; OT, occupational
therapist; PT, physiotherapist.
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TABLE 68 Comparison of study ESD services with available national data about ESD services
Characteristic Study ESD services (n= 20, 2016)
National data ESD services
(n= 142, 2015/16)
Nursing 2 ESD services (10%) did not have a nurse 39% of ESD services did not have a nurse116
Physiotherapy 20 ESD services (100%) had a physiotherapist(s) 100% of ESD services had a physiotherapist117
Occupational therapy 20 ESD services (100%) had an occupational
therapist(s)
100% of ESD services had an occupational
therapist117
Speech and language
therapy
2 ESD services (10%) did not have a SLT 3% of ESD services did not have a SLT117
Psychology 11 ESD services (55%) did not have a
psychologist (or access to one)a
58% of ESD services did not have a
psychologist116
Referral to treatment time 1–2 days 1–2 days116
7-day working 15 (75%) ESD teams operated 7 days a week 29% of ESD teams operated 7 days a week118
a One additional service did not have a psychologist at the time of data collection, but expected to have a stroke-specific
psychologist in place later in the study delivery period.
TABLE 69 Number of cases where utility estimates were imputed
Group
Utility (n)
Baseline 12 months 24 months
Usual care 2 3 1
Intervention 1 3 0
Total 3 6 1
TABLE 70 Breakdown of cost items between randomisation groups
Cost (£)
Intervention (n= 235),
mean (95% CI)
Control (n= 259),
mean (95% CI)
Adjusted difference,a
EXTRAS minus usual
care, mean (95% CI)
NHS costs
Outpatient costs 795 (675 to 915) 848 (677 to 1020) 80 (–99 to 259)
Inpatient costs 1898 (1469 to 2327) 1922 (1507 to 2338) –122 (–932 to 687)
Day patient costs 500 (225 to 776) 1529 (–938 to 3995) 117 (–40 to 274)
Primary health costs 1469 (1210 to 1727) 1493 (1247 to 1739) 50 (–252 to 352)
Social care costs
Home help (home service,
personal care, shopping)
54 (12 to 95) 397 (41 to 754) –216 (–419 to –13)b
Benefit/allowance 4900 (4103 to 5607) 5782 (4972 to 6592) –727 (–1478 to 24)
a Age, sex, baseline utility/costs, standard errors clustered by site.
b Not adjusted for age.
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TABLE 71 Unit costs of some of the resource items utilised
Resource utilisation unit Cost (£) Reference Notes
GP surgery visit 42.68 PSSRU 2016/1782
GP home visit 142.28 PSSRU 2016/1782
GP telephone call 26.08 PSSRU 2016/1782
GP nurse surgery visit 14.23 PSSRU 2016/1782
Physiotherapist hospital 47.43 PSSRU 2016/1782
Physiotherapist surgery 20.16 PSSRU 2016/1782
Physiotherapist home 55.73 PSSRU 2016/1782
Physiotherapist elsewhere 20.16 PSSRU 2016/1782 Assuming the cost of surgery visit
Occupational therapist hospital 50.98 PSSRU 2016/1782
Occupational therapist surgery 20.16 PSSRU 2016/1782
Occupational therapist home 54.54 PSSRU 2016/1782
Occupational therapist elsewhere 20.16 PSSRU 2016/1782
Speech therapist hospital 49.80 PSSRU 2016/1782
Speech therapist surgery 20.16 PSSRU 2016/1782
Speech therapist home 55.73 PSSRU 2016/1782
Speech therapist elsewhere 20.16 PSSRU 2016/1782
Community nurse 28.85 PSSRU 2016/1782
Health visitor 49.80 PSSRU 2016/1782
Geriatrician 42.68 PSSRU 2016/1782
Psychiatrist 388.90 PSSRU 2016/1782
Psychologist 54.54 PSSRU 2016/1782
Chiropodist 13.04 PSSRU 2016/1782
Optician 21.31 PSSRU 2016/1782
Meals on wheels 4.23 PSSRU 2016/1782 Assuming £25.00 per week
Help (personal care) 26.00 PSSRU 2016/1782 Assuming cost of 1 hour per day during the weekdays
Help (household) 26.00 PSSRU 2016/1782 Assuming cost of 1 hour per day during the weekdays
Help (shopping) 31.00 PSSRU 2016/1782 Assuming cost of 1 hour per day during the weekdays
Attendance allowance (lower) 55.65 Department for
Work and Pensions119
Per week
Attendance allowance (higher) 83.10 Department for
Work and Pensions119
Per week
Disability allowance (mobility) 58.00 Department for
Work and Pensions119
Per week: personal independence payment
Disability allowance (care) 83.10 Department for
Work and Pensions119
Employment and support
allowance
73.10 Department for
Work and Pensions119
Per week
Statutory sick pay 89.35 Department for
Work and Pensions119
Per week; paid maximum 28 weeks
Personal independence
payment
58.00 +
73.10
Department for
Work and Pensions119
Per week, sum of disability allowance
(mobility) and disability allowance (care)
Nursing allowance 155.05 PSSRU 2016/1782 Per week
Nursing nights 122.80 PSSRU 2016/1782 Per night, derived from weekly cost of £725
Resident nights 87.74 PSSRU 2016/1782 Per night, derived from weekly cost of £518
A&E attendance 115.01 PSSRU 2016/1782
A&E, accident and emergency.
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TABLE 72 The EQ-5D-5L by domain and trial group at baseline: patients who contributed to the CEA
Levela
Mobility, n (%) Self-care, n (%) Usual activities, n (%) Pain/discomfort, n (%) Anxiety/depression, n (%)
Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care
1 50 (21.37) 48 (18.68) 119 (50.85) 113 (43.97) 34 (14.53) 32 (12.45) 95 (40.60) 101 (39.30) 100 (42.74) 116 (45.14)
2 78 (33.33) 76 (29.57) 64 (27.35) 75 (29.18) 76 (32.48) 75 (29.18) 73 (31.20) 67 (26.07) 87 (37.18) 90 (35.02)
3 86 (36.75) 99 (38.52) 37 (15.81) 53 (20.62) 64 (27.35) 80 (31.13) 46 (19.66) 70 (27.24) 37 (15.81) 39 (15.18)
4 12 (5.13) 29 (11.28) 9 (3.85) 8 (3.11) 25 (10.68) 30 (11.67) 17 (7.26) 17 (6.61) 5 (2.14) 11 (4.28)
5 8 (3.42) 5 (1.95) 5 (2.14) 8 (3.11) 35 (14.96) 40 (15.56) 3 (1.28) 2 (0.78) 5 (2.14) 1 (0.39)
Total (n) 234 257 234 257 234 257 234 257 234 257
Patients reporting
some problems (%)
78.63 81.32 49.15 56.03 85.47 87.55 59.40 60.70 57.26 54.86
a 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, unable/extreme.
TABLE 73 The EQ-5D-5L by domain and trial group at 12 months: patients who contributed to the CEA
Levela
Mobility, n (%) Self-care, n (%) Usual activities, n (%) Pain/discomfort, n (%) Anxiety/depression, n (%)
Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care
1 53 (23.77) 53 (22.18) 111 (49.78) 102 (42.86) 52 (23.32) 47 (19.67) 76 (34.23) 59 (24.69) 101 (45.29) 89 (37.24)
2 79 (35.43) 65 (27.20) 58 (26.01) 57 (23.95) 78 (34.98) 58 (24.27) 65 (29.28) 79 (33.05) 75 (33.63) 87 (36.40)
3 57 (25.56) 74 (30.96) 36 (16.14) 50 (21.01) 49 (21.97) 65 (27.20) 56 (25.23) 72 (30.13) 36 (16.14) 45 (18.83)
4 27 (12.11) 44 (18.41) 10 (4.48) 18 (7.56) 23 (10.31) 33 (13.81) 24 (10.81) 23 (9.62) 9 (4.04) 14 (5.86)
5 7 (3.14) 3 (1.26) 8 (3.59) 11 (4.62) 21 (9.42) 36 (15.06) 1 (0.45) 6 (2.51) 2 (0.90) 4 (1.67)
Total (n) 223 239 223 238 223 239 222 239 223 239
Patients reporting
some problems (%)
76.23 77.82 50.22 57.14 76.68 80.33 65.77 75.31 54.71 62.76
a 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, unable/extreme.
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TABLE 74 The EQ-5D-5L by domain and trial group at 24 months: patients who contributed to the CEA
Levela
Mobility, n (%) Self-care, n (%) Usual activities, n (%) Pain/discomfort, n (%) Anxiety/depression, n (%)
Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care
1 56 (26.42) 43 (18.45) 102 (48.11) 100 (44.05) 52 (24.53) 44 (19.38) 73 (34.43) 54 (23.89) 98 (46.23) 90 (39.82)
2 48 (22.64) 53 (22.75) 43 (20.28) 43 (18.94) 62 (29.25) 54 (23.79) 56 (26.42) 75 (33.19) 63 (29.72) 77 (34.07)
3 64 (30.19) 70 (30.04) 44 (20.75) 44 (19.38) 54 (25.47) 66 (29.07) 57 (26.89) 64 (28.32) 39 (18.40) 51 (22.57)
4 35 (16.51) 57 (24.46) 11 (5.19) 27 (11.89) 21 (9.91) 26 (11.45) 21 (9.91) 26 (11.50) 8 (3.77) 4 (1.77)
5 9 (4.25) 10 (4.29) 12 (5.66) 13 (5.73) 23 (10.85) 37 (16.30) 5 (2.36) 7 (3.10) 4 (1.89) 4 (1.77)
Total (n) 212 233 212 227 212 227 212 226 212 226
Patients reporting
some problems (%)
73.58 81.55 51.89 55.95 75.47 80.62 65.57 76.11 53.77 60.18
a 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, unable/extreme.
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FIGURE 41 Cost-effectiveness acceptability curve: no imputed data.
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TABLE 75 The EQ-5D-5L by domain and trial group at baseline: carers
Levela
Mobility, n (%) Self-care, n (%) Usual activities, n (%) Pain/discomfort, n (%) Anxiety/depression, n (%)
Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care
1 70 (70.71) 62 (74.70) 89 (89.90) 82 (98.80) 50 (49.50) 51 (63.75) 42 (41.58) 37 (45.68) 38 (37.62) 35 (42.68)
2 15 (15.15) 11 (13.25) 7 (7.07) 1 (1.20) 29 (28.71) 13 (16.25) 34 (33.66) 23 (28.40) 47 (46.53) 36 (43.90)
3 8 (8.08) 8 (9.64) 3 (3.03) 0 (0) 16 (15.84) 13 (16.25) 20 (19.80) 15 (18.52) 12 (11.88) 10 (12.20)
4 6 (6.06) 2 (2.41) 0 (0) 0 (0) 3 (2.97) 2 (2.5) 5 (4.95) 4 (4.94) 3 (2.97) 1 (1.22)
5 0 (0) 0 (0) 0 (0) 0 (0) 2 (1.98) 1 (1.25) 0 (0) 2 (2.47) 1 (0.99) 0 (0)
Total (n) 99 83 99 83 100 80 101 81 101 82
Carers reporting
some problems (%)
29.29 25.30 10.10 1.20 50.00 36.25 58.42 54.32 62.38 57.32
a 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, unable/extreme.
TABLE 76 The EQ-5D-5L by domain and trial group at 12 months: carers
Levela
Mobility, n (%) Self-care, n (%) Usual activities, n (%) Pain/discomfort, n (%) Anxiety/depression, n (%)
Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care
1 55 (59.78) 54 (73.97) 81 (88.04) 70 (95.89) 42 (45.65) 38 (52.05) 35 (38.04) 29 (39.73) 38 (41.30) 35 (47.95)
2 19 (20.65) 11 (15.07) 8 (8.70) 2 (2.74) 25 (27.17) 16 (21.92) 31 (33.70) 25 (34.25) 32 (34.78) 25 (34.25)
3 14 (15.22) 7 (9.59) 3 (3.26) 1 (1.37) 19 (20.65) 11 (15.07) 18 (19.57) 15 (20.55) 19 (20.65) 11 (15.07)
4 4 (4.35) 1 (1.37) 0 (0) 0 (0) 5 (5.43) 7 (9.59) 7 (97.61) 4 (5.48) 2 (2.17) 2 (2.74)
5 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.09) 1 (1.37) 1 (1.09) 0 (0) 1 (1.09) 0 (0)
Total (n) 92 73 92 73 92 73 92 73 92 73
Carers reporting
some problems (%)
40.22 26.03 11.96 4.11 54.35 47.95 61.96 60.27 58.70 52.05
a 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, unable/extreme.
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TABLE 77 The EQ-5D-5L by domain and trial group at 24 months: carers
Levela
Mobility, n (%) Self-care, n (%) Usual activities, n (%) Pain/discomfort, n (%) Anxiety/depression, n (%)
Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care
1 54 (65.85) 48 (68.57) 73 (89.02) 67 (95.71) 47 (57.32) 38 (54.29) 35 (42.68) 27 (39.13) 42 (51.22) 33 (48.53)
2 14 (17.07) 10 (14.29) 5 (6.10) 1 (1.43) 15 (18.29) 13 (18.57) 27 (32.93) 21 (30.43) 25 (30.49) 23 (33.82)
3 11 (13.41) 9 (12.86) 4 (4.88) 2 (2.86) 15 (18.29) 13 (18.57) 15 (18.29) 16 (23.19) 12 (14.63) 10 (14.71)
4 3 (3.66) 3 (4.29) 0 (0) 0 (0) 4 (4.88) 3 (4.29) 4 (4.88) 5 (7.25) 2 (2.44) 2 (2.94)
5 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.22) 3 (4.29) 1 (1.22) 0 (0) 1 (1.22) 0 (0)
Total (n) 82 70 82 70 82 70 82 69 82 68
Carers reporting
some problems (%)
34.15 31.43 10.98 4.29 42.68 45.71 57.32 60.87 48.78 51.47
a 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, unable/extreme.
TABLE 78 The EQ-5D-5L by domain and trial group at baseline: all patients who provided EQ-5D-5L data
Levela
Mobility, n (%) Self-care, n (%) Usual activities, n (%) Pain/discomfort, n (%) Anxiety/depression, n (%)
Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care
1 60 (21.2) 54 (18.9) 135 (47.7) 126 (44.1) 39 (13.8) 40 (14) 113 (39.9) 114 (39.9) 123 (43.5) 127 (44.4)
2 91 (32.2) 82 (28.7) 76 (26.9) 82 (28.7) 89 (31.4) 80 (28) 88 (31.1) 74 (25.9) 96 (33.9) 99 (34.6)
3 102 (36) 107 (37.4) 54 (19.1) 60 (21) 82 (29) 88 (30.8) 59 (20.8) 74 (25.9) 49 (17.3) 45 (15.7)
4 20 (7.1) 37 (12.9) 12 (4.2) 10 (3.5) 32 (11.3) 37 (12.9) 20 (7.1) 22 (7.7) 6 (2.1) 14 (4.9)
5 10 (3.5) 6 (2.1) 6 (2.1) 8 (2.8) 41 (14.5) 41 (14.3) 3 (1.1) 2 (0.7) 9 (3.2) 1 (0.3)
Total (n) 283 286 283 286 283 286 283 286 283 286
Patients reporting
some problems (%)
78.8 81.1 52.3 55.9 86.2 86 60.1 60.1 56.5 55.6
a 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, unable/extreme.
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TABLE 79 The EQ-5D-5L by domain and trial group at 12 months: all patients who provided EQ-5D-5L data
Levela
Mobility, n (%) Self-care, n (%) Usual activities, n (%) Pain/discomfort, n (%) Anxiety/depression, n (%)
Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care
1 55 (23) 55 (22.3) 116 (48.5) 106 (43.1) 53 (22.2) 50 (20.2) 78 (32.8) 62 (25.1) 107 (44.8) 93 (37.7)
2 82 (34.3) 66 (26.7) 63 (26.4) 61 (24.8) 82 (34.3) 59 (23.9) 72 (30.3) 81 (32.8) 78 (32.6) 90 (36.4)
3 63 (26.4) 79 (32) 38 (15.9) 50 (20.3) 54 (22.6) 69 (27.9) 60 (25.2) 75 (30.4) 40 (16.7) 46 (18.6)
4 32 (13.4) 44 (17.8) 13 (5.4) 18 (7.3) 28 (11.7) 33 (13.4) 27 (11.3) 23 (9.3) 10 (4.2) 14 (5.7)
5 7 (2.9) 3 (1.2) 9 (3.8) 11 (4.5) 22 (9.2) 36 (14.6) 1 (0.4) 6 (2.4) 4 (1.7) 4 (1.6)
Total (n) 239 247 239 246 239 247 238 247 239 247
Patients reporting
some problems (%)
77 77.7 51.5 56.9 77.8 79.8 67.2 74.9 55.2 62.3
a 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, unable/extreme.
TABLE 80 The EQ-5D-5L by domain and trial group at 24 months: all patients who provided EQ-5D-5L data
Levela
Mobility, n (%) Self-care, n (%) Usual activities, n (%) Pain/discomfort, n (%) Anxiety/depression, n (%)
Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care Intervention Usual care
1 56 (25.6) 43 (18.6) 103 (47) 102 (44.2) 52 (23.7) 45 (19.5) 74 (33.8) 54 (23.5) 101 (46.1) 93 (40.3)
2 48 (21.9) 54 (23.4) 44 (20.1) 44 (19.0) 62 (28.3) 54 (23.4) 57 (26) 76 (33) 65 (29.7) 77 (33.3)
3 67 (30.6) 72 (31.2) 46 (21) 45 (19.5) 54 (24.7) 68 (29.4) 62 (28.3) 66 (28.7) 40 (18.3) 51 (22.1)
4 38 (17.4) 52 (22.5) 13 (5.9) 27 (11.7) 25 (11.4) 27 (11.7) 21 (9.6) 27 (11.7) 9 (4.1) 5 (2.2)
5 10 (4.6) 10 (4.3) 13 (5.9) 13 (5.6) 26 (11.9) 37 (16.0) 5 (2.3) 7 (3) 4 (1.8) 5 (2.2)
Total (n) 219 231 219 231 219 231 219 230 219 231
Patients reporting
some problems (%)
74.4 81.4 53 55.8 76.3 80.5 66.2 76.5 53.9 59.7
a 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; 5, unable/extreme.
A
PPEN
D
IX
2
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
198
TABLE 81 Resource utilisation in the control group: all patients who provided CSRI data
Resource
Sample at
12 months, n
Participants
with at least one
contact between
randomisation and
12 months, n (%)
Mean number of
contacts between
randomisation and
12 months, median (IQR)
Sample at
24 months, n
Participants
with at least one
contact between
12 months and
24 months, n (%)
Mean number of
contacts between
12 months and
24 months,
median (IQR)
GP 245 232 (94.69) 7.66, 5 (7) 229 214 (93.45) 6.33, 4 (6)
Physiotherapist 242 115 (47.52) 8.10, 0 (6) 227 52 (22.91) 2.62, 0 (0)
Occupational therapist 242 79 (32.64) 2.36, 0 (2) 228 24 (10.53) 0.62, 0 (0)
Speech and language therapist 244 46 (18.85) 1.92, 0 (0) 226 11 (4.87) 0.23, 0 (0)
Community or district nurse 242 68 (28.10) 2.42, 0 (1) 229 42 (18.34) 1.79, 0 (0)
Health visitor 234 6 (2.56) 0.047, 0 (0) 221 3 (1.36) 0.05, 0 (0)
Geriatrician 235 2 (0.85) 0.021, 0 (0) 220 3 (1.36) 0.041, 0 (0)
Psychiatrist 235 6 (2.55) 0.089, 0 (0) 219 4 (1.83) 0.023, 0 (0)
Psychologist 235 17 (7.23) 0.40, 0 (0) 222 8 (3.60) 0.1, 0 (0)
Chiropodist 235 85 (36.17) 1.51, 0 (2) 224 82 (36.61) 1.71, 0 (3)
Optician 236 131 (55.51) 0.74, 1 (1) 223 127 (56.95) 0.67, 1 (1)
Other NHS and social care services 244 45 (18.44) NAa 228 39 (17.11) NAa
Residential care 246 7 (2.85) 1.3, 0 (0) 229 9 (3.93) 3.08, 0 (0)
Nursing home 245 2 (0.82) 0.18, 0 (0) 229 1 (0.44) 0.04, 0 (0)
A&E 246 81(32.93) 0.54, 0 (1) 230 66 (28.70) 0.49, 0 (0)
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TABLE 81 Resource utilisation in the control group: all patients who provided CSRI data (continued )
Resource
Sample at
12 months, n
Participants
with at least one
contact between
randomisation and
12 months, n (%)
Mean number of
contacts between
randomisation and
12 months, median (IQR)
Sample at
24 months, n
Participants
with at least one
contact between
12 months and
24 months, n (%)
Mean number of
contacts between
12 months and
24 months,
median (IQR)
Outpatients 248 175 (70.56) 3.19, 2 (4) 231 126 (54.55) 2.27, 1 (3)
Meals on wheels 245 2 (0.82) 0.20, 0 (0) 225 1 (0.44) 0.44, 0 (0)
Home help (personal care) 243 6 (2.47) 1.19, 0 (0) 225 4 (1.78) 9.65, 0 (0)
Home help (household) 244 4 (1.64) 0.75, 0 (0) 224 5 (2.23) 2.33, 0 (0)
Home help (shopping) 244 2 (0.82) 0.29, 0 (0) 222 2 (0.90) 0.49, 0 (0)
Receiving health benefits 245 132 (53.88) NAa 228 132 (57.89) NAa
Inpatient 247 62 (25.10) NAa 230 49 (21.30) NAa
Day patient 246 40 (16.26) NAa 229 32 (13.97) NAa
A&E, accident and emergency; NA, not applicable.
a NA, those with a number of different items of utilisation and a combined frequency was not possible.
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TABLE 82 Resource utilisation in the intervention group: all patients who provided CSRI data
Resource
Sample at
12 months, n
Participants
with at least one
contact between
randomisation and
12 months, n (%)
Mean number of
contacts between
randomisation and
12 months, median (IQR)
Sample at
24 months, n
Participants
with at least one
contact between
12 months and
24 months, n (%)
Mean number of
contacts between
12 months and
24 months,
median (IQR)
GP 237 227 (95.78) 7.46, 5 (7) 217 205 (94.47) 6.6, 5 (7)
Physiotherapist 236 111 (47.03) 7, 0 (7) 215 56 (26.05) 2.32, 0 (10)
Occupational therapist 236 72 (30.51) 3.4, 0 (2) 214 30 (14.02) 0.58, 0 (0)
Speech and language therapist 235 38 (16.17) 0.87, 0 (0) 214 11 (5.14) 0.43, 0 (0)
Community or district nurse 231 54 (23.38) 5.4, 0 (0) 215 38 (17.67) 3.38, 0 (0)
Health visitor 226 4 (1.77) 0.03, 0 (0) 209 3 (1.44) 0.02, 0 (0)
Geriatrician 225 1 (0.44) 0.02, 0 (0) 210 2 (0.95) 0.03, 0 (0)
Psychiatrist 225 6 (2.67) 0.08, 0 (0) 210 4 (1.90) 0.03, 0 (0)
Psychologist 226 16 (7.08) 0.32, 0 (0) 210 7 (3.33) 0.05, 0 (0)
Chiropodist 179 62 (34.64) 1.03, 0 (1) 212 70 (33.02) 1.55, 0 (2.55)
Optician 230 127 (55.22) 0.99, 1 (1) 213 113 (53.05) 0.76, 1 (1)
Other NHS and social care services 235 42 (17.87) NAa 215 37 (17.21) NAa
Residential care 235 8 (3.40) 3.56, 0 (0) 217 6 (2.76) 5.53, 0 (0)
Nursing home 235 4 (1.70) 2.5, 0 (0) 217 4 (1.84) 1.32, 0 (0)
A&E 237 78 (32.91) 0.5, 0 (1) 217 59 (27.19) 0.42, 0 (1)
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TABLE 82 Resource utilisation in the intervention group: all patients who provided CSRI data (continued )
Resource
Sample at
12 months, n
Participants
with at least one
contact between
randomisation and
12 months, n (%)
Mean number of
contacts between
randomisation and
12 months, median (IQR)
Sample at
24 months, n
Participants
with at least one
contact between
12 months and
24 months, n (%)
Mean number of
contacts between
12 months and
24 months,
median (IQR)
Outpatients 239 172 (71.97) 3.1, 2 (4) 219 138 (63.01) 2.5, 1 (3)
Meals on wheels 236 2 (0.85) 1.56, 0 (0) 211 1 (0.47) 0.005, 0 (0)
Home help (personal care) 236 5 (2.12) 0.63, 0 (0) 210 3 (1.43) 1.15, 0 (0)
Home help (household) 236 0 (0) 0, 0 (0) 209 0 (0) 0, 0 (0)
Home help (shopping) 236 0 (0) 0, 0 (0) 208 0 (0) 0, 0 (0)
Receiving health benefits 238 118 (49.58) NAa 228 132 (57.89) NAa
Inpatient 239 61 (25.52) NAa 218 46 (21.10) NAa
Day patient 239 48 (20.08) NAa 217 46 (21.20) NAa
A&E, accident and emergency; NA, not applicable.
a NA, those with a number of different items of utilisation and a combined frequency was not possible.
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